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I Adrenergic Agonists 
Catecholamines 
dobutamine 
L1 dopamine {lntropin) 
L1 epinephrine {Parenteral: Adrenalin) {Inhalation: Primatene Mist) 
L1 isoproterenol (Oral: lsuprel) (Inhalation: Vaso-lso) 
L1 norepinephrine (Levophed, Noradrenaline) 
Noncatecholamines 
M albuterol (Proventil, Ventolin) #21 & #24 drugs in 1991 
L1 ephedrine (Efedron) 
isoetharine 
mephentermine 
L1 metaproterenol {Aiupent) 
metaraminol 
methoxamine 
nylidrin 
L1 phenylephrine (Nee-Synephrine) 
ritodrine 
L1 terbutaline (Brethine) 
II M II indicates a top 200 drug in 1991 --note ranking after trade name 
II L1 II indicates major drugs -- see table 
Indications for Use: 
- Catecholamines-- the therapeutic uses of catecholamines are related 
to both their systemic effects and to their local effects 
a) local vasoconstrictive actions of the drugs make them useful as: 
- nasal decongestants to treat inflammatory and allergic 
conditions 
- ophthalmic decongestants to treat conjunctivitis and ocular 
congestion 
- intraocular hypotensive agents to treat open-angle 
glaucoma 
- topical hemostatics to control superficial bleeding 
- antiallergens to treat hypersensitivity and anaphylaxis 
- local application of various drugs dilate pupils without 
concurrent cycloplegia or increased lOP to provide 
beneficial effects in ophthalmic examinations 
b) beta1-active drugs are used: 
- to treat bradycardia and heart block and insufficient cardiac 
output 
- to terminate paroxysmal atrial or nodal tachycardia 
• in cases of ventricular fibrillation, asystole, or cardiac arrest 
1 
c) beta2-active catecholamines are used to: 
- treat acute and chronic bronchial asthma, emphysema, 
bronchitis, and acute hypersensitivity reactions to 
drugs 
- Noncatecholamines -- have a wide variety of therapeutic uses related to 
the many physiologic effects of the drugs including: 
- local or systemic vasoconstriction 
- nasal and ophthalmic decongestion 
- bronchodilation 
- smooth muscle relaxation 
CATECHOLAMINES 
Mechanism of Action: 
- mechanisms of action for all classes of drugs are listed in the tables for 
each of the specific major drugs 
Adverse Reactions: 
- adverse reactions for all classes of drugs are listed in the tables for each 
of the specific major drugs 
Ocular Adverse Reactions: 
- ocular adverse reactions for all classes of drugs are listed in the tables 
for each of the specific major drugs 
Contraindications and Precautions: 
- note signs of overdose such as headache, vomiting, hypotension, 
hypertension, blurred vision, cardiac dysrhythmias, or chest pains 
use cautiously in the following conditiions: 
- elderly patients due to possible reduced cardiac reserve and likelihood 
of dysrhythmias, confusion, or cerebrovascular accident 
pregnant patients due to possible adverse effects on the fetus 
hypertensive patients since drugs may cause further increase in blood 
pressure, cardiac output, or vasoconstriction 
diabetes mellitus since may have an anti-insulin effect with unpredictable 
effects on diabetes control 
circulatory or cardiovascular disease since may cause vasoconstriction, 
dysrhythmias, tachycardia or bradycardia, hypertension or 
hypotension 
glaucoma since may cause increased intraocular pressure 
Drug Interactions: 
- drug interactions involving catecholamines can be among the most 
serious 
- knowledge of the interactions between catecholamines and other agents 
is essential because of the potential for additive effects which might 
lead to a hypertensive crisis or cardiac dysrhythmias 
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- drugs that must not be used with catecholamines or that should be used 
concurrently only with extreme caution include MAO inhibitors, 
tricyclic antidepressants, oxytocics, furazolidone, ergot alkaloids, 
antihistamines, some general anesthetics, digitalis,or other 
sympathomimetic agents 
- catecholamines can produce similar and significant reactions throughout 
the body including hypotension, hypertension, cardiac 
dysrhythmias, seizures, and hyperglycemia in diabetics 
- beta-blockers such as propranolol reduce the effects of the 
catecholam ines and increase total peripheral resistance by allowing 
·uncompensated alpha stimulation with beta blockade, which may 
result in hypertension and reflex bradycardia 
NONCATECHOLAMINES 
Mechanism of Action: 
- mechanism of action for all classes of drugs are listed in the tables for 
each of the specific major drugs 
Adverse Reactions: 
- adverse reactions for all classes of drugs are listed in the tables for each 
of the specific major drugs 
Ocular Adverse Reactions: 
- ocular adverse reactions for all classes of drugs are listed in the tables 
for each of the specific major drugs 
Contraindications and Precautions: 
- use noncatecholam ines cautiously in diabetic patients because of the 
possiblility of hyperglycemia 
- don't use mephentermine with epinephrine or hydralazine because they 
are incompatible 
Drug Interactions: 
- drugs known to interact with various noncatecholamines encompass 
many of the drugs also contraindicted with catecholamines 
including MAO inhibitors, furazolidone, beta blockers, other 
sympathomimetics, acetazolamide, ascorbic acid, and many others 
- can produce significant reactions throughout the body, including 
hypotension, hypertension, cardiac dysrhythmias, seizures, and 
hyperglycemia in diabetics 
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stimulates dopaminergic, alpha, used to treat cardiogenic or ectopic heart beats, nausea, I high doses may cause dilated 
and beta1 receptors to increase bacteremic shock with related vomiting, tachycardia, anginal pupils 
force of myocardial contractions renal shutdown and chronic pain, headache, hypotension 
and increase cardiac output congestive heart failure 
epinephrine (Adrenalin) I stimulates alpha, beta1, beta2 used to treat bronchospasm, transient anxiety, headache, - mydriasis-may precipitate 
receptors to to increase cardiac asthma, open-angle fear and heart palpitations narrow-angle glaucoma 
output and to relieve respiratory glaucoma, allergic conditions, - red-green color vision defect 
distress due to brochospasm hypotension, cardiac arrest - hemianopsia 
isoproterenol (lsuprel) I stimulates beta1 and beta2 used to treat asthma, nervousness, headache, 
receptors of the heart and smooth bronchospasm, shock cardiac dizziness, tachycardia, 
muscle of bronchi to produce arrest, cardiac dysrhythmias palpitations, angina, flushing 
cardiac stimulation and of the skin, sweating 
bronchodilation I 
norepineprine (Levophed) I stimulates alpha and beta1 used to treat acute -bradycardia as a reflex result I none listed 
receptors to produce peripheral hypotension, shock, cardiac of a rise in blood pressure . 
vasoconstriction and to increase arrest. myocardial infarctions. - headache may indicate 
cardiac output due to increased anaphylactic shock overdosage 
myocardial contractions 
DRUGS Mechanism of Action · Indication for Use Adverse Reactions Ocular Adverse Reactions 
Generic Name (Brand} 
albuterol (Proventil, Stimulates beta2 adrenergic used to relieve acute bronchial nervousness, heart decreased vision, edema of 
Vento lin) receptors of the lung's smooth asthma and to reduce palpitations, hand tremor, eyelids and conjunctiva, 
#21 & #24 drugs in 1991 muscle causing relaxation frequency and severity of headache, leg cramps, blepharoconjunctivitis, 
chronic, recurrrent asthmatic dizziness decreased lacrimation, and 
attacks decreased intraocular 
pressure 
ephedrine (Efedron) dual acting drug that stimulates used to treat nasal congestion, heart palpitation, tachycardia, w/systemic use: mydriasis, 
alpha, beta, and CNS receptors to hypotension, and narcolepsy headache, insomnia, decreased intraocular 
cause brochodilation and sweating, nervousness, pressure 
vasoconstriction nausea, vomiting, w/local ocular use: 
conjunctival vasoconstriction, 
decreased vision 
metaproterenol (Aiupent) direct acting beta2-selective agent used to treat asthma, tachycardia, hypertension, no ocular effects reported 
-- stimulation of beta2 adrenergic bronchitis, and emphysema heart palpitations, after systemic administration 
receptors of lung smooth muscle nervousness, tremor, nausea, 
causes relaxation resulting in and vomiting 
brochodi latory effects 
phenylephrine (Neo- potent direct -acting agent with used for its systemic and headache, reflex bradycardia, w/systemic use: visual 
Synephrine) strong alpha-receptor and weak topical vasopressor effects excitability, restlessness, hallucinations 
beta-receptor actions to produce with anesthesia and for drowsiness, lassitude, nausea, w/local ocular use : mydriasis, 
vasoconstriction treating shock, tachycardia, and rarely arrhythmias decreased vision, conjunctival 
rhinitis, allergies, uveitis, and vasoconstrictioin, lacrimal 
to produce mydriasis. irritation, punctate keratitis 
terbutaline (Brethine) direct-acting agen! which exerts -- used to treat bronchial nervousness, tremor, no ocular effects have been 
selective beta2 activity to produce asthma, bronchitis, and headache, increased heart reported 
bronchodilation effects emphysema rate, palpitations, drowsiness, 
-- may also be used to delay nausea, vomiting, sweating, 
delivery in preterm labor and muscle crampls 
~------
------
I Adrenergic Antagonists I 
Alpha-Adrenergic Blockers 
ergoloid · 
~ ergotamine (Ergostat, Cafergot suppositories) 
phenoxybenzam ine 
~ phentolamine (Regitine) 
Beta-Adrenergic Blockers 
acebutolol 
~ atenolol (Tenormin) 
labetalol 
M metoprolol (Lopressor) #23 drug in 1991 
M nadolol (Corgard) #90 drug in 1991 
pindolol 
M propranolol (lnderal) #41 drug in 1991 
M timolol (Timoptic) #60 drug in 1991 
Autonomic Ganglionic Blockers 
mecamylamine 
trimethaphan (Artonad) 
" M " indicates a top 200 drug in 1991 -- note ranking after trade name 
" ~ " indicates major drugs -- see table 
Indications for Use: 
Alpha-Adrenergic Blockers 
- use is based on their smooth muscle relaxation and vasodilation 
and the resultant increased local blood flow to skin and other 
organs and decreased blood pressure from dedreased 
peripheral vascular resistance 
hypertension and peripheral vascular disorders are conditions in 
which these effects prove beneficial 
peripheral vascular disorder with a vasospastic component 
causing poor local blood flow such as Raynaud's disease, 
acrocyanosis, and aftereffects of frostbite respond well to 
alpha-adrenergic therapy 
migraine headaches are treated with ergotamine because it 
causes vasoconstriction of the dilated carotid artery 
- Beta-Adrenergic Blockers 
- used extensively to treat hypertension, cardiac dysrhythmias, 
angina pectoris, hyperthyroidism, and other related disorders 
of sympathetic nervous system overstimulation 
- other uses include treatment of migraine headaches, anxiety, 
wide-angle glaucoma, and cardiovascular symptoms 
associated with thyrotoxicosis 
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- Autonomic Ganglionic Blockers 
- used in the management of moderate to severe hypertension and 
are use to produce controlled hypotension for the reduction 
of surgical hemorrhage 
ALPHA-ADRENERGIC BLOCKERS 
Mechanism of Action: 
- mechanisms of action for the specific drugs are listed in the tables 
Adverse Reactions: 
- adverse reactions for the specific drugs are listed in the table 
Ocular Adverse Reactions: 
- ocular adverse reactions for the specific drugs are listed in the table 
Contraindications and Precautions: 
- do not use in patients with congestive heart failure, angina, Ml, or 
cerebrovascular insufficiency 
- use cautiously in pregnant patients, patients with renal insufficiency, or 
marked cerebral or coronary arteriosclerosis, or respiratory infection 
- alcohol consumption should be avoided because alcohol used in 
combination with alpha-adrenergic blocking agents may cause 
tachycardia and hypotension 
Drug Interactions: . 
- many agents interact synergistically with alpha-adrenergic blocking 
agents and can potentiate or cause mutually additive effects 
- the interactions primarily affect the cardiovascular system and 
may include profound hypotension or vascular collapse, 
hypertension, and cardiac dysrhythmias 
- interactions with: 
- alcohol may cause hypotension 
- caffeine increases ergotamine effects 
- dopamine increases pressor effects 
- nitroglycerin may cause potential hypotension by excessive 
vasodilation 
- sympathomimetics enhance cardiac stimulation and may cause 
hypotension rebound hypertension 
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BETA-ADRENERGIC BLOCKERS 
Mechanism of Action: 
- mechanisms of action for the specific drugs are listed in the table 
Adverse Reactions: 
- adverse reactions for the specific drugs are listed in the table 
Ocular Adverse Reactions: 
- ocular adverse reactions for the specific drugs are listed in the table 
Contraindications and Precautions: 
- contraindictions include a history of congestive heart failure, 
bradycardia, heart block, liver or kidney disease, thyroid disease, 
myasthenia gravis, current pregnancy, use of psychotropic drugs, or 
use of MAO inhibitors 
use of beta-adrenergic blockers can potentiate hypoglycemia in diabetes 
and mask its signs and symptoms 
use beta-blockers with extreme caution in cases of respiratory conditions 
such as asthma, hayfever, bronchitis, emphysema, or allergic 
rhinitis since severe bronchospasm may occur 
Drug Interactions: 
- many agents interact synergistically with beta-adrenergic blockers to 
primarily affect the cardiovascular and respiratory systems 
- some of the most serious potential effects include cardiac 
depression, dysrhythmias, respiratory depression, severe 
bronchospasm, and severe hypotension that could lead to 
vascular collapse 
AUTONOMIC GANGLIONIC BLOCKERS 
Mechanism of Action: 
- by inhibiting the action of acetylcholine, ganglionic blocking agents 
reduce or prevent the transmission of impulses in the autonomic 
nervous system 
mecamylamine and trimethaphan belong to the nondepolarizing 
category of of autonomic ganglionic blockers which function as 
competitive antagonists of acetylcholine at postganglionic 
receptor sites and exert no initial stimulatory action 
- they cause primarily sympatholytic effects; vasodilation 
and decreased blood pressure 
Adverse Reactions: 
- possible cardiovascular manifestations include either tachycardia or 
bradycardia and orthostatic hypotension 
- CNS effects may include restlessness, weakness, fatigue, sedation, 
cycloplegia, or mydriasis 
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- Gl and genitourinary signs and symptoms may include nausea, vomiting, 
or anorexia as well as parasympathetic manifestations--dry mouth, 
constipation 
- dose-related severe adverse reactions can include extreme hypotension, 
rapid pulse, angina-like pain, vascular collapse, abdominal 
distention, dizziness, syncope, tremors, mental disturbance, and 
impaired sexual function 
Ocular Adverse Reactions: 
with systemic administration 
- decreased vision 
- mydriasis-- may precipitate narrow-angle glaucoma 
- paralysis of accommodation 
- conjunctival edema 
- decreased lOP 
Contraindications and Precautions: 
- trimethaphan should be used with extreme caution in patients with 
histories of allergy because it can cause histamine release 
- mecamylami;ne should be used with caution in patients with renal, 
cerebral, or coronary hypertrophy; bladder neck or urethral 
obstruction; prostatic hypertrophy; or elevated serum blood urea 
nitrogen levels 
Drug Interactions: 
- combining certain drugs with ganglionic blocking agents can cause 
significant adverse reactions, including tachycardia, orthostatic 
hypotension, congestive heart failure, and stroke 
- alcohol, anesthetics, anticholinergics, reserpine, MAO inhibitors, 
thiazide diuretics, and vasodilators all increase hypotensive 
effects 
- depolarizing muscle relaxants and nondepolarizing muscle 
relaxants increase neuromuscular blocking effects with 
prolonged respiratory depression 
- sympathomimetics increase sympathomimetic effects 
9 
DRUGS 
Generic Name 
ergotamine (Ergostat, 
Cafergot suppositories} 
•• has partial antagonist activity 
against alpha-adrenergic receptors 
-- constricts peripheral and cranial 
blood vessels and depresses 
central vasomotor centers 
•• is a highly active uterine 
stimulant 
presy 
postsynaptic ( 
adrenergic receptors 
lpha2)and 
alpha-
-- acts on both the arterial tree and 
venous bed so total peripheral 
resistance is lowered and venous 
return to the heart is diminished 
treatment 
vascular headaches, 
especially migraine and 
"cluster" headaches 
•• often effective in terminating 
the headache if taken within 
the first hour following onset of 
pain 
used to magnos 
pheochromocytoma (<:\ 
chromaffin cell tumor of the 
sympatho-adrenal system that 
produces catecholamines) and 
to control hypertension during 
surgical excision of the tumor 
-- nausea and vomrttng occur 
in up to 1 0% of patients 
•· numbness and tingling of 
fingers and toes, muscle pain 
in the extremities, weakness in 
the legs, transient tachycardia 
or bradycarida 
-- acute and prolonged 
hypotensive episodes, 
tachycardia and cardiac 
arrhythmias 
-· weakness, dizziness, 
flushing, orthostatic 
hypotension 
none 
none reported 
DRUGS 
I Generic Name (Brandl 
atenolol ((Tenormin) 
metoprolol (Lopressor) 
#23 drug in 1991 
nadolol (Corgard) 
#90 drug in 1991 
Mechanism of Action 
-- competes with epinephrine for 
beta-receptor sites 
-- antagonizes the effect of 
epinephrine and blocks 
sympathetic stimulation, resulting 
in decreased cardiac output, and 
lor decreased central sympathetic 
outflow 
-- reduces rate and contraction 
force of the heart to decrease the 
oxygen requirement for heart 
function and reduce the degree of 
contraction of blood vessel walls , 
resulting in lowered blood 
pressure 
-competes with epinephrine for 
beta-receptor sites 
- antagonizes the effect of 
epinephrine and blocks 
sympathetic stimulation, resulting 
in decreased cardiac output , 
and/or decreased central 
sympathetic outflow 
-- competitive blockade of beta 
adrenergic receptors 
-- antagonizes the effect of 
epinephrine and blocks 
sympathetic stimulation, resulting 
in decreased cardiac output, 
and/or decreased central 
sympathetic outflow 
-- actions in angina to decrease 
cardiac work 
Indication for Use 
used for treatment of angina 
pectoris and hypertension 
I Adverse Reactions 
Expected: lethargy, 
fatigability, cold extremities, 
slow heart rate, orthostatic 
hypotension 
Unusual: headache, dizziness, 
drowsiness, nausea, 
Serious unusual : mental 
depression, anxiety, chest 
pain, shortness of breath 
used to treat hypertension and I same adverse reactions as for 
myocardial infarction atenolol 
used to treat angina pectoris 
and hypertension 
Expected: lethargy, 
fatigability, cold extremities, 
slow heart rate, orthostatic 
hypotension 
Unusual: headache, dizziness, 
drowsiness, nausea, 
Serious unusual: facial 
swelling, chest pain, shortness 
of breath, precipitation of 
congestive heart failure 
Ocular Adverse Reactions 
rare and transient and may 
include ocular irritation, dry 
eyes, decreased tear 
production, and blurred vision 
effects are rare but may 
include decreased vison, 
conjunctival irritation, ocular 
pain, dry eyes and decreased 
tear production 
rare and transient and may 
include diplopia, decreased 
vision , allergic reactions ol 
conjunctiva and lids, 
decreased lOP, and visual 
hallucinations 
DRUGS Mechanism of Action Indication for Use Adverse Reactions Ocular Adverse Reactions 
Generic Name (Brand) 
propranolol ( lnderal) -- non-selective competitive used to treat hypertension, Expected: lethargy, rare and transient and may 
#41 drug in 1991 blocker of beta receptors angina pectoris, cardiac fatigability, cold extremities, include diplopia, decreased 
--decreased cardiac output, arrhythmias, and migraine slow heart rate, orthostatic vision, allergic reactions of 
and/or decreased central headaches hypotension conjunctiva and lids, 
sympatheric outflow decreased lOP, and visual 
--actions in angina to decrease Unusual : skin rash, temporary hallucinations 
heart rate and cardiac work loss of hair, headache, 
-- has a membrane stabilizing or dizziness, drowsiness, nausea 
local anesthetic effect to decrease 
. action potential conduction and Serious unusual: acute 
prolong the conduction time of behavioral disturbances, 
nerve impulses through the heart disorientation, confusion, 
amnesia, mental depression, 
anxiety, chest pain, shortness 
of breath, precipitation of 
congestive heart failure 
timolol (Timoptic) -- non-selective beta adrenergic used to treat angina pectoris, Expected: lethargy, -- mild ocular irritation 
#60 drug in 1991 blocking agent glaucoma, hypertension, to fatigability, cold extremities, including conjunctivitis , 
-- antagonizes the effect of prevent the recurrence of slow heart rate, orthostatic blepharitis, and keratitis 
epinephrine and blocks myocardial infarction, and to hypotension -- has infrequently caused 
sympathetic stimulation, resulting reduce the frequency and refractive changes, corneal 
in decreased cardiac output, severity of migraine Unusual: skin rash, temporary hypoesthesia, and 
and/or decreased central headaches loss of hair, headache , blepharoptosis 
sympathetic outflow dizziness, drowsiness, nausea 
-- has a membrane stabilizing or 
local anesthetic effect to decrease Serious unusual: 
action potential conduction and laryngospasm, severe 
prolong the conduction time of dermatitis, acute behavioral 
nerve impulses through the heart disturbances, mental 
-- decreases aqueous formation in ' depression, chest pain, 
the anterior chamber to lower lOP shortness of breath, 
precipitation of congestive 
heart failure 
I Cholinergic Agonists 
.1. bethanechol (Duvoid) 
.1. carbachol (Carbacel) 
M metoclopramide (Reglan) #176 drug in 1991 
.1. pilocarpine (Pilocar) 
"M" indicates a top 200 drug in 1991 --note ranking after trade name 
" .1. " indicates major drugs -- see table 
Indications for Use: 
- used to treat atonic conditions of the Gl tract or bladder 
- used to reduce intraocualr pressure in the anterior chamber of the eye 
(useful in patients with glaucoma and those undergoing 
ophthalmologic surgery) 
Mechanism of Action: 
- mechanisms of action for the specific drugs are listed in the table 
Adverse Reactions: 
- adverse reactions for the specific drugs are listed in the table 
Ocular Adverse Reactions: 
- ocular adverse reactions for the specific drugs are listed in the table 
Contraindications and Precautions: 
- cholinergic overstimulation can result from patient hypersensitivity or 
drug overdose which may cause circulatory collapse resulting in 
hypotension, shock, and cardiac arrest 
- note the patient's cardiovascular function to detect adverse reactions 
Drug Interactions: 
- drug interactions involving the cholinergic agonists usually occur with · 
drugs that also act at the autonomic effector cells 
- other cholinergic agents, particularly anticholinesterase agents increase 
potential for cholinergic toxicity 
- cholinergic blocking agents antagonize the effect of acetylcholine at the 
muscarinic receptors 
- ganglionic blocking agents antagonize the effect of cholinergic agonists 
at autonomic ganglia 
- neuromuscular blocking agents antagonize the effect of acetylcholine at 
neuromuscular junction 
- sympathomimetics antagonize effects of cholinergic agonists 
- procainamide and quinidine dimin ish vagal transmission 
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carbachol 
(Reglan) 
#176 drug in 1991 
pilocarpine (Pilocar) 
-- combines with cholinergic 
receptors at organs innervated by 
the parasympathetic nervous 
system to produce stimulation of 
the PNS and release of 
acetylcholine at the nerve endings 
-- produces a contraction strong 
enough to initiate emptying of the 
bladder and stimulates gastric 
moti 
cholinergic 
receptors at organs innervated by 
the parasympathetic nervous 
system to produce stimulation of 
the PNS and release of 
acetylcholine at the nerve endings 
-- direct acting stimulation of 
muscarinic rec 
-- combines with cholinergic 
receptors at organs innervated by 
the parasympathetic nervous 
system to produce stimulation of 
the PNS and release of 
acetylcholine at the nerve endings 
-- stimulates motility of the upper 
Gl tract without stimulating gastric, 
biliary or pancreatic secretions 
-- combines with cholinergic 
receptors at organs innervated by 
the parasympathetic nervous 
system to produce stimulation of 
the PNS and release of 
acetylcholine at the nerve endings 
--direct stimulation of muscarinic 
receptor 
-- directly stimulates constriction of 
the pupil to enlarge outflow canal 
in the anterior chamber and 
promote drainage of aqueous to 
lower lOP 
--urine ret 
-- postoperative abdominal 
distention 
--used in open-angle 
glaucoma 
-- effective in the management 
of postoperative lack of 
intestinal muscle tone and 
urinary retention 
used to stimulate contractions 
of the stomach and facilitate 
emptying of the stomach in 
disorders such as: 
1) diabetic gastric stasis 
2) acid reflux from the 
stomach into the esophagus 
3) nausea and vomiting of 
migraine headaches 
4) nausea and vomiting 
induced bv anticancer d 
-- used for management of all 
types of glaucoma 
-- combined with epinephrine 
(dilation) to ultilize actions of 
both drugs in lowering lOP 
-- (pilocarpine constricts, 
epinephrine dilates) to provide 
a balance that prevents 
excessive constriction or 
dilation 
ise, abdominal 
discomfort, salivation, flushing 
of the skin, sweating, nausea, 
vomiting, urinary urgency, and 
headaches 
--fever, syncope, nausea, 
diarrhea 
--skin rash 
-- headache, dizziness, 
restlessness, depression 
--dry mouth, nausea, diarrhea 
headache, perspiration, 
nausea and vomiting, heart 
palpitations, tremors 
-- w/systemic use: hyperemia, 
lacrimation, decreased 
accommodation, and miosis 
-- w/systemic use: decreased 
accommodation 
-- w/local ocular use: miOSIS, 
decreased vision, decreased 
intraocular pressure, 
accommodative spasm 
-- inability to close the eyes, 
nystagmus, diplopia, 
strabismus, 
-- decreased vision 
-- edema and urticaria of 
eyelids or conjunctiva 
-- miosis, decreased v1s 
paralysis or spasm of 
accommodation, decreased 
anterior chamber depth, 
itching or swelling of the 
eyelids 
I Cholinergic Antagonists 
Anticholinesterase Agents 
ambenonium 
L\ demecarium (Humorsol) 
L\ echothiophate (Phospholine Iodine) 
L\ edrophonium (Tensilon) 
L\ neostigmine (Prostigmin) 
L\ physostigmine (Antilirium) 
pyridostigm ine 
Cholinergic Blockers 
L\ atropine (Atropine Sulfate Injection) 
L\ belladonna 
L\ benztropine (Cogentin) 
clidinium 
L\ dicyclomine (Bentyl) 
ethopropazine 
glycopyrrolate 
L\ homatropine (Homatrocel Ophthalmic) 
hyoscyamine 
oxybutynin 
L\ propantheline (Banth ine) 
L\ scopolamine (Transderm Scop) 
trihexyphenidyl 
II M II indicates a top 200 drug in 1991 -- note ranking after trade name 
II L\ II indicates major drugs -- see table 
Indications for Use: 
Anticholinesterase Agents 
- anticholinesterase agents inhibit the enzyme acetylcholinesterase, 
thereby slowing the destruction of acetylcholine 
with reversible anticholinesterase agents, the blocking effect lasts for 
minutes to hours 
reversible (short-term) agents are used therapeutically 
used to promote muscle contraction in patients with myasthenia gravis 
ability to reduce intraocular pressure makes them useful in 
ophthalmologic surgery and in treating glaucoma 
used to stimulate tone and peristalsis in the Gl tract in patients with 
. gastroparesis 
with irreversible anticholinesterase agents, the effects are sustained for 
days or even weeks 
irreversible (long-term) agents, the organophosphates, are used 
primarily as toxic insecticides and pesticides and have also been 
used as nerve gases in chemical warfare 
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Indications for Use: (continued) 
Cholinergic Blockers 
- cholinergic blocking agents interrupt parasympathetic nerve impulses in 
the central and autonomic nervous systems 
primary indications include spastic conditions of the Gl and urinary 
tracts, cardiac dysrhythmias, motion sickness, parkinsonism, and 
chronic asthma 
used as preanesthesia medications and as relaxants for the Gl tract 
during diagnostic procedures and for the eye and pupil during 
ophthalmologic surgery 
serve as antidotes to cholinergic agents,certain organophosphate 
pesticides, and neuromuscular blocking agents 
ANTICHOLINESTERASE AGENTS 
Mechanism of Action: 
- inactivate the enzyme cholinesterase, allowing acetylcholine to exert its 
cholinergic effects which include pupil constriction and 
accommodative spasm 
may be one of three types (specifics indicsted in table) 
a) long-acting, irreversible anticholinesterase 
i.e. demecarium, echothiophate 
b) short-acting anticholinesterase 
i.e. physostigmine 
c) a reversible anticholinesterase 
i.e. edrophonium, neostigmine 
Adverse Reactions: 
- adverse reaactions for the specific drugs are listed in the table 
Ocular Adverse Reactions: 
- ocular adverse reactions for the specific drugs are listed in the table 
Contraindications and Precautions: 
- reaction to the anticholinesterase agents is difficult to predict in patients 
with myasthenia gravis 
when the agents are used for parasympathomimetic effects, 
contraindications and precautions are the same as for the 
cholinergic agonists 
1) overstimulation can result from patient hypersensitivity or drug 
overdose which may cause circulatory collapse resulting in 
hypotension, shock, and cardiac arrest 
2) note the patient's cardiovascular function to detect adverse 
reactions 
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Anticholinesterase Agents (continued) 
Drug Interactions: 
- drug interactions involving anticholinesterase agents usually occur at 
either nicotinic or muscarinic receptor sites 
anesthetics and antibiotics antagonize neuromuscualr blockade effect 
other cholinergic agents, particularly cholinergic agonists increase 
potential for toxicity 
cholinergic blocking agents antagonize effect of acetylcholine at 
muscarinic receptors 
ganglionic blocking agents antagonize effect of anticholinesterase 
agents at autonomic ganglia, producing both an anticholinergic and 
a cholinergic effect 
neuromuscular blocking agents antagonize the effect of acetylcholine at 
the neuromuscular junction 
procainamide and quinidine diminish vagal transmission and produce 
neuromuscular blockade 
quinine increases the refractory period of skeletal muscle, reducing its 
response to acetylcholine 
CHOLINERGIC BLOCKERS 
Mechanism of Action: 
- all compete with acetylcholine and cholinergic agonists at muscarinic 
receptor sites in the CNS and at the neuromuscular junction 
between the postganglionic parasympathetic nerve and the smooth 
muscle 
some block cholinergic stimulation of the iris sphincter muscle and ciliary 
body producing pupillary dilation and paralysis of accommodation 
i.e. atropine, belladonna, homatropine 
others are tertiary amines with little antimuscarinic activity; exhibit a 
selective CNS activity 
i.e. benztropine, dicyclomine 
Adverse Reactions: 
- adverse reactions for the specific drugs are listed in the tables 
Ocular Adverse Reactions: 
- ocular adverse reactions for the specific drugs are listed in the tables 
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Cholinergic Blockers (continued) 
Contraindications and Precautions: 
- drugs should be administered cautiously to patients over age 40 
because of the chance of undiagnosed glaucoma 
tachycardia secondary to administration of cholinergic blocking agents in 
coronary artery disease patients can lead to congestive heart failure 
may produce urinary obstruction in patients with benign prostatic 
hypertrophy 
since these drugs inhibit such heat-regulating mechanisms as sweating, 
heatstroke is a potential complication 
should not be administered concurrently with antacids or antidiarrheals 
order analgesics for patients in pain when they are receiving cholinergic 
blocking agents; otherwise, the likelihood of CNS excitation 
increases 
Drug Interactions: 
- carbonic anhydrase inhibitors enhance antimuscarinic effect from 
alkalinization of the urine 
- antacids and antidiarrheals reduce absorption of cholinergic blockers 
- antiarrhythmics, tricyclic and tetracyclic antidepressants, antidyskinetics, 
antiemetids and antivertigo agents, and diphenhydramine 
antipsychotics enhance antimuscarinic effects 
- cholinergic agonists reverse antimuscarinic action . 
- interact with digoxin to increase serum concentration levels of digoxin by 
decreasing gastrointestinal motility 
- ganglionic blocking agents decrease anticholinergic effect in the eye and 
the Gl tract 
- opiate-like analgesics decrease gastrointestinal motility 
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demecarium (Humorsol) 
echo! 
(Phospholine Iodine) 
edrophonium 
-- inactivate tne enzyme 
cholinesterase, allowing 
acetylcholine to exert its 
cholinergic effects which include 
pupil constriction and 
accommodative spasm 
-- long acting, irreversible 
anticholinesterase 
-- inactivate the enzyme 
cholinesterase, allowing 
acetylcholine to exert its 
cholinergic effects which include 
pupil constriction and 
accommodative spasm 
-- long acting, irreversible 
anticholinesterase 
- 1nact1vate tne enzyme 
cholinesterase, allowing 
acetylcholine to exert its 
cholinergic effects which include 
pupil constriction and 
accommodative spasm 
-- a reversible anticholinesterase 
used to treat glaucoma and 
accommodative esotropia in 
children 
used to treat: 
-- open-angle glaucoma 
-- conditions obstructing 
aqueous outflow 
-- accommodative esotropia 
rug or choice for 
diagnosis of myasthenia gravis 
-- also used to differentiate 
myasthenia gravis from 
cholinergic toxicity 
-- used to terminate attacks of 
paroxysmal supraventricular 
tachycardia and 
tachydysrhythmia 
unresponsive to digitalis 
-- nausea, vomiting, diarrhea 
-- urinary incontinence (loss of 
bladder control) 
-- dyspnea (labored or difficult 
breathing) 
-- bradycardia, cardiac 
arrhythmia 
-- nausea, vomiting, diarrhea 
-- urinary incontinence (loss of 
bladder control) 
-- dyspnea (labored or difficult 
breathing) 
-- bradycardia, cardiac 
arrhythmia 
--asthma 
--apnea 
-- bradycardia, cardiac arrest, 
hypotension 
-- miosis 
-- decreased vision 
-- accommodative spasm 
-- hyperemia, photophobia, 
edema 
-- cataracts (anterior or PSC) 
-- miosis 
-- decreased vision 
-- accommodative spasm 
-- hyperemia, photophobia, 
edema 
--cataracts (anterior or PSC) 
--miOSIS 
-- decreased vision 
--diplopia 
-- blepharoclonus (sustained 
contraction of muscles closing 
the eyes) 
b5a Anticholinesterase Agents (continued) 
DRUGS 
Generic Name 
l!!ri) r1 ci > 
neostigmine (Prostigmin) 
physostigmine (Antilirium) 
Mechanism of Action I Indications for Use 
-- inactivate the enzyme 
cholinesterase, allowing 
acetylcholine to exert its 
cholinergic effects which include 
pupil constriction and 
accommodative spasm 
-- a reversible anticholinesterase 
-- inactivate the enzyme 
cholinesterase, allowing 
acetylcholine to exert its 
cholinergic effects which include 
pupil constriction and 
accommodative spasm 
-- short-acting anticholinesterase 
-- diagnosis and treatment of 
myasthenia gravis 
-- prevention and treatment of 
postoperative distention and 
urine retention 
-- used as an antidote to 
neuromuscular blocking 
agents 
- used to treat open-angle 
glaucoma 
-- used to reverse the CNS 
effects caused by clinical or 
toxic dosages of drugs 
capable of producing an 
anticholinergic syndrome 
--used to treat tricyclic 
antidepressant and diazepam 
overdose (its ability to cross 
the blood-brain barrier makes it 
the drug of choice for this 
purpose) 
Adverse Reactions 
-- allergic reactions and 
anaphylaxis 
--dizziness. convulsions. loss 
of consciousness. 
drowsiness, headache 
-- cardiac arrhythmias 
(bradycardias, tachycardias) 
-- dyspnea, respiratory 
depression 
-- nausea, vomiting 
-- nausea. vomiting 
-- salivation 
-- bradycardia 
-- convulsions 
Ocular Adverse 
Reactions 
w/systemic use: 
--miosis 
-- decreased vision 
--urticaria and allergic 
reactions to eyelids or 
conjunctiva 
w/ocular use : 
--miosis 
--decreased intraocular 
pressure 
-- hyperemia, photophobia 
-- accommodative spasm 
-- decreased vision 
w/systemic use: 
--miosis 
-- decreased vision 
-- urticaria and allergic 
reactions to eyelids or 
conjunctiva 
w/ocular use : 
--miosis 
-- decreased intraocular 
pressure 
-- hyperemia, photophobia 
-- accommodative spasm 
-- decreased vision 
!fi~~~iiW~If5~i~r~~)l4f~;Jl.~tlfkllittJJI~ll~i~l!iJ1!11i~~-~~til!frlfl~~~~~).;~~~ 
DRUu::s 
Generic Name 
(Brand) 
Mechanism ot Acnon Indications for Use Adverse Reactions Ocular Adverse 
Reactions 
atropine (Atropine Sulfate 
Injection) 
belladonna (combinations 
of belladonna alkaloids) 
-- competes with acetylcholine 
and cholinergic agonists at 
muscarinic receptor sites in the 
CNS and at the neuromuscular 
junction between the 
postganglionic parasympathetic 
nerve and the smooth muscle 
-- blocks cholinergic stimulation of 
the iris sphincter muscle and ciliary 
body producing pupillary dilation 
and paralysis of accommodation 
-- competes with acetylcholine 
and cholinergic agonists at 
muscarinic receptor sites in the 
CNS and at the neuromuscular 
junction between the 
postganglionic parasympathetic 
nerve and the smooth muscle 
-- blocks cholinergic stimulation of 
the iris sphincter muscle and ciliary 
body producing pupillary dilation 
and paralysis of accommodation 
-- used to treat bradycardia, 
spastic conditions of the Gl 
tract, and asthma 
-- used to decrease 
secretions of the respiratory 
tract 
-- also used in treatment of 
hyperactive carotid sinus 
reflex and Parkinson's disease 
-- topically used for mydriatic 
and cycloplegic effects in 
refractions, semiocclusive 
therapy, and treatment of 
accommodative spasms and 
uveitis 
-- primarily used to decrease 
Gl motility and inhibit gastric 
secretions in peptic ulcer, 
irritable bowel syndrome, and 
other Gl disorders 
-- topically used for mydriatic 
and cycloplegic effects in 
refractions, semiocclusive 
therapy, and treatment of 
accommodative spasms and 
uveitis 
-- adverse reactions increase 
in severity as the dosage 
increases 
-- agitation, confusion, 
psychosis, delirium, 
hallucinations, ataxia, hostility, 
fever, dry mouth, vasodiation , 
tachycardia, and convulsions 
larger doses produce : 
-- psychotic reactions, 
hypotension, and progressive 
respiratory depression 
-- adverse reactions increase 
in severity as the dosage 
increases 
-- agitation, confusion , 
psychosis, delirium, 
hallucinations, ataxia, hostility, 
fever , dry mouth, vasodiation 
larger doses produce : 
-- psychotic reactions, 
hypotension, and progressive 
respir(ltory ci~Qression 
w/systemic use: 
-- decreased vision 
-- mydriasis may precipitate 
narrow-angle glaucoma 
-- absence of reaction to light 
-- paralysis of accommodation 
-- photophobia 
-- decreased lacrimation 
w/ocular use: 
-- decreased vision 
-- paralysis of accommodation 
-- mydriasis may precipitate 
narrow-angle glaucoma 
-- irritation including 
hyperemia, photophobia, 
ocular pain, edema 
w/systemic use : 
-- decreased vision 
-- mydriasis may precipitate 
narrow-angle glaucoma 
-- absence of reaction to light 
-- paralysis of accommodation 
-- photophobia 
-- decreased lacrimation 
b5b Cholinergic Blockers (continued 
DRUGS I Mechanism of Action 
Generic Name 
(Brand} 
benztropine (Cogentin) 
dicyclomine (Bentyl) 
-- competes with acetylcholine 
and cholinergic agonists at 
muscarinic receptor sites in the 
CNS and at the neuromuscular 
junction between the 
postganglionic parasympathetic 
nerve and the smooth muscle 
-- a tertiary amine with little 
antimuscarinic activity; exhibits a 
selective CNS activity 
-- competes with acetylcholine 
and cholinergic agonists at 
muscarinic receptor sites in the 
CNS and at the neuromuscular 
junction between the 
postganglionic parasympathetic 
nerve and the smooth muscle 
-- a tertiary amine with little 
antimuscarinic activity; exhibits a 
nonspecific direct relaxant effect 
on smooth muscle 
Indications for Use 
-- primarily used as an 
antidyskinetic in treating 
parkinsonism 
-- also used in the control of 
extrapyramidal disorders due 
to central nervous system 
drugs, such as reserpine or 
the phenothiazines 
-- used to treat irritable bowel 
syndrome (irritable colon, 
spastic colon, mucous colitis) 
Adverse Reactions 
-- adverse reactions increase 
in severity as the dosage 
increases 
-- decreased salivation, 
bronchial secretions, and 
sweating with small doses 
-- pupil dilation, decreased 
visual accommodation, and 
increased heart rate with 
increased doses 
-- larger doses inhibit urination 
and intestinal motility 
-- adverse reactions increase 
in severity as the dosage 
increases 
-- decreased salivation, 
bronchial secretions, and 
sweating with small doses 
-- pupil dilation, decreased 
visual accommodation, and 
increased heart rate with 
increased doses 
-- larger doses inhibit urination 
and intestinal motility 
Ocular Adverse 
Reactions 
adverse ocular reactions are 
common with benztropine 
w/systemic administration 
-- pupils 
a. mydriasis 
b. decreased reaction to light 
-- decreased vision 
-- decrease or paralysis of 
accommodation 
-- visual hallucinations 
w/systemic administration 
-- decreased vision 
-- mydriasis (may precipitate 
narrow-angle glaucoma) 
-- paralysis of accommodation 
-- photophobia 
-- diplopia 
-- problems with color vision 
b5b Cholinergic Blockers (continued 
DRUGS 
Generic Name 
(Brand) 
homatropine (Homatrocel 
Ophthalmic) 
propantheline (Banthine) 
Mechanism of Action 
-- competes with acetylcholine 
and cholinergic agonists at 
muscarinic receptor sites in the 
CNS and at the neuromuscular 
junction between the 
postganglionic parasympathetic 
nerve and the smooth muscle 
-- blocks cholinergic stimulation of 
the iris sphincter muscle and ciliary 
body producing pupillary dilation 
and paralysis of accommodation 
-- competes with acetylcholine 
and cholinergic agonists at 
muscarinic receptor sites in the 
CNS and at the neuromuscular 
junction between the 
postganglionic parasympathetic 
nerve and the smooth muscle 
Indications for Use 
-- a moderately long-acting 
mydriatic and cycloplegic for 
refraction and in the treatment 
of inflammatory conditions of 
the uveal tract 
-- for preoperative and 
postoperative states when 
mydriasis is required 
-- used as an optical aid in 
some cases of axial lens 
opacities 
-- also used in treatment of 
painful menstruation 
-- used in the treatment of 
peptic ulcer 
-- has been used for its 
antisecretory and 
antispasmodic effects 
Adverse Reactions 
-- adverse reactions increase 
in severity as the dosage 
increases 
-- agitation, confusion, 
psychosis, delirium, 
halluCinations, ataxia, hostility, 
fever, dry mouth, vasodiation, 
tachycardia, and convulsions 
larger doses produce: 
-- psychotic reactions, 
hypotension, and progressive 
respiratory depression 
-- adverse reactions increase 
in severity as the dosage 
increases 
-- decreased salivation, 
bronchial secretions, and 
sweating with small doses 
-- pupil dilation, decreased 
visual accommodation, and 
increased heart rate with 
increased doses 
-- larger doses inhibit urination 
and intestinal motili!Y_ 
Ocular Adverse 
Reactions 
w/systemic use: 
-- decreased vision 
-- mydriasis may precipitate 
narrow-angle glaucoma 
-- absence of reaction to light 
-- paralysis of accommodation 
-- photophobia 
-- decreased lacrimation 
w/ocular use: 
-- decreased vision 
-- paralysis of accommodation 
-- mydriasis may precipitate 
narrow-angle glaucoma 
-- irritation including 
hyperemia, photophobia, 
ocular pain, edema 
w/systemic administration 
-- decreased vision 
-- mydriasis (may precipitate 
narrow-angle glaucoma) 
-- paralysis of accommodation 
-- photophobia 
-- diplopia 
-- problems with color vision 
w/inadvertent ocular exposure 
-- mydriasis 
-- absence of reaction to light 
b5b Cholinergic Blockers (continued 
DRUGS Mechanism of Action Indications for Use Adverse Reactions Ocular Adverse 
Generic Name Reactions 
(Brand) 
scopolamine (Transderm -- competes with acetylcholine -- drug of choice for motion -- adverse reactions increase w/systemic administration 
Scop) and cholinergic agonists at sickness (administered in severity as the dosage -- mydriasis (may precipitate 
muscarinic receptor sites in the topically via a skin patch increases narrow-angle glaucoma) 
CNS and at the neuromuscular behind the ear) -- paralysis of accommodation 
junction between the -- useful as a preanesthesia -- agitation, confusion, --·decreased vision 
postganglionic parasympathetic medication (reduces psychosis, delirium, -- decreased lacrimation 
nerve and the smooth muscle excessive salivation and hallucinations, ataxia, hostility, -- decreased tear lysozymes 
respiratiory tract secretions in fever, dry mouth, vasodiation 
-- blocks cholinergic stimulation of anesthesia, and produces a w/ocular use 
the iris sphincter muscle and ciliary sense of euphoria and larger doses produce: -- decreased vision 
body producing pupillary dilation amnesia) -- psychotic reactions, -- mydriasis 
and paralysis of accommodation hypotension, and progressive -- paralysis of accommodation 
respiratory depression -- follicular conjunctivitis 
-- hyperemia, photophobia 
w/systemic absorption from 
topical application 
-- mydriasis, anisocoria of 
pupils, absent reacton to light 
-- paralysis of accommodation 
-- decreased vision 
-- decresed lacrimation 
- ----- --~ -----
I Ganglionic Agonists 
Catecholamines 
dobutamine 
~ dopamine (lntropin) 
~ epinephrine (Parenteral: Adrenalin) 
~ isoproterenol (Oral: lsuprel) 
~ norepinephrine (Levophed, Noradrenaline) 
Noncatecholamines 
M albuterol (Proventil, Ventolin) #21 & #24 drugs in 1991 
L1 ephedrine (Efedron) 
isoetharine 
mephentermine 
~ metaproterenol (Aiupent) 
metaraminol 
methoxamine 
nylidrin 
~ phenylephrine (Nee-Synephrine) 
ritodrine 
~ terbutaline (Brethine) 
I Ganglionic Antagonists I 
Sympatholytic Agents 
M clonidine (Catapres) #152 drug in 1991 
guanabenz 
guanfacine 
~ methyldopa (Aidomet) 
mecamylamine 
trimethaphan 
M atenolol (Tenormin) #12 drug in 1991 
M metoprolol (Lopressor) #23 drug in 1991 
M nadolol (Corgard) #90 drug in 1991 
pindolol 
M propranolol (lnderal) #41 drug in 1991 
M timolol (Timoptic) #60 drug in 1991 
phentolamine 
prazosin 
terazosin 
labetalol 
guanadrel 
guanethidine 
~ reserpine (Serpasil) 
II M II indicates a top 200 drug in 1991 --note ranking after trade name 
II ~ II indicates major drugs -- see table 
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Indications for Use: 
- adrenergic agents are compounds that cause biological responses 
similar to those produced by activation of the sympathetic nervous 
system (SNS) 
adrenergics are divided into two groups: catecholamines (including 
endogenous and synthetic agents) and noncatecholamines and are 
further divided by their method of action 
- direct-acting (acting directly on the sympathetically innervated 
organ or tissue) 
- indirect-acting (triggering the release of a neurotransmitter, 
usually norepinephrine) 
- dual-acting (combining both direct and indirect action) 
Catecholamines 
- the particular receptor activity that exists alone or predominates if more 
than one receptor type is activated determines how the drug is used 
therapeutically 
local vasoconstrictive actions of the drugs make them useful as: 
- nasal decongestants to treat inflammatory and allergic conditions 
- ophthalmic decongestants to treat conjunctivitis and ocular 
congestion 
- intraocular hypotensive agents to treat simple, open-angle 
glaucoma 
- antiallergens to treat hypersensitivity and anaphylaxis 
alpha stimulators can be used systemically to relieve hypotension 
beta1-active drugs are used to treat bradycardia and heart block and to 
terminate paroxysmal atrial or nodal tachycardia 
- also used in cases of ventricular fibrillation, asystole, or cardiac 
arrest 
beta2-active drugs are used to treat acute and chronic bronchial 
asthma,emphysema, bronchitis, and acute hypersensitivity 
reactions to drugs 
the specific mechanisms of action and uses of the individual drugs are 
listed in the tables to follow 
Noncatecholamines 
- noncatecholamine adrenergic drugs have a wide variety of therapeutic 
uses related to the many physiologic effects of these drugs 
- the effects include: 
- local or systemic vasoconstriction 
- nasal and ophthalmic decongestion 
- bronchodilation 
- smooth muscle relaxation 
- CNS stimulation and appetite suppression 
bronchodilator effects of the drugs are used to treat acute and chronic 
bronchial asthma, emphysema, pulmonary fibrosis, and chronic 
bronchitis 
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Indications for Use (continued) 
Noncatecholamines (continued) 
- the pressor effects of the drugs are useful with spinal anesthesia; for 
hypotension and nosebleeds; and vasoconstriction during regional 
anesthesia 
- ephedrine is used to treat nasal congestion, hypotension, and 
narcolepsy 
- the specific mechanisms of action and uses of the individual drugs are 
listed in the tables to follow 
Sympatholytic Agents 
- · used to lower the blood pressure of patients with mild-to -severe 
essential hypertension 
- the type of drug used can be changed and the dosage altered to achieve 
effective therapeutic effects with the fewest adverse reactions 
CATECHOLAMINES 
Mechanism of Action: 
- mechanisms of action for all classes of drugs are listed in the tables for 
each of the specific major drugs 
Adverse Reactions: 
- adverse reactions for all classes of drugs are listed in the tables for each 
of the specific major drugs 
Ocular Adverse Reactions: 
- ocular adverse reactions for all classes of drugs are listed in the tables 
for each of the specific major drugs 
Contraindications and Precautions: 
- use cautiously in elderly patients because of possible reduced cardiac 
reserve and the likelihood of dysrhythmias, confusion, or 
cerebrovascular accident 
use cautiously in pregnant patients because of possible adverse effects 
on the fetus 
use cautiously in hypertensive patients since catecholamines may cause 
further increase in blood pressure, cardiac output, or 
vasoconstriction 
use cautiously in patients with hyperthyroidism since may cause 
increase in hypermetabolic state 
use cautiously in patients with diabetes mellitus since may produce an 
anti-insulin effect with unpredictable effects on diabetes control 
use cautiously in patients with glaucoma since may cause increased 
intraocular pressure 
also use cautiously in patients with parkinsonism, circulatory or 
cardiovascular disease, and prostate hypertrophy 
note signs of overdose, such as headache, vomiting, hypotension, 
hypertension, blurred vision, cardiac dysrhythmias, or chest pains 
be alert for the possiblility of edema, oliguria, anuria, or hemorrhage with 
prolonged use 
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Catecholamines (continued) 
Drug Interactions: 
- drug interactions involving catecholamines can be among the most 
serious 
knowledge of the interactions between catecholamines and other agents 
is essential because of the potential for additive effects which might 
lead to a hypertensive crisis or cardiac dysrhythmias 
drugs that must not be used with catecholamines or that should be used 
concurrently only with extreme caution include MAO 
inhibitors,tricyclic antidepressants, oxytocics, furazolidone, ergot 
alkaloids, antihistamines, some general anesthetics, digitalis, or 
other sympathomimetic agents 
catecholamines can produce similar and significant reactions throughout 
the body including hypotension, hypertension, caridiac dysrhythmia, 
seizures, and hyperglycemia in diabetics 
beta-blockers such as propranolol reduce the effects of the 
catecholamines and increase total peripheral resistance by allowing 
uncompensated alpha stimulation with beta blockade, which may 
result in hypertension and reflex bradycardia 
NONCATECHOLAMINES 
Mechanism of Action: 
- mechanisms of action for all classes of drugs are listed in the tables for 
each of the specific major drugs 
Adverse Reactions: 
- adverse reactions for all classes of drugs are listed in the tables for each 
of the specific major drugs 
Ocular Adverse Reactions: 
- ocular adverse reactions for all classes of drugs are listed in the tables 
for each of the specific major drugs 
Contraindications and Precautions: 
- use cautiously in diabetic patients because of the possibility of 
hyperglycemia 
although rare, overdose of nasal decongestants can cause marked 
somnolence, sedation, hypotension, bradycardia, and even coma 
confusion, delirium, or even hallucinations, as well as tremors, may 
follow large doses of ephedrine 
ephedrine may also produce pardoxical bronchospasm or aggravation of 
ketoacidosis 
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Noncatecholamines (continued) 
Drug Interactions: 
- drugs known to interact with various noncatecholamines encompass 
many of the drugs also contraindicated with catecholamones 
including MAO inhibitors, furazolidone, beta blockers, other 
sympathomimetics, acetazolamide, ascorbic acid, and many others 
- can produce significant reactions throughout the body, including 
hypotension, hypertension, cardiac dysrhythmias, seizures, and 
hyperglycemia in diabetics 
SYMPATHOLYTIC AGENTS 
Mechanism of Action: 
- mechanisms of action for all classes of drugs are listed in the tables for 
each of the specific major drugs 
Adverse Reactions: 
- adverse reactions for all classes of drugs are listed in the tables for each 
of the specific major drugs 
Ocular Adverse Reactions: 
- ocular adverse reactions for all classes of drugs are listed in the tables 
for each of the specific major drugs 
Contraindications and Precautions: 
- use central-acting nervous system inhibitors cautiously in patients with 
coronary insufficiency, recent Ml, cerebrovascular disease, or 
severe hepatic or renal impairment because of the risks of adverse 
reactions · 
to prevent severe first-dose orthostatic hypotension, have the patient 
take the first dose of prazosin or terazosin at bedtime or remain 
lying down for at least 3 hours after taking it 
use reserpine cautiously in a patient with epilepsy because this ageJ1t 
may lower the threshold for seizures 
beta-adrenergic blocking agents may mask signs of hypoglycemia 
gradually discontinue a beta-adrenergic blocking agent over 3 to 14 days 
- during this time, the patient should avoid vigorous physical activity 
Drug Interactions: 
- sympatholytic agents can interact with many drugs to produce blood 
pressure changes as well as other severe reactions 
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dopamine (lntropin) I stimulates dopaminergic, alpha, used to treat cardiogenic or ectopic heart beats, nausea, I high doses may cause dilated 
and beta1 receptors to increase bacteremic shock with related vomiting, tachycardia, anginal pupils 
force of myocardial contractions renal shutdown and chronic pain, headache, hypotension 
I 
and increase cardiac output congestive heart failure 
epinephrine (Adrenalin) 1 stimulates alpha, beta1, beta2 used to treat bronchospasm, transient anxiety, headache, - mydriasis-may precipitate 
receptors to to increase cardiac asthma, open-angle fear and heart palpitations narrow-angle glaucoma 
output and to relieve respiratory glaucoma, allergic conditions, - red-green color vision defect 
distress due to brochospasm hypotension, cardiac arrest - hemianopsia 
stimulates beta1 and beta2 used to treat asthma, nervousness, headac 
receptors of the heart and smooth bronchospasm, shock cardiac dizziness, tachycardia, 
muscle of bronchi to produce arrest, cardiac dysrhythmias palpitations, angina, flushing 
cardiac stimulation and of the skin, sweating 
bronchodilation 
I 
norepi nepri ne I stimulates alpha and beta1 used to treat acute - bradycardia as a reflex result I none listed (Levophed) receptors to produce peripheral hypotension, shock, cardiac of a rise in blood pressure. 
vasoconstriction and to increase arrest, myocardial infarctions, - headache may indicate 
cardiac output due to increased anaphylactic shock overdosage 
myocardial contractions 
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DRUGS Mechanism of Action Indications for Use Adverse Reactions Ocular Adverse 
Generic Name Reactions 
(Brand) 
albuterol (Proventil, Stimulates beta2 adrenergic used to relieve acute bronchial nervousness, heart decreased vision, edema of 
Ventolin) receptors of the lung's smooth asthma and to reduce palpitations, hand tremor, eyelids and conjunctiva, 
#21 & #24 drugs in 1991 muscle causing relaxation frequency and severity of headache, leg cramps, blepharoconj u nctivit is, 
chronic, recurrrent asthmatic dizziness decreased lacrimation, and 
attacks decreased intraocular 
pressure 
ephedrine (Efedron) dual acting drug that stimulates used to treat nasal heart palpitation, tachycardia, w/systemic use: mydriasis, 
alpha, beta, and CNS receptors to congestion, hypotension, and headache, insomnia, decreased intraocular 
cause brochodilation and narcolepsy sweating, nervousness, pressure 
vasoconstriction nausea, vomiting, w/local ocular use: 
conjunctival vasoconstriction, 
decreased vision 
metaproterenol (Aiupent) direct acting beta2.selective agent used to treat asthma, tachycardia, hypertension, no ocular effects reported 
-- stimulation of beta2 adrenergic bronchitis, and emphysema heart palpitations, after systemic administration 
receptors of lung smooth muscle nervousness, tremor, nausea, 
causes relaxation resulting in and vomiting 
brochodilatory effects 
phenylephrine (Neo- potent direct -acting agent with used for its systemic and headache, reflex bradycardia, w/systemic use: visual 
Synephrine) strong alpha-receptor and weak topical vasopressor effects excitability, restlessness, hallucinations 
beta-receptor actions to produce with anesthesia and for drowsiness, lassitude, w/local ocular use: mydriasis, 
vasoconstriction treating shock, tachycardia, nausea, and rarely arrhythmias decreased vision, conjunctival 
rhinitis, allergies, uveitis, and vasoconstriction, lacrimal 
to produce mydriasis irritation, punctate keratitis 
terbutaline (Brethine) direct-acting agent which exerts -- used to treat bronchial nervousness, tremor, no ocular effects have been 
selective beta2 activity to produce asthma, bronchitis, and headache, increased heart reported 
bronchodilation effects emphysema rate, palpitations, drowsiness, 
-- may also be used to delay nausea, vomiting, sweating, 
delivery in preterm labor and muscle crampls 
met 
atenolol ( (T enorrnin) 
#12 drug in 1991 
-- a central-acting neJVous system 
inhibitor 
-- acts in the CNS to reduce 
sympathetic activity and thus 
decrease arteriolar 
vasoconstriction 
-- a central-acting neJVous system 
inhibitor 
-- acts in the CNS to reduce 
sympathetic activity and thus 
decrease arteriolar 
vasoconstrict ion 
-- competes with epinephrine for 
beta-receptor sites 
-- antagonizes the effect of 
epinephrine and blocks 
sympathetic stimulation, resulting 
in decreased cardiac output, and 
lor decreased central sympathetic 
outflow 
-- reduces rate and contraction 
force of the heart to decrease the 
oxygen requirement for heart 
function and reduce the degree of 
contraction of blood vessel walls, 
resulting in lowered blood 
pressure 
as a step-2 drug in the 
treatment of mild to moderate 
hypertension 
-- lowers the supine and 
standing blood pressures and 
is frequently given with a 
diuretic or another 
antihypertensive agent to 
achieve the maximum blood 
pressure reduction 
to control mild to 
moderate hypertension 
(produces water and sodium 
retention, so frequently 
combined with a diuretic) 
-- useful for treating patients 
with impaired renal function 
-- used to treat hypertensive 
crisis 
used for treatment of angina 
pectoris and hypertension 
-- most common: dry mouth, 
drowsiness, duzziness, 
sedation and constipation 
-- CNS effects: depression, 
forgetfulness, inability to 
concentrate, vivid dreams 
-- additional reactions include: 
water retention, edema, nasal 
congestion, weakness, may 
decrease libido and produce 
impotence 
sedation, 
drowsiness, dizziness, 
depression, forgetfulness, 
inability to concentrate, vivid 
dreams 
-- additional reactions include: 
water retention, edema, nasal 
congestion, weakness, 
constipation, may decrease 
libido and produce impotence 
Expected: lethargy, 
fatigability, cold extremities, 
slow heart rate, orthostatic 
hypotension 
Unusual: headache, 
dizziness, drowsiness, 
nausea, 
Serious unusual: mental 
depression, anxiety, chest 
pain, shortness of breath 
w/systemic administration: 
-- decreased vision 
-- decreased lOP 
-- urticaria of eyelids or 
conjunctiva 
-- visual hallucinations 
w/ocular administration: 
-- decreased lOP 
-- urticaria of eyelids or 
conjunctiva 
n1strat1on: 
vision 
-- decreased lOP 
-" eyelids or conjunctiva: 
allergic reactions, hyperemia, 
conjunctivitis, edema, urticaria 
-- subconjunctival or retinal 
hemorrhages secondary to 
drug-induced anemia 
-- paralysis of extraocular 
muscles 
rare and transient and may 
include ocular irritation, dry 
eyes, decreased tear 
production, and blurred vision 
b6b Sympatholytic Agen!~ __ (COQ!if1~ed} 
DRUGS I Mechanism of Action !Indications for Use 
Generic Name 
(Brand) 
metoprolol (Lopressor) 
#23 drug in 1991 
nadolol (Corgard) 
#90 drug in 1991 
propranolol (lnderal) 
#41 drug in 1991 
- competes with epinephrine for 
beta-receptor sites 
- antagonizes the effect of 
epinephrine and blocks 
sympathetic stimulation, resulting 
in decreased cardiac output, 
and/or decreased central 
sympathetic outflow 
-- competitive blockade of beta 
adrenergic receptors 
-- antagonizes the effect of 
epinephrine and blocks 
sympathetic stimulation, resulting 
in decreased cardiac output, 
and/or decreased central 
sympathetic outflow 
--actions in angina to decrease 
cardiac work 
-- non-selective competitive 
blocker of beta receptors 
-- decreased cardiac output. 
and/or decreased central 
sympatheric outflow 
-- actions in angina to decrease 
heart rate and cardiac work 
-- has a membrane stabilizing or 
local anesthetic effect to decrease 
action potential conduction and 
prolong the conduction time of 
nerve impulses through the heart 
used to treat hypertension 
and myocardial infarction 
used to treat angina pectoris 
and hypertension 
used to treat hypertension, 
angina pectoris, cardiac 
arrhythmias, and migraine 
headaches 
Adverse Reactions I Ocular Adverse 
Reactions 
same adverse reactions as for I effects are rare but may 
atenolol include decreased vison, 
conjunctival irritation, ocular 
pain, dry eyes and decreased 
Expected: lethargy, 
fatigability, cold extremities, 
slow heart rate, orthostatic 
hypotension 
Unusual: headache , 
dizziness, drowsiness, 
nausea, 
Serious unusual: facial 
swelling, chest pain, 
shortness of breath, 
precipitation of congestive 
heart failure 
Expected: lethargy, 
fatigability, cold extremities, 
slow heart rate, orthostatic 
hypotension 
Unusual: skin rash, temporary 
loss of hair, headache, 
dizziness, drowsiness, nausea 
Serious unusual: acute 
behavioral disturbances, 
disorientation, confusion, 
amnesia, mental depression, 
anxiety, chest pain, shortness 
of breath, precipitation of 
congestive heart failure 
· tear production 
rare and transient and may 
include diplopia, decreased 
vision, allergic reactions of 
conjunctiva and lids, 
decreased lOP, and visual 
hallucinations 
rare and transient and may 
include diplopia, decreased 
vision, allergic reactions of 
conjunctiva and lids, 
decreased lOP, and visual 
hallucinations 
b6b Sympatholytic Agents (continuedl 
DRUGS 
Generic Name 
_(_E3rand) 
timolol (Timoptic) 
#60 drug in 1991 
reserpine (Serpasil) 
Mechanism of Action I Indications for Use 
-- non-selective beta adrenergic 
blocking agent 
-- antagonizes the effect of 
epinephrine and blocks 
sympathetic stimulation, resulting 
in decreased cardiac output, 
and/or decreased central 
sympathetic outflow 
-- has a membrane stabilizing or 
local anesthetic effect to decrease 
action potential conduction and 
prolong the conduction time of 
nerve impulses through the heart 
-- decreases aqueous formation in 
the anterior chamber to lower lOP 
-- a norepinephrine depletor 
-- interferes with the synthesis, 
storage, and release of 
norepinephrine from the nerve 
terminals leading to loss of 
peripheral sympathetic tone. 
decreased peripheral resistance 
and a reduction in blood pressure 
-- (sometimes referred to as 
peripheral-acting sympatholytic 
agents) 
used to treat angina pectoris, 
glaucoma, hypertension, to 
prevent the recurrence of 
myocardial infarction, and to 
reduce the frequency and 
severity of migraine 
headaches 
-- used to treat mild essential 
hypertension 
-- also useful as adjunctive 
therapy with other 
antihypertensive agents in the 
more severe forms of 
hypertension 
Adverse Reactions 
Expected: lethargy, 
fatigability, cold extremities, 
slow heart rate, orthostatic 
hypotension 
Unusual: skin rash, temporary 
loss of hair, headache, 
dizziness, drowsiness, nausea 
Serious unusual: 
laryngospasm, severe 
dermatitis, acute behavioral 
disturbances, mental 
depression, chest pain, 
shortness of breath, 
precipitation of congestive 
heart failure 
-- frequent adverse reactions: 
drowsiness, sleep alterations, 
weight gain, and nasal 
congestion 
-- also may produce: 
increased Gl motility, 
abdominal cramps, diarrhea. 
nightmares, depression, 
uterine contractions, and 
bronchoconstriction 
Ocular Adverse 
Reactions 
-- mild ocular irritation including 
conjunctivitis, blepharitis, and 
keratitis 
-- has infrequently caused 
refractive changes, corneal 
hypoesthesia, and 
blepharoptosis 
w/ systemic administration: 
-- conjunctival hyperemia 
-- Horner's syndrome (miosis, 
ptosis, increased sensitivity to 
epinephrine) 
-- nonspecific ocular irritation 
(lacrimation, hyperemia) 
-- extraocular muscles: 
(decreased spontaneous 
movements, jerky pursuit 
movements) 
-- decreased vision 
-- retinal hemorrhc:~ges 
I Neuromuscular Transmission Agonists 
acetylcholine 
I Neuromuscular Transmission Antagonists I 
Nondepolarizing Blocking Agents 
atracurium 
gallamine 
metocurine 
L\ pancuronium (Pavulon) 
L\ tubocurarine. (Tubarine) 
vecuroniurn 
Depolarizing Blocking Agents 
L\ succinylcholine (Quelicin) 
II M II indicates a top 200 drug in 1991 --note ranking after trade name 
II L\ II indicates major drugs -- see table 
Indications for Use: 
Neuromuscular Transmission Agonists 
- to produce complete miosis in seconds by irrigating the iris after delivery 
of the lens in cataract surgery 
- in penetrating keratoplasty, iridectomy and other anterior segment 
surgery where rapid, complete miosis may be required 
Neuromuscular Transmission Antagonists 
Nondepolarizing Blocking Agents 
- used as an adjunct to induce skeletal muscle relaxation; to reduce the i 
ntensity of muscle contractions in pharmacologically or electrically 
induced convulsions; to facilitate management of patients 
undergoing mechanical ventilation 
- produce intermediate to prolonged muscle relaxation, such as that 
required during surgery for intubation and ventilation 
- tubocurarine is used as a diagnostic agent for myasthenia gravis when 
the results of tests with neostigmine or edrophonium are 
inconclusive 
Depolarizing Blocking Agents 
- succinylcholine is the drug of choice for short-term muscle 
relaxation,such as during intubation and electroshock therapy 
- used as an adjunct to general anesthesia to facilitate endotracheal 
intubation, and to induce skeletal muscle relaxation during surgery 
or mechanical ventilation 
- used to reduce the intensity of muscle contractions of pharmacologically-
induced or electrically-induced convulsions 
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NEUROMUSCUALR TRANSMISSION AGENTS 
Mechanism of Action: 
- mechanisms of action for all classes of drugs are listed in the tables for 
each of the specific major drugs 
Adverse Reactions: 
- adverse reactions for all classes of drugs are listed in the tables for 
each of the specific major drugs 
Ocular Adverse Reactions: 
- ocular adverse reactions for all classes of drugs are listed in the tables 
for each of the specific major drugs 
Contraindications and Precautions: 
- hypersensitivity to any component of the product 
Drug Interactions: 
- anticholinergics decrease the activity of acetylcholine 
- sympathomimetics decrease the activity of acetylcholine 
NONDEPOLARIZING BLOCKING AGENTS 
Mechanism of Action: 
- mechanisms of action for all classes of drugs are listed in the tables for 
each of the specific major drugs 
Adverse Reactions: 
- adverse reactions for all classes of drugs are listed in the tables for 
each of the specific major drugs 
Ocular Adverse Reactions: 
- ocular adverse reactions for all classes of drugs are listed in the tables 
for each of the specific major drugs 
Contraindications and Precautions: 
- use nondepolarizing blocking agents cautiously in patients with renal, 
hepatic, cardiac, or pulmonary impairment; fluid and electrolyte 
imbalances; or myasthenia gravis 
order pain medication becuse neuromuscular blocking agents do not 
relieve pain 
contraindicated in patients who have shown an allergic reaction or 
hypersensitivity to these drugs 
use with caution in patients in whom a sudden increase of histartl ine 
release is a definite hazard 
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Nondepolarizing Blocking Agents (continued) 
Drug Interactions: 
- most interacting drugs enhance the blocking action of the neuromuscular 
blocking agents and require that the patient be closely observed to 
prevent fatal complications 
- the following interacting drugs potentiate neuromuscular blockade 
- local or parenteral anesthetics, inhalation anesthetics, 
aminoglycosides, clindamycin, polymyxin, calcium 
channel blockers, magnesium salts, potassium-
depleting medications (including amphotericin B, 
furosemide, and thiazide diuretics) 
the anticholinesterases (neostigmine, pyridostigmine, and edrophonium) 
are antagonistc to nondepolarizing blocking agents and are used as 
antidotes to the neuromuscular blocking agents 
DEPOLARIZING BLOCKING AGENTS 
Mechanism of Action: 
- mechanisms of action for all classes of drugs are listed in the tables for 
each of the specific major drugs 
Adverse Reactions: 
- adverse reactions for all classes of drugs are listed in the tables for 
each of the specific major drugs 
Ocular Adverse Reactions: 
- ocular adverse reactions for all classes of drugs are listed in the tables 
for each of the specific major drugs 
Contraindications and Precautions: 
- the overall implications for succinylcholine are the same as those for the 
nondepolarizing blocking agents 
Drug Interactions: 
- the action of succinylcholine is potentiated by a number of anesthetics, 
antibiotics, and cholinesterase inhibitors 
- cholinesterase inhibitors antagonize phase II of succinylcholine's 
blocking action 
- succinylcholine does not interact with the majority of drugs that alter 
serum electrolyte levels 
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-- major neurotransmitter (NT) of 
the motorneurons, autonomic 
preganglionic fibers, 
postgnaglionic cholinergic 
(parasympathetic fibers 
-- synthesized from choline and 
acetyl-coenzyme A by the enzyme 
choline acetyltransferase (CAT) 
-- upon release, Ach stimulates 
cholinergic receptors of adjacent 
structures 
-- interaction terminated by 
hydrolysis of Ach to choline and 
acetate by acetylcholinestrase 
(ACE) 
-- levels of acetylcholine regulated 
by the activity of choline 
acetyltransferase and by choline 
re-
-- intraocular quaternary 
ammonium 
parasympathomimetic agent 
used to produce prompt, 
short-term miosis 
w/local ophthalmic use--
subconjunctival or intracameral 
injection: 
-- bradycardia 
-- hypotension 
-- vasodilation 
-- dyspnea 
-- perspiration 
w/local ophthalmic use--
subconjunctival or intracameral 
injection: 
-- miosis 
-- increased lOP 
-- conjunctival hyperemia 
-- accommodative spasm 
-- iris atrophy 
-- blepharoclonus 
pancuronium {Pavulon) 
tubocurarine 
-- compete with Ach at the 
cholinergic receptor sites of the 
skeletal muscle membrane 
-- blocks Ach's transmitter action, 
preventing the muscle membrane 
from depolarizing 
-- initial muscle weakness 
produced quickly changes to a 
flaccid paralysis affecting muscles 
in a specific sequence 
-- first muscles to exhibit faccid 
paralysis are those innervated by 
the motor portions of the CN's and 
small rapidly moving muscles in the 
eyes, face, and neck 
-- next, the limb, abdomen, and 
trunk muscles become flaccid and 
finally the intercostal muscles and 
rlbnhr::.nm are 
-- compete with Ach at 
cholinergic receptor sites of the 
skeletal muscle membrane 
-- blocks Ach's transmitter action, 
preventing the muscle membrane 
from depolarizing 
-- initial muscle weakness 
produced quickly changes to a 
flaccid paralysis affecting muscles 
in a specific sequence 
-- first muscles to exhibit faccid 
paralysis are those innervated by 
the motor portions of the CN's and 
small rapidly moving muscles in the 
eyes, face, and neck 
-- next, the limb, abdomen, and 
trunk muscles become flaccid and 
the intercostal muscles and 
n~r~l\17ed 
as adJUnct to 
anesthesia to induce skeletal 
muscle relaxation 
-- used as to manage patients 
undergoing mechanical 
intubation and ventilation 
as adJunct to 
anesthesia to induce skeletal 
muscle relaxation 
-- used as to manage patients 
undergoing mechanical 
intubation and ventilation 
-- used as a diagnostic aid for 
myasthenia gravis 
-- most serious adverse 
reaction is apnea 
-- ganglionic blockade and 
histamine release may cause 
hypotension 
-- histamine release may also 
produce skin reactions (rash), 
bronchospasm, and excessive 
bronchial and salivary 
secretions 
-- selectively block the vagus 
nerve and may resu~ in 
tachycardia, cardiac 
dysrhythmias, and 
hypertension 
-- most senous 
reaction is apnea 
-- ganglionic blockade and 
histamine release may cause 
hypotension 
-- histamine release may also 
produce skin reactions (rash), 
bronchospasm, and excessive 
bronchial and salivary 
secretions 
muscle 
quicklly changing to flaccid 
paralysis of rapidly moving 
muscles of the eyes 
-- 1n1tial muscle weakness 
quicklly changing to flaccid 
paralysis of rapidly moving 
muscles of the eyes 
w/systemic administration: 
-- decreased convergence 
--diplopia 
-- nystagmus 
-- paralysis of extraocualr 
muscles 
-- ptosis 
-- decreased lOP 
succinylcholine (Quelicin) -- an ultrashort-acting depolarizing 
skeletal muscle relaxant 
-- like Ach, it combines with 
cholinergic receptors of the motor 
endplate to produce depolariztion 
observed as fasciculations 
-- neuromuscular transmission is 
inhibited as long as an adequate 
concentration of drug remains at 
the redeptor site; the 
neuromuscular block produces a 
flaccid · · 
-- primarily used to induce 
short-term muscle relaxation 
-- used as adjunct to 
anesthesia to induce skeletal 
muscle relaxation 
-- used as to manage patients 
undergoing mechanical 
intubation and orthopedic 
manipulation 
-- most senous 
reaction is apnea 
-- cardiovascular: bradycardia, 
tachycardia, hypertension, 
hypotension, cardiac arrest, 
arrhythmias 
w/systemic administration: 
-- eyelid retraction 
•• enophthalmos 
-- globe rotaes inferiorly 
-- paralysis of EOM's 
-- initial increased lOP, then 
decreased lOP 
-- ptosis 
-- diplopia 
-- edema and allergic reactions 
of eyelids or conjunctiva 
I Pituitary Agents I 
Anterior Pituitary Hormones 
~ corticotropin (ACTH) (Acthar) 
~ cosyntropin (Cortrosyn) 
~ somatrem (Protropin) 
Posterior Pituitary Hormones 
~ posterior pituitary injection (Pituitrin) 
~ vasopressin (Pitressin) 
~ oxytocin (Pitocin) 
I Androgenic and Anabolic Steroid Agents 
~ fluoxymesterone (Halotestin) 
~ testosterone cypionate (Andro-Cyp) 
~ . nandrolone decanoate (Deca-Durabolin) 
~ oxandrolone (Anavar) 
~ stanozolol (Winstrol) 
I Thyroid and Antithyroid Agents 
Thyroid Agents 
~ thyroid USP (dessicated) 
M levothyroxine (Synthroid) #6 drug in 1991 
~ thyrotropin TSH (Thytropar) 
~ protirelin TRH (Thypinone) 
Antithyroid Agents 
~ methimazole (Tapazole) 
~ propylthiouracil (PTU) 
~ iodine (Potassium iodide Solution, USP) 
llnsulin and Synthetic Antidiabetics 1 
~ insulin 
~ chlorpropamide (Diabinese) 
~ tolazamide (Tolinase) 
~ tolbutamide (Orinase) 
M glipizide (Giucotrol) #47 drug in 1991 
M glyburide (Micronase, Diabeta) #28 & #46 drugs in 1991 
I Glucagon 
~ glucagon 
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I Estrogens, Progestins, Contraceptive Agents, and Androgens 
Estrogens 
M estradiol (Estrace) #170 drug in 1991 
M estradiol transdermal system (Estraderm) #58 drug in 1991 
M estropipate (Ogen) #160 drug in 1991 
Progestins 
M medroxyprogesterone (Provera) #26i drug in 1991 
Contraceptive Agents 
M ethinyl estradiol and levonorgostrel (Triphasil) 
#37 drug in 1991, other brands of this drug 
#91, #122 in 1991 
M ethinyl estradiol and norethindrone (Ortho-Novum 7/7/7) 
#15 drug in 1991, other brands of this drug 
#127, #155 in 1991 
M norethindrone and ethinyl estradiol (Ortho-Novum) 
#33 drug in 1991 
M norgestrel and ethinyl estradiol (Lo/Ovral) 
#48 drug in 1991 
Androgens 
~ fluoxymesterone (Halotestin) 
~ methyltestosterone (Metandren) 
~ testosterone cypionate (Andro-Cyp) 
"M" indicates a top 200 drug in 1991 -- note ranking after trade name 
" ~ " indicates major drugs -- see table 
Since so many different agents among the numerous classes of autacoid 
(hormone) agonists and antagonists are in current usage, only the more widely 
used agents are listed in the tables that follow in this section. 
Within the tables for the major agents will be included mechanisms of action, 
indications for use, adverse reactions, and ocular adverse reactions. The 
complete lists for all agents and drugs within the classes of hormone agents can 
be found in the sections which list all the drugs acting of the endocrine system 
and in the sections covering steroids. Within those sections are also listed drug 
interactions as well as contraindictions and precautions. The specific sections 
to find any additional information are as follows: 
- Adenohypophyseal hormones 
- Thyroid and antithyroid drugs 
- lnsullin and synthetic antidiabetics 
- Estrogens, progestins and androgens 
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cosyntropin (Cortrosyn) 
somatrem (Protropin) 
-- secreted by the anterior pituitary 
and stimulates the adrenal cortex 
to produce and secrete 
adrenocortical hormones 
-- ACTH secretion is regulated by 
a negative feedback mechanism, 
whereby elevated plasma 
corticosteroid levels suppress 
ACTH secretion 
-- in the absence of ACTH 
stimulation, the adrenal cortex may 
atrophy 
-- synthetic peptide 
corresponding to the amino acid 
residues 1 to 24 of human ACTH 
-- more potent and less allerginic 
than the exogneous ACTH 
preparations 
-- stimulates the adrenal cortex to 
produce and secrete 
adrenocortical hormones 
-- regulate growth by stimulating 
the actions of other endocrine 
glands 
-- the pharmacokinetic equivalent 
of the natural pituitary growth 
hormaone 
-- when administered parenterally, 
somatrem is well absorbed, 
distributed, metabolized in the 
liver, and excreted in the urine 
-- used for diagnostic testing 
of adrenocortical function 
-- treatment of adrenal 
insufficiency from long-term 
use of corticosteroids 
-- also used like 
corticosteroids for many anti-
inflammatory and 
immunosuppressive purposes 
-- used to treat symptoms of 
acute episodes of multiple 
sclerosis 
-- used to increase muscle 
strength in patients with 
sthenia 
-- because it is unavailable 1n a 
repository form, it is not used 
therapeutically, only 
diagnostically 
-- diagnostically used to 
differentiate between primary 
(adrenal) and secondary 
(pituitary) adrenal insufficiency 
-- used to treat linear growth 
failure from hormonal 
deficiency 
-- may be used as 
replacement therapy before 
epiphyseal closure in patients 
with GH deficiency 
-- produces an increase in the 
size and number of muscle 
cells, affecting organ growth 
and tissue metabolism 
-- sodium and water retention 
-- impaired wound healing 
-- dizziness, convulsions, and 
euphoria 
-- may mask signs of infection 
-- long-term ACTH use can 
cause iatrogenic Cushing's 
syndrome indistiguishable 
from the naturally occurring 
condition 
-- more potent 
allergenic than the exogenous 
ACTH preparations 
-- can cause pruritus and 
flushing 
-- pain at injection site 
-- glucose intolerance 
-- transient hypothyroidism 
during treatment 
-- development of antibodies 
that enterfere with treatment 
(rare) 
-- posterior subcapsular 
cataracts 
-- increased lOP 
-- glaucoma with possible 
damage to optic nerve 
-- exophthalmos 
-- none reported with 
diagnostic testing 
- none listed 
nr~c:.tAnnr pituitary injection 
vasopressin (Pitressin) 
-- includes all forms of 
hormone (ADH) 
-- an increase in cyclic AMP in the 
target cells mediates the effects of 
ADH 
-- normally synthesized by the 
nerve bodies of the hypothalamus 
and stored in the posterior pituitary 
•• must be given by injection or 
topical intranasal spray 
-- have a pressor effect from 
arteriole and capillary 
vasoconstriction, an antidiuretic 
action from increased 
reabsoorption of water in the renal 
tubular and collecting duct, and a 
stimulation effect on smooth 
muscles in the 
-- possesses vasopressor and 
antidiuretic hormone (ADH) activity 
- an increase in cyclic AMP in the 
target cells mediates the effects of 
ADH 
-- normally synthesized by the 
nerve bodies of the hypothalamus 
and stored in the posterior pituitary 
·- must be given by injection or 
topical intranasal spray 
-- have a pressor effect from 
arteriole and capillary 
vasoconstriction, an antidiuretic 
action from increased 
reabsoorption of water in the renal 
tubular and collecting duct, and a 
stimulation effect on smooth 
muscles in the 
extract with oxytocic, 
vasopressor, and antidiuretic 
properties has a rapid pressor 
effect that makes its use 
hazardous 
-- can be used to treat 
postoperative intestinal 
obstruction 
-- can be used to treat 
diabetes insipidus 
-· can be used to stimulate the 
uterus after incomplete 
expulsion of the placenta 
-- used to treat neurogenic 
diabetes insipidus 
-- used in treatment of 
postoperative abdominal 
distention, and in abdominal 
roentgenography to dispel 
interfering gas shadows 
-- tremors, diaphores.~, 
vertigo, circumoral and facial 
pallor, increased Gl motility, 
abdominal and uterine cramps, 
tinnitus, anxiety, 
-- tremor, sweating, vertigo, 
cardiac arrest, circumoral 
pallor, "pounding" in head, 
abdominal cramps, passage of 
gas, nausea, vomiting, 
urticaria,and bronchial 
constriction 
- mydriasis 
-· blindness 
- none listed 
Name 
fluoxymesterone 
(Halotestin) 
Mechanism of Action 
-- has uterine stimulant properties, 
as well as vasopressive and 
antidiuretic effects 
-- exact role in labor is not fully 
understood, but may act primarily 
on uterine myofibril activity to 
augment the number of 
contractign myofibrils 
-- has a weak antidiuretic effects 
-- has transient relaxing effect on 
vascular smooth muscle 
-- synthetic derivative of 
testosterone 
-- produces androgenic and 
anabolic effects by binding to 
androgen receptors in target 
organs,such as skeletal muscle, 
the prostate gland, and bone 
marrow 
-- receptor binding stimulates 
development in these organs and 
also increases protein synthesis 
-- may promote anabolic effects by 
blocking cortisol uptake in muscle 
and liver cells (cortisol normally 
acts as a catabolic agent increasing 
muscle breakdown and body 
stress mechanisms) 
-- by blocking cortisol uptake in 
muscle cells, steroid agents 
reduce muscle breakdown and 
increase muscle mass 
Indications for Use 
-- used to initiate or improve 
uterine contractions to 
achieve early vaginal delivery 
-- used to treat preeclampsia, 
eclampsia, and the premature 
rupture of membranes 
-- used to control postpartum 
hemorrhage, hasten uterine 
involution, and complete 
inevitable abortions after the 
20th week of 
....... _ . ./,~ • ......_ ~-~ ., .... .w. 
-- has a predominant 
androgenic activity 
-- used to treat hypogonadism 
and impotence caused by a 
testicular deficiency 
-- can also be used to prevent 
hereditary angioedema 
·- inoperaable breast 
cardnoma in females 
Adverse Reactions 
-- anaphylactic reaction 
-- postpartum hemorrhage 
-- cardiac arrhythmia 
-- nausea 
-- vomiting 
-- premature ventricular 
contractions 
-- Gl: nausea, vomiting, 
diarrhea, abdominal fullness 
-- CNS: excitation, insomnia, 
chills 
-- Endocrine adverse effects: 
a) virilization, acne, in all age 
groups 
b) in prepubertal males: first 
signs of virilization are phallic 
enlargement and increase in 
frequency of erections 
c) in postpubertal males: 
inhibition of testicular function 
with oligospermia, 
gynecomastia, testicular 
atrophy, male-pattern 
baldness 
d) in females: hisutism, 
hoarseness or deepening of 
the voice, clitoral enlargement, 
change in libido, male-pattern 
baldness 
Ocular Adverse 
Reactions 
-- decreased vision 
-- paralysis of accommodation 
-- mydriasis--acute 
- miiosis 
-- decreased reaction to light 
-- tox ic amblyopia 
-- none listed 
DRUGS 
Generic Name 
(Brand) 
testosterone cypionate 
(Andro-Cyp) 
nandrolone decanoate 
(Deca-Durabolin) 
Mechanism of Action 
--used primarily as an androgen 
-- produces androgenic and 
anabolic effects by binding to 
androgen receptors in target 
organs such as skeletal muscle, 
the prostate gland, and bone 
marrow 
-- receptor binding stimulates 
development in these organs and 
also increases protein synthesis 
-- may promote anabolic effects by 
blocking cortisol uptake in muscle 
and liver cells (cortisol normally 
acts as a catabolic agent increasing 
muscle breakdown and body 
stress mechanisms) 
-- by blocking cortisol uptake in 
muscle cells, steroid agents 
reduce muscle breakdown and 
increase muscle mass 
-- predominantly used as an 
anabolic agent 
-- may promote anabolic effects by 
blocking cortisol uptake in muscle 
and liver cells (cortisol normally 
acts as a catabolic agent increasing 
muscle breakdown and body 
stress mechanisms) 
-- by blocking cortisol uptake in 
muscle cells, steroid agents 
reduce muscle breakdown and 
increase muscle mass 
Indications for Use 
used to treat: 
-- eunuchism, 
-- male hormone deficiency 
after castration 
-- male climacteric symptoms 
-- also used to treat metastatic 
breast cancer in women 
-- management of anemia of 
renal insufficiency (this drug 
increases hemoglobin and red 
cell mass) 
-- indicated to build tissue 
Adverse Reactions 
1) in females: 
- produces masculinizing 
effects 
- hoarseness or deepening of 
the voice and clitoral 
enlargement 
- male-pattern hair distribution 
- menstrual irregularities 
- acne 
- increased libido 
2) in males: 
- gynecomastia 
- testicular atrophy 
- decreased levels of pituitary 
reproductive hormones 
- prostatic hypertrophy 
3) Gl: nausea, jaundice 
4) CNS: increased or 
decreased libido, headache, 
anxiety, depression 
5) retention of sodium, 
chloride, water,_potassium 
1) in females: 
- hoarseness or deepening of 
the voice 
- male-pattern hair distribution 
- menstrual irregularities 
- acne 
- increased libido 
2) in males: 
- gynecomastia 
- testicular atrophy 
- decreased levels of pituitary 
reproductive hormones 
- prostatic hypertrophy 
3) Gl: nausea, jaundice 
4) CNS: increased or 
decreased libido, headache, 
anxiety, depression 
5) retention of sodium, 
chloride. water,potassium 
Ocular Adverse 
Reactions 
-- none listed 
~ none listed 
DRUGS 
Generic Name 
(Brand) 
oxandrolone (Anavar) 
stanozolol (Winstrol) 
Mechanism of Action 
- used primarily for its anabolic 
effects 
- may promote anabolic effects by 
blocking cortisol uptake in muscle 
and liver cells (cortisol normally 
acts as a catabolic agent increasing 
muscle breakdown and body 
stress mechanisms) 
-- by blocking cortisol uptake in 
muscle cells, steroid agents 
reduce muscle breakdown and 
inqease muscle mass 
- primarily used for its anabolic 
activity 
- may promote anabolic effects by 
blocking cortisol uptake in muscle 
and liver cells (cortisol normally 
acts as a catabolic agent increasing 
muscle breakdown and body 
stress mechanisms) 
-- by blocking cortisol uptake in 
muscle cells, steroid agents 
reduce muscle breakdown and 
increase muscle mass 
Indications for Use 
- adjunct treatment to promote 
weight gain after extensive 
surgery, chronic infection, 
trauma, or other medically 
related weight loss 
- may also be used to relieve 
bone pain in osteoporosis or 
to offset catabolism from long-
term corticosteroid use 
- can be used to treat 
hereditary angioedema 
Adverse Reactions 
1) in females: 
- hoarseness or deepening of 
the voice 
- male-pattern hair distribution 
- menstrual irregularities 
-acne 
- increased libido 
2) in males: 
- gynecomastia 
• testicular atrophy 
· decreased levels of pituitary 
reproductive hormones 
- prostatic hypertrophy 
3) Gl: nausea, jaundice 
4} CNS: increased or 
decreased libido, headache, 
anxiety. depression 
5) retention of sodium, 
chloride, water, potassium 
1) in females: 
- hoarseness or deepening of 
the voice 
• male-pattern hair distribution 
- menstrual irregularities 
- acne 
- increased libido 
2) in males: 
- gynecomastia 
- testicular atrophy 
- decreased levels of pituitary 
reproductive hormones 
- prostatic hypertrophy 
3) Gl: nausea, jaundice 
4) CNS: increased or 
decreased libido, headache, 
anxiety, depression 
5) retention of sodium, 
chloride. water,. potassium 
Ocular Adverse 
Reactions 
- none listed 
- none listed 
sms are not well 
understood 
- the principal effect of thyroid 
hormones is an increased 
metabolic rate in body tissues 
- affect protein and carbohydrate 
metabolism and stimulate protein 
synthesis 
- promote gluconeogenesis and 
increase the use of glycogen 
stores 
- by decreasing hepatic and serum 
cholesterol concentrations, 
thyroid hormones affect lipid 
metabolism 
- stimulate heart and increase 
cardiac o 
understood 
- the principal effect of thyroid 
hormones is an increased 
metabolic rate in body tissues 
- affect protein and carbohydrate 
metabolism and stimulate protein 
synthesis 
- promote gluconeogenesis and 
increase the use of glycogen 
stores 
- by decreasing hepatic and serum 
cholesterol concentrations, 
thyroid hormones affect lipid 
metabolism 
- stimulate heart and increase 
cardiac outout 
- act as replacement or 
substitute hormones when 
the body's hormone level 
cannot meet its need 
- thyroid hormone 
replacement in 
hypothyroidism 
- for suppression of 
thyrotropin secretion in 
patients with goiters or chronic 
lymphocytic thyroiditis 
- act as replacement or 
substitute hormones when 
the body's hormone level 
cannot meet its need 
- drug of choice for thyroid 
hormone replacement in 
hypothyroidism; 
- drug of choice for thyroid 
stimulating hormone 
suppression therapy 
- Gl reactions: diarrhea, 
cramps, weight loss, increased 
appetite 
- cardiovascular: palpitations, 
sweating, tachycardia, 
increased blood pressure 
- CNS: headache, tremors, 
nervousness, insomnia 
reactions: 
cramps, weight loss, increased 
appetite 
- cardiovascular: palpitations, 
sweating, tachycardia, 
increased blood pressure 
- CNS: headache, tremors, 
nervousness, insomnia 
- decreased vision, eyelid 
edema and hyperemia, 
blepharospasm, photophobia, 
visual hallucinations, 
exophthalmos, and paralysis 
of extraocular muscles 
resulting in ptosis and diplopia 
- decreased vision, eyelid 
edema and hyperemia, 
blepharospasm, photophobia, 
visual hallucinations, 
exophthalmos, and paralysis 
of extraocular muscles 
resulting in ptosis and diplopia 
DRUGS 
Generic Name 
(Brand) 
thyrotropin TSH 
(Thytropar) 
protirelin TRH (Thypinone) 
Mechanism of Action 
- mechanisms are not well 
understood 
- the principal effect of thyroid 
hormones is an increased 
metabolic rate in body tissues 
- affect protein and carbohydrate 
metabolism and stimulate protein 
synthesis 
- promote gluconeogenesis and 
increase the use of glycogen 
stores 
- by decreasing hepatic and serum 
cholesterol concentrations, 
thyroid hormones affect lipid 
metabolism 
- stimulate heart and increase 
cardiac output 
- mechanisms are not well 
understood 
- the principal effect of thyroid 
hormones is an increased 
metabolic rate in body tissues 
- affect protein and carbohydrate 
metabolism and stimulate protein 
synthesis 
- promote gluconeogenesis and 
increase the use of glycogen 
stores 
- by decreasing hepatic and serum 
cholesterol concentrations, 
thyroid hormones affect lipid 
metabolism 
- stimulate heart and increase 
cardiac output 
Indications for Use 
- for differential diagnosis 
between primary and 
secondary hypothyroidism 
- for differential diagnosis of 
secondary and tertiary 
hypothyroidism 
Adverse Reactions 
- Gl reactions: diarrhea, 
cramps, weight loss, increased 
appetite 
- cardiovascular: palpitations, 
sweating, tachycardia, 
increased blood pressure 
- CNS: headache, tremors, 
nervousness, insomnia 
- G I reactions: diarrhea, 
cramps, weight loss, increased 
appetite 
- cardiovascular: palpitations, 
sweating, tachycardia, 
increased blood pressure 
- CNS: headache, tremors, 
nervousness, insomnia 
Ocular Adverse 
Reactions 
- decreased vision, eyelid 
edema and hyperemia, 
blepharospasm, photophobia, 
visual hallucinations, 
exophthalmos, and paralysis 
of extraocular muscles 
resulting in ptosis and diplopia 
- decreased vision, eyelid 
edema and hyperemia, 
blepharospasm, photophobia, 
visual hallucinations, 
exophthalmos, and paralysis 
of extraocular muscles 
resulting in ptosis and diplopia 
propyhhiouracil (PTU) 
iodine (Potassium Iodide 
Solution, USP) 
- prevents thyroid hormone 
synthesis by blocking the 
combination of iodine and tyrosine 
- prevents t 
synthesis by blocking the 
combination of iod ine and tyrosine 
- inhibits thyroid hormone 
synthesis through the Wolff-
Chaikoff effect, in which above--
critical concentrations of 
intracellular iodide seem to deter 
hormone synthesis 
- can limit the release of thyroid 
hormones by inhibiting 
thyroglobulin endocytosis, which 
results in colloid accumulation in 
the follicles 
- used to treat 
hyperthyroidism by 
decreasing concentarations of 
thyroid hormones in circulation 
- can also serve as an adjunct 
before thyroid surgery and 
with radioactive iodine therapy 
- 10 times as potent as 
propylthiouracil 
- used to treat severe 
hyperthyroidism because it 
takes effect faster than 
methimazole 
- used to treat thyroid crisis 
because it inhibits the 
conversion of T 4 to T 3 
- drug of choice during 
pregnancy because it is safer 
for the fetus 
- used for rapid treatment of 
hyperthyroidism (produces 
visible effectes in three days) 
- used to prepare thyroid for 
surgery by firming the gland 
and reducing vascularity 
- adverse reactions occur in 
less than 3% of patients 
- can produce toxic reactions 
such as hypersensitivity 
reactions and 
granulocytopenia 
- paresthesias, neuritis, 
headache, nausea and 
vomiting, skin rash, urticaria, 
jaundice, hepatitis 
adverse reactions occur in 
less than 3% of patients 
- can produce toxic reactions 
such as hypersensitivity 
reactions and 
granulocytopenia 
- paresthesias, neuritis, 
headache, nausea and 
vomiting, skin rash, urticaria, 
ndice, 
- iodism, chronic toxicity 
related to iodine therapy is 
dose dependent 
- can produce unpleasant 
brassy taste, burning 
sensation in the mouth, 
increased salivation, and 
swelling of the parotid and 
submaxillary glands 
- other signs and symptoms 
may include headache, 
rhinitis, conjunctivitis gastric 
irritation, bloody diarrhea, 
and deoression 
- nystagmus 
- keratitis 
- eyelids or conjunctiva: 
a) allergic reactions 
b) conjunctivitis 
c) depigmentaion 
- decreased lacrimation 
- exophthalmos 
- subconjunctival or retinal 
hemorrhages secondary to 
-induced anemia 
- keratitis 
- eyelids or conjunctiva; 
a) allergic reactions 
b) conjunctivitis 
c) depigmentaion 
- exophthalmos 
- subconjunctival or retinal 
hemorrhages secondary to 
drug-induced anemia 
- decreased vision 
- decreased accommodation 
- exophthalmos 
- lacrimation, ocular pain, 
burning sensation 
- eyelids or conjunctiva: 
allergic reactions. hyperemia, 
conjunctivitis, edema 
- punctate keratitis 
- decreases blood y,u~_;u~t:: 
facilitating the uptake and 
metabolism of glucose by insulin-
dependent target cells located in 
striated muscle and adipose tissue 
- also inhibits hepatic glucose 
production and the breakdown of 
glycogen, protein, and fat 
- increases the active transport of 
amino acids in muscle, thereby 
increasing protein synthesis 
act1on 
unknown but the pancreas must 
already be functioning at a minimal 
level 
- probably stimulate pancreatic 
beta cells to release insulin 
- decrease glucose production by 
the liver 
- may increase the number and 
sensitivity of cellular insulin 
receptors 
- may partially reverse the post-
receptor deficit in insulin action 
enabling the completion of 
intracellular glucose metabolism 
- pnmary use 1s for patients 
with Type I diabetes mellitus 
(characterized by insufficient 
insulin production ability of 
pancreatic beta cells) who 
require exogenous insulin to 
control blood glucose 
- also used for Type II and 
other types of diabetes 
mellitus when other methods 
are ineffective or 
contraindicated 
- sometimes used for 
hyperkalemia because it 
lowers potassium levels 
patients 
Type II diabetes mellitus if diet 
and exercise do not maintain 
blood glucose at normal or 
near-normallevels 
- not indicated for patients 
with Type I diabetes mellitus, 
because pancreatic beta cells 
are not functioning at a 
sufficient level 
- a first-generation 
sulfonylurea used to assist in 
the control of mild to 
moderately severe type II 
diabetes mellitus (adult, 
maturity-onset) that doesn't 
require insulin but can't be 
conrolled by diet alone 
hi/Doglycemla from too much 
in, too little food or too 
much exercise 
- signs of hypoglycemia are 
nervousness, shakiness, 
sweating, weakness, 
irritabiility, hynger, tachycardia, 
changes in speech, hearing or 
vision 
- if hypoglycemia is untreated, 
it may progress to 
unconsciousness, 
convulsions, coma, or death 
- Somogyi phenomenon: 
patient experiences 
hypoglycemia followed by a 
compensatory period of 
rebound hyperglycemia as the 
body increases glucose 
production to correct the 
resulting from too little food or 
too much medication 
- signs of hypoglycemia are 
nervousness, shakiness, 
sweating, weakness, 
irritabiility, hunger, tachycardia, 
changes in speech, hearing or 
vision 
- other rare reactions may 
include nausea, vomiting, skin 
rashes, pruritis, headache, 
numbness and tingling 
vision 
- nystagmus 
- paresis of extraocular 
muscles 
- diplopia 
- pupil mydriasis 
ecreased vision 
- paresis of extraocular 
muscles 
- diplopia 
- eyelids or conjunctiva: 
a) allergic reactions 
b) hyperemia 
c) conjunctiv~is 
photophobia 
- red-green defect 
DRUGS 
Generic Name 
(Brand) 
tolazamide (Tolinase) 
tolbutamide (Orinase) 
Mechanism of Action 
- mechanism of action remains 
unknown but the pancreas must 
already be functioning at a minimal 
level 
- probably stimulate pancreatic 
beta cells to release insulin 
- decrease glucose production by 
the liver 
- may increase the-number and 
sensitivity of cellular insulin 
receptors 
- may partially reverse the post-
receptor deficit in insulin action 
enabling the completion of 
intracellular glucose metabolism 
- mechanism of action remains 
unknown but the pancreas must 
already be functioning at a minimal 
level 
- probably stimulate pancreatic 
beta cells to release insulin 
- decrease glucose production by 
the liver 
- may increase the number and 
sensitivity of cellular insulin 
receptors 
- may partially reverse the post-
receptor deficit in insulin action 
enabling the completion of 
intracellular glucose metabolism 
Indications for Use 
- indicated for patients with · 
Type II diabetes mellitus if diet 
and exercise do not maintain 
blood glucose at normal or 
near-normallevels 
- not indicated for patients 
with Type I diabetes mellitus, 
because pancreatic beta cells 
are not functioning at a 
sufficient level 
- a first-generation 
sulfonylurea used to assist in 
the control of mild to 
moderately severe type II 
diabetes mellitus (adult, 
maturity-onset) that doesn't 
require insulin but can't be 
controlled by diet alone 
- indicated for patients with 
Type II diabetes mellitus if diet 
and exercise do not maintain 
blood glucose at normal or 
near-normallevels 
- not indicated for patients 
with Type I diabetes mellitus, 
because pancreatic beta cells 
are not functioning at a 
sufficient level 
- a first-generation 
sulfonylurea used to assist in 
the control of mild to 
moderately severe type II 
diabetes mellitus (adult, 
maturity-onset) that doesn't 
require insulin but can't be 
controlled by diet alone 
Adverse Reactions 
- hypoglycemia typically 
resulting from too little food or 
too much medication 
- signs of hypoglycemia are 
nervousness, shakiness, 
sweating, weakness, 
irritabiility, hunger, tachycardia, 
changes in speech, hearing or 
vision 
- other rare reactions may 
include nausea, vomiting, skin 
rashes, pruritis, headache, 
numbness and tingling 
- hypoglycemia typically 
resulting from too little food or 
too much medication 
- signs of hypoglycemia are 
nervousness, shakiness, 
sweating, weakness, 
irritabiility, hunger, tachycardia, 
changes in speech, hearing or 
vision 
- other rare reactions may 
include nausea, vomiting, skin 
rashes, pruritis, headache, 
numbness and tingling 
Ocular Adverse 
Reactions 
- decreased vision 
- paresis of extraocular 
muscles 
- diplopia 
- eyelids or conjunctiva: 
a) allergic reactions 
b) hyperemia 
c) conjunctivitis 
- photophobia 
- red-green defect 
- decreased vision 
- paresis of extraocular 
muscles 
- diplopia 
- eyelids or conjunctiva: 
a) allergic reactions 
b) hyperemia 
c) conjunctivitis 
- photophobia 
- red-green defect 
DRUGS 
Generic Name 
_@ranc:J) 
glipizide (Giucotrol) 
#47 drug in 1991 
glyburide (Micronase, 
Diabeta) 
#28 & #46 drugs in 1991 
Mechanism of Action 
- mechanism of action remains 
unknown but the pancreas must 
already be functioning at a minimal 
level · 
- probably stimulate pancreatic 
beta cells to release insulin 
- decrease glucose production by 
the liver 
- may increase the number and 
sensitivity of cellular insulin 
receptors 
- may partially reverse the post-
receptor deficit in insulin action 
enabling the completion of 
intracellular glucose metabolism 
- mechanism of action remains 
unknown but the pancreas must 
already be functioning at a minimal 
level 
- probably stimulate pancreatic 
beta cells to release insulin 
- decrease glucose production by 
the liver 
- may increase the number and 
sensitivity of cellular insulin 
receptors 
- may partially reverse the post-
receptor deficit in insulin action 
enabling the completion of 
intracellular glucose metabolism 
Indications for Use 
- indicated for patients with 
Type II diabetes mellitus if diet 
and exercise do not maintain 
blood glucose at normal or 
near-normallevels 
- not indicated for patients 
with Type I diabetes mellitus, 
because pancreatic beta cells 
are not functioning at a 
sufficient level 
- a second-generation 
sulfonylurea used to assist in 
the control of mild to 
moderately severe type II 
diabetes mellitus (adult, 
maturity-onset) that doesn't 
require insulin but can't be 
controlled by diet alone 
- indicated for patients with 
Type II diabetes mellitus if diet 
and exercise do not maintain 
blood glucose at normal or 
near-normal levels 
- not indicated for patients 
with Type I diabetes mellitus, 
because pancreatic beta cells 
are not functioning at a 
sufficient level 
- a second-generation 
sulfonylurea used to assist in 
the control of mild to 
moderately severe type II 
diabetes mellitus (adult, 
maturity-onset) that doesn't 
require insulin but can't be 
controlled by diet alone 
Adverse Reactions 
- hypoglycemia typically 
resulting from too little food or 
too much medication 
- signs of hypoglycemia are 
nervousness, shakiness, 
sweating, weakness, 
irritabiility, hunger, tachycardia, 
changes in speech, hearing or 
vision 
- other rare reactions may 
include nausea, vomiting, skin 
rashes, pruritis, headache, 
dizziness. fatigue, drowsiness 
- hypoglycemia typically 
resulting from too little food or 
too much medication 
- signs of hypoglycemia are 
nervousness, shakiness, 
sweating, weakness, 
irritabiility, hunger, tachycardia, 
changes in speech, hearing or 
vision 
- other rare reactions may 
include nausea, vomiting, skin 
rashes, pruritis, headache, 
dizziness, fatigue, drowsiness 
Ocular Adverse 
Reactions 
- decreased vision 
- paresis of extraocular 
muscles 
- diplopia 
- eyelids or conjunctiva: 
a) allergic reactions 
b) hyperemia 
c) conjunctiv~is 
- photophobia 
- red-green defect 
- decreased vision 
- paresis of extraocular 
muscles 
- diplopia 
- eyelids or conjunctiva: 
a) allergic reactions 
b) hyperemia 
c) conjunctiv~is 
- photophobia 
- red-green defect 
#170 drug in 1991 
- opposes the actions of insulin 
- regulates the rate of glucose 
production through 
glycogenolysis, gluconeogenesis, 
and lipolysis 
- stimulates the conversion of 
glycogen to glucose through the 
process of glycogenolysis 
- also stimulates the production of 
glucose from plasma amino acids 
resulting form gluconeogenesis 
- increases lipolysis and inhibits 
the stora e of tri I cerides 
- believed to involve cytoplasmic 
receptor proteins found in 
estrogen-responsive tissues in 
the female breast and 
genitourinary tract 
- estrogen binds to these 
cytoplasmic receptors and the 
resulting estrogen-receptor 
complex is transported into the 
nucleus 
- this action stimulates the 
synthesis of mANA and DNA 
which promotes the synthesis of 
specific proteins responsible for 
the actions of the estrogens 
Indications 
- indicated for the emergency 
treatment of severe 
hypoglycemia 
- also used during radiologic 
examination of the Gl tract to 
produce a hypokinetic state 
pnmary use is suppleme 
("replacement" therapy) of the 
hormone in the following 
conditions: 
- ovarian failure or removal in 
the young woman 
- menopausal syndrome 
- postmenopausal atrophy of 
genital tissues 
- postmenopausal 
osteoporosis 
- also used in selected cases 
of breast cancer and prostate 
cancer 
- adverse reactions are rare 
- nausea and vomiting may 
occur occasionally 
- with large doses or 
prolonged treatment with 
glucagon, hypokalemia can 
result 
- since glucagon is a protein a 
patient can develop an allergy 
to it (this reaction is rare) 
rough bleeamg 
change in menstrual flow, 
dysmenorrhea 
- Gl : nausea, vomiting, 
abdominal cramps, bloating 
- Dermatologic: chloasma or 
melasma, erythema 
nodosum/multiforme, scalp 
hair loss 
- CNS: headache, migraine, 
dizziness, mental depression 
- increased risk of endometrial 
cancer 
- increased incidence of gall 
bladder disease 
- thromboembolisms 
- hypertension 
Ocular Adverse 
n ,aac.tlons 
- none 
- steepening of corneal 
curvature 
- contact lens intolerance 
- increased risk of retinal 
thrombosis and optic neuritis 
c6a Estrogens (continued) 
DRUGS 
Generic Name 
I (Brand) 
estradiiol transdermal 
system (Estraderm) 
#58 drug in 1991 
estropipate (Ogen) 
#160 drug in 1991 
Mechanism of Action 
- believed to involve cytoplasmic 
receptor proteins found in 
estrogen-responsive tissues in 
the female breast and 
genitourinary tract 
- estrogen binds to these 
cytoplasmic receptors and the 
resulting estrogen-receptor 
complex is transported into the 
nucleus 
- this action stimulates the 
synthesis of mANA and DNA 
which promotes the synthesis of 
specific proteins responsible for 
the actions of the estrogens 
- believed to involve cytoplasmic 
receptor proteins found in 
estrogen-responsive tissues in 
the female breast and 
genitourinary tract 
- estrogen binds to these 
cytoplasmic receptors and the 
resulting estrogen-receptor 
complex is transported into the 
nucleus 
- this action stimulates the 
synthesis of mANA and DNA 
which promotes the synthesis of 
specific proteins responsible for 
the actions of the estrogens 
Indications for Use 
primary use is supplemental 
("replacement" therapy) of the 
hormone in the following 
conditions: 
- ovarian failure or removal in 
the young woman 
- menopausal syndrome 
- postmenopausal atrophy of 
genital tissues 
- postmenopausal 
osteoporosis 
- also used in selected cases 
of breast cancer and prostate 
cancer 
primary use is supplemental 
("replacement" therapy) of the 
hormone in the following 
conditions: 
- ovarian failure or removal in 
the young woman 
- menopausal syndrome 
- postmenopausal atrophy of 
genital tissues 
- postmenopausal 
osteoporosis 
- also used in selected cases 
of breast cancer and prostate 
cancer 
Adverse Reactions 
- GU: breakthrough bleeding, 
change in menstrual flow, 
dysmenorrhea 
- Gl: nausea, vomiting, 
abdominal cramps, bloating 
- Dermatologic: chloasma or 
melasma, erythema 
nodosurnlmultiforme, scalp 
hair loss 
- CNS: headache, migraine, 
dizziness, mental depression 
- increased risk of endometrial 
cancer 
- increased incidence of gall 
bladder disease 
- thromboembolisms 
- hypertension 
- GU: breakthrough bleeding, 
change in menstrual flow, 
dysmenorrhea 
- Gl: nausea, vomiting, 
abdominal cramps, bloating 
- Dermatologic: chloasma or 
melasma, erythema 
nodosurnlmultiforme, scalp 
hair loss 
- CNS: headache, migraine, 
dizziness, mental depression 
- increased risk of endometrial 
cancer 
- increased incidence of gall 
bladder disease 
- thromboembolisms 
- hypertension 
Ocular Adverse 
Reactions 
- steepening of corneal 
curvature 
- contact lens intolerance 
- increased risk of retinal 
thrombosis and optic neuritis 
- steepening of corneal 
curvature 
- contact lens intolerance 
- increased risk of retinal 
thrombosis and optic neuritis 
medroxyprogesterone 
(Provera) #26 drug in 
1991 
- act at the cellular level on 
receptor proteins in cellular 
cytoplasm 
- resulting progesterone-receptor 
complex is transported into the 
cell nucleus where the synthesis 
of mANA is stimulated and the cell 
is directed to produce various 
proteins responsible for the 
pharmacologic effects of the 
progestins 
- by inducing and maintaining a 
lining in the uterus that resembles 
pregnancy, uterine bleeding can 
be prevented 
- by suppressing the release of 
the pituitary gland hormone that 
induces ovulation and by 
stimulating the secretion of mucus 
by the uterine cervix, pregnancy 
Can be nr~VPnfArf 
- used in a cyclic manner with 
estrogens to regulate or 
restore the menstrual cycle 
and treat uterine bleeding due 
to hormonal imbalance and 
enometriosis 
- used to treat endometrial or 
renal cancer, endometriosis 
and premenstrual syndrome 
(PMS) 
- used for oral contraception in 
combination with estrogens 
- breakthrough bleeding, 
spotting, change in menstrual 
flow, amenorrhea, breast 
changes (tenderness) 
- edema, changes in weight 
- less common: cervical 
erosions, abnormal 
secretions, uterine fibrosis, 
vaginal candidiasis, mental 
depression, melasma (skin 
discoloration) 
- CNS reactions sometimes 
occur: migraines, dizziness, 
nervousness, insomnia, 
fatigue 
- thrombophlebitis, pain or 
tenderness in thigh or leg 
- rare except when used in 
higher concentrations : retinal 
thrombosis (sudden 
impairment or loss of vision) 
ethinyl estradiol and 
levonorgestrel (Triphasil) 
#37 drug in 1991 
other brands of this drug 
#91, #122 in 1991 
ethinyl estradiiol and 
norethindrone (Ortho-
Novum 7/7/7) #15 drug in 
1991 
other brands of this drug 
#127, #155 in 1991 
- act as contraceptives by 
suppressing ovulation and 
inhibiting implantation of the 
fertilized ovum 
- create negative feedback upon 
the hypothalamus and pituitary 
gland, reducing follicle-stimulating 
hormone (FSH) and luteininzing 
hormone (LH) concentration levels 
- the diminished FSH 
concentration level prevents 
follicle development, and the 
absence of the midcycle surge of 
LH prevents ovulation 
- alters the cervical mucus so that it 
resists the passage of sperm 
- alters the lining of the uterus so 
that it resists implantation of the 
if ovulation occ 
- act as contraceptives by 
suppressing ovulation and 
inhibiting implantation of the 
fertilized ovum 
• create negative feedback upon 
the hypothalamus and pituitary 
gland, reducing follicle-stimulating 
hormone (FSH) and luteininzing 
hormone (LH) concentration levels 
• the diminished FSH 
concentration level prevents 
follicle development, and the 
absence of the midcycle surge of 
LH prevents ovulation 
- alters the cervical mucus so that it 
resists the passage of sperm 
- alters the lining of the uterus so 
that it resists implantation of the 
ovulation 
nmarny to prevent 
pregnancy and are the most 
effective form of reversible 
contraception available 
• sometimes used to treat 
menstrual irrregularity, 
excessively heavy menstrual 
flow , and endometriosis 
• used primarily to prevent 
pregnancy and are the most 
effective form of reversible 
contraception available 
• sometimes used to treat 
menstrual irrregularity, 
excessively heavy menstrual 
flow , and endometriosis 
• most are 
estrogen content 
· Gl reactions: nausea is #1 
reaction, vomiting, abdominal 
cramping, diarrhea, 
constipation 
- hypertension and increased 
risk of myocardial infarction 
• increased risk of 
thromboembolism 
- can affect levels of several 
serum proteins produced by 
the liver 
• increased risk of liver tumors 
and gall bladder disease 
- most are related to dose 
estrogen content 
- Gl reactions: nausea is #1 
reaction, vomiting, abdominal 
cramping, diarrhea, 
constipation 
- hypertension and increased 
risk of myocardial infarction 
- increased risk of 
thromboembolism 
- can affect levels of several 
serum proteins produced by 
the liver 
- increased risk of liver tumors 
and gall bladder disease 
vision 
- retinal vascular disorders 
1) occlusion 
2) thrombosis 
3) hemorrhage 
4) retinal or macular edema 
- visual field scotomas, 
constriction, quadrantanopsia 
or hemianopsia 
- retrobulbar or optic neuritis 
- diplopia 
- papilledema secondary to 
pseudotumor cerebri 
• decreased VISion 
- retinal vascular disorders 
1) occlusion 
2) thrombosis 
3) hemorrhage 
4) retinal or macular edema 
- visual field scotomas, 
constriction, quadrantanopsia 
or hemianopsia 
- retrobulbar or optic neuritis 
• diplopia 
• papilledema secondary to 
pseudotumor cerebri 
c6c Contraceptive agents (continued) 
DRUGS 
Generic Name 
(Brand) 
norethindrone and ethinyl 
estradiol (Ortho-Novum) 
#33 drug nn 1991 
norgestrel and ethinyl 
estradiol (Lo/Ovral) 
#48 drug in 1991 
Mechanism of Action !Indications for Use 
- act as contraceptives by 
suppressing ovulation and 
inhibiting implantation of the 
fertilized ovum 
- create negative feedback upon 
the hypothalamus and pituitary 
gland, reducing follicle-stimulating 
hormone (FSH) and luteininzing 
hormone (LH) concentration levels 
- the diminished FSH 
concentration level prevents 
follicle development, and the 
absence of the midcycle surge of 
LH prevents ovulation 
- alters the cervical mucus so that it 
resists the passage of sperm 
- alters the lining of the uterus so 
that it resists implantation of the 
egg (if ()Vl!i~tion occurs) 
- act as contraceptives by 
suppressing ovulation and 
inhibiting implantation of the 
fertilized ovum 
- create negative feedback upon 
the hypothalamus and pituitary 
gland, reducing follicle-stimulating 
hormone (FSH) and luteininzing 
hormone (LH) concentration levels 
- the diminished FSH 
concentration level prevents 
follicle development, and the 
absence of the midcycle surge of 
LH prevents ovulation 
- ahers the cervical mucus so that it 
resists the passage of sperm 
- alters the lining of the uterus so 
that it resists implantation of the 
egg (if ovulation occurs) 
- used primarily to prevent 
pregnancy and are the most 
effective form of reversible 
contraception available 
- sometimes used to treat 
menstrual irrregularity, 
excessively heavy menstrual 
flow , and endometriosis 
- used primarily to prevent 
pregnancy and are the most 
effective form of reversible 
contraception available 
- sometimes used to treat 
menstrual irrregularity, 
excessively heavy menstrual 
flow , and endometriosis 
Adverse Reactions 
- most are related to dose and 
estrogen content 
- Gl reactions: nausea is #1 
reaction, vomiting, abdominal 
cramping, diarrhea, 
constipation 
- hypertension and increased 
risk of myocardial infarction 
- increased risk of 
thromboembolism 
- can affect levels of several 
serum proteins produced by 
the liver 
- increased risk of liver tumors 
and gall bladder disease 
- most are related to dose and 
estrogen content 
- Gl reactions: nausea is #1 
reaction, vomiting, abdominal 
cramping, diarrhea, 
constipation 
- hypertension and increased 
risk of myocardial infarction 
- increased risk of 
thromboembolism 
- can affect levels of several 
serum proteins produced by 
the liver 
- increased risk of liver tumors 
and gall bladder disease 
Ocular Adverse 
Reactions 
- decreased vision 
- retinal vascular disorders 
1) occlusion 
2) thrombOsis 
3) hemorrhage 
4) retinal or macular edema 
- visual field scotomas, 
constriction, quadrantanopsia 
or hemianopsia 
- retrobulbar or optic neuritis 
- diplopia 
- papilledema secondary to 
pseudotumor cerebri 
- decreased vision 
- retinal vascular disorders 
1) occlusion 
2) thrombosis 
3) hemorrhage 
4) retinal or macular edema 
- visual field scotomas, 
constriction, quadrantanopsia 
or hemianopsia 
- retrobulbar or optic neuritis 
- ·diplopia 
- papilledema secondary to 
pseudotumor cerebri 
fluoxymesterone 
(Halotestin) 
-- synthetic derivative of 
testosterone 
-- produces androgenic and 
anabolic effects by binding to 
androgen receptors in target 
organs,such as skeletal muscle, 
the prostate gland, and bone 
marrow 
-- receptor binding stimulates 
development in these organs and 
also increases protein synthesis 
-- may promote anabolic effects by 
blocking cortisol uptake in muscle 
and liver cells (cortisol normally 
acts as a catabolic agent increasing 
muscle breakdown and body 
stress mechanisms) 
-- by blocking cortisol uptake in 
muscle cells, steroid agents 
reduce muscle breakdown and 
increase muscle mass 
-- has a predominant 
androgenic activity 
-- used to treat hypogonadism 
and impotence caused by a 
testicular deficiency 
-- can also be used to prevent 
hereditary angioedema 
-- inoperaable breast 
carcinoma in females 
-- Gl: nausea, .~ ........ ~. 
diarrhea, abdominal fullness 
-- CNS: excitation, insomnia, 
chills 
-- Endocrine adverse effects: 
a) virilization, acne, in all age 
groups 
b) in prepubertal males: first 
signs of virilization are phallic 
enlargement and increase in 
frequency of erections 
c) in postpubertal males: 
inhibition of testicular function 
with oligospermia, 
gynecomastia, testicular 
atrophy, male-pattern 
baldness 
d) in females: hisutism, 
hoarseness or deepening of 
the voice, clitoral enlargement, 
change in libido, male-pattern 
baldness 
-- none listed 
DRUGS 
Generic Name 
(Brand) 
methyltestosterone 
(Metandren) 
testosterone cypionate 
(Andro-Cyp) 
Mechanism of Action 
-- synthetic derivative of 
testosterone 
-- produces androgenic and 
anabolic effects by binding to 
androgen receptors in target 
organs,such as skeletal muscle, 
the prostate gland, and bone 
marrow 
-- receptor binding stimulates 
development in these organs and 
also increases protein synthesis 
-- may promote anabolic effects by 
blocking cortisol uptake in muscle 
and liver cells (cortisol normally 
acts as a catabolic agent increasing 
muscle breakdown and body 
stress mechanisms) 
-- by blocking cortisol uptake in 
muscle cells, steroid agents 
reduce muscle breakdown and 
increase muscle mass 
--used primarily as an androgen 
-- produces androgenic and 
anabolic effects by binding to 
androgen receptors in target 
organs such as skeletal muscle, 
the prostate gland. and bone 
marrow 
-- receptor binding stimulates 
development in these organs and 
also increases protein synthesis 
-- may promote anabolic effects by 
blocking cortisol uptake in muscle 
and liver cells (cortisol normally 
acts as a catabolic agent increasing 
muscle breakdown and body 
stress mechanisms) 
-- by blocking cortisol uptake in 
muscle cells, steroid agents 
reduce muscle breakdown and 
increase muscle mass 
Indications for Use 
- used to treat eunuchism, 
eunuchoidinsm, and 
hypogonadism 
- also used to treat male 
climacteric syndrome 
- also used to treat breast 
cancer 1 to 5 years after 
menopause and postpartum 
breast engorgement in 
women 
used to treat: 
-- eunuchism, 
-- male hormone deficiency 
after castration 
-- male climacteric symptoms 
-- also used to treat metastatic 
breast cancer in women 
Adverse Reactions 
-- Gl: nausea, vomiting, 
diarrhea, abdominal fullness 
-- CNS: excitation, insomnia, 
chills 
-- Endocrine adverse effects: 
a) virilization, acne, in all age 
groups 
b) in prepubertal males: first 
signs of virilization are phallic 
enlargement and increase in 
frequency of erections 
c) in postpubertal males: 
inhibition of testicular function 
with oligospermia, 
gynecomastia, testicular 
atrophy, male-pattern 
baldness 
d) in females: hisutism, 
hoarseness or deepening of 
the voice, clitoral enlargement, 
change in libido, male-pattern 
baldness 
1) in females: 
- produces masculinizing 
effects 
- hoarseness or deepening of 
the voice and clitoral 
enlargement 
- male-pattern hair distribution 
- menstrual irregularities 
-acne 
- increased libido 
2) in males: 
- gynecomastia 
- testicular atrophy 
- decreased levels of pituitary 
reproductive hormones 
- prostatic hypertrophy 
3) Gl: nausea, jaundice 
4) CNS: increased or 
decreased libido, headache, 
anxiety. depression 
5) retention of sodium, 
chloride, water, potassium 
Ocular Adverse 
Reactions 
-· none listed 
-- none listed 
BRONCHODILATORS 
M albuterol 
bitolterol 
A ephedrine 
A metapranolol 
A pirbuterol 
A terbutaline 
"A" indicates major drugs-- see table 
(Proventil #21, Ventolin #24) 
(Tornalate) 
(Efedron, Vantronol) 
(Aiupent) 
(Maxair) 
(Brethine) 
"M" indicates a Top 200 Drug in 1991 --note ranking after trade name 
Indications for Use: 
These noncatecholamine adrenergic agents are used to treat acute and 
chronic asthma, emphysema, pulmonary fibrosis, and chronic bronchitis. 
Additionally, some are used for sytemic and local vasoconstriction, nasal 
and ophthalmic decongestion, smooth muscle relaxation, CNS 
stimulation and appetite suppression. 
Mechanism of Action: 
Direct-acting agents, such as albuterol, metaproteranol, pirbuterol and 
terbutaline, act by stimulating beta receptor sites (beta2 more so than 
beta1). The indirect-acting agents work by stimulating the release of 
norepinephrine. Dual-acting agents, like epinephrine, combine both 
actions. 
:m;~k~"¥Jroai~~.~t:r#9$~ttt~~ ~~W¥W-t~~~1tiif19s:~,,:~;tg,,::~m~mgg~g;E;~~A: ~,,,~::\f,~a 
albuterol -available as metered dose inhaler 
-
for bronchospasm associated with reversible 
obstructive airway disease and exercise induced 
bronchospasm 
ephedrine - in oral or injectable forms 
- for acute and chronic asthma, hay fever, allergic 
rhinitis, and sinusitis 
metapranolol - in oral or inhaler forms 
- for asthma, bronchitis and emphysema 
pirbuterol - in inhaler form 
- prevention and reversal of bronchospasm in 
patients with asthma 
terbutaline - in oral injectable and inhaler forms 
- for asthma, bronchitis and emphysema 
61 
Adverse Reactions: 
- often causes headache, anxiety or euphoria, irritability, trembling, 
drowsiness or insomnia, lethargy, dizziness, light-headedness, 
incoherence, and convulsions. 
- ocasional hypotension or hypertension, palpitations, bradycardia or 
tachycardia, dysrhythmias, cardiac arrest, cerebral hemorrhage, 
weakness, muscle cramps, sweating, increased urination, incontinence, 
vomiting. 
Ocular Adverse Reactions: 
- stinging, blurred vision 
Contraindications and Precautions: 
- use caution in cases of pregnancy or diabetes 
Drug Interactions: 
-with general anesthetics: cardiac dysrhythmias, increased 
hypertension 
- with beta blockers: increases effects of agents with beta activity 
- with MAO inhibitors and tricyclic antidepressants: increased 
hypertension 
62 
MAST CELL STABILIZERS 
M cromolyn sodium (lntal #119, Nasalcrom) 
"M" indicates a Top 200 Drug in 1991 -· note ranking after trade name 
Indications for Use: 
Mast cell stabilizers are used prophylacticly to prevent topical allergic 
reactions from occuring on the lung mucosa, nasal mucosa, and ocular 
tissue. lntal is also approved as an antiasthmatic. 
Mechanism of Action: 
Mast cell stabilizers inhibit the degranulation of sensitized mast cells 
which occurs after exposure to specific antigens. Mast cells contain the 
chemical mediators which trigger the allergic response. 
cromolyn sod um 
(Nasalcrom) 
cromolyn sodium (lntal) 
Adverse Reactions: 
with Nasalcrom: 
-a mete se r 
-for the prevention and treatment of the symptoms 
of aile ic rhinitis 
- a metered dose inhaler 
- a actic for atients with asthma 
- commonly: stinging, burning, sneezing upon application. 
- rarely: headaches, rash, post-nasal drip, epistaxis occur 
with lntal: 
- commonly: throat irritation and dryness, bad taste, cough, wheeze, 
nausea 
- rarely: anaphylaxis, angioedma, dizziness, headache, rash, urticaria 
Ocular Adverse Reactions: 
- Tansient burning and stinging upon instiillaton were reported with 
Opticrom, a cromolyn sodium approved for ocular use, but now no longer 
available. 
- lntal rarely causes increased lacrimation 
Contraindications and Precautions: 
- contraindicated in patients with known hypersensitivity 
- caution advised in patients with renal or hepatic impairment, pregnancy, 
breast feeding mothers 
Drug Interactions: 
no known drug interactions 
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MUCOLYTICS 
8. acetylcysteine (Mucomyst) 
"8." indicates major drugs in 1991 --see table 
Indications for Use: 
- Acetylcysteine is used as an adjunct therapy (with the bronchodilator 
isoproterenol) to treat patients with obstructive mucus secretions. 
Patients with bronchitis, emphysema, or cystic fibrosis may benefit from 
mucolytic therapy. 
- Acetylcysteine is the antidote for acetaminophen overdosage. 
Mechanism of Action: 
Acetylcysteine reduces the viscocity of respiratory tract secretions by 
splitting disulfide bonds on glycoprotein molecules. 
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acetylcysteine - available as an inhaler 
Adverse Reactions: 
- used for lung disorders in which overproduction of 
mucus causes an accumulation of secretions. 
- available in combination with isoproterenol 
With prolonged use, acetylcysteine may produce stomatitis, nausea, 
vomiting, drowsiness, and severe rhinorrhea. Asthmatic patients may have 
difficulty breathing due to severe brochospasm. 
Contraindications and Precautions: 
Use caution in patients with asthma or respiratory insufficiency due to 
increased airway obstruction. 
Drug Interactions: 
- Acetylcysteine is incompatible with: amphotericin B, chlortetracycline, 
erythromycin, oxytetracycline, ampicillin, tetracycline, iodized oil, 
hydrogen peroxide, chymotrypsin and trypsin. 
- Activated charcoal decreases acetylcysteine's effectiveness, so when 
using as a remedy for acetaminophen overdose, any activated charcoal 
administerred prior to acetylcysteine therapy should be removed by 
gastric lavage. 
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adsorbent agents 
A activated charcoal 
antiflatulant agents 
A simethicone 
digestive agents 
A glutamic acid hydrochloride 
A dehydrocholic acid 
A pancreatin · 
A pancrelipase 
antidiarrheal agents 
A opium tincture 
(Mylicon) 
(Acidulin) 
(Decholin) 
(Dizymes) 
(Cotazym) 
A paregoric or camphorated opium tincture 
A loperamide (lmodium) 
A diphenoxylate hydrochloride (Lomotil) 
A diphenoxin with atropine (Motofen) 
A kaolin and pectin mixtures (Kaopectate, Peete kay) 
laxative agents 
A lactulose (Cephalac, Chronulac) 
A magnesium salts (Milk of Magnesia) 
A sodium phosphate, sodium biphosphate 
A glycerin 
dietary fiber 
A psyllium hydrophilic mucilloid 
A methylcellulose 
A docusate sodium 
bisacodyl 
cascara sagrada 
castor oil 
phenolphthalein 
senna 
mineral oil 
emetic agents 
A ipecac syrup 
apomorphine 
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(Metamucil) 
(Cologel) 
(Dolace, Doxinate, Regutol) 
antiemetic agents 
buclizine 
cyclizine 
~ dimenhydrinate 
diphenhydramine 
M hydroxyzine 
M meclizine 
~ trimethobenzamide 
chlorpromazine 
M promethazine 
M prochlorperazine 
thiethylperazine 
perphenazine 
triflupromazine 
trimeprazine tartrate 
peptic ulcer agents 
(Dramamine) 
(Benadryl) 
(generic #183, Vistraril, Atorax) 
(generic #199) 
(Phenergan #143) 
(Compazine #163) 
~ magnesium hydroxide, aluminum hydroxide with simethicone 
(Maalox TC, Mylanta-11) 
~ magaldrate or aluminum magnesium complex 
M 
M 
M 
M 
M 
calcium carbonate 
cimetidine 
ranitidine 
famotidine 
nizatidine 
sucralfate 
"S' indicates major drugs -- see table 
(Riopan, Riopan Plus) 
(Turns) 
(Tagamet #19) 
(Zantac #3) 
(Pepcid #54) 
(Axid #125) 
(Carafate #75) 
"M" indicates a Top 200 Drug in 1991 --note ranking after trade name 
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ADSORBENTS 
Indications for Use: 
- used in acute oral poisoning to prevent the absorption of drugs or toxins 
from the Gl tract 
Mechanism of Action: 
- attracts and binds molecules of liquid, gas, or dissolved substance in 
the Gl tract 
- No adsorbent is effective for all toxins, but activated charcoal is 
indicated for most cases of acute oral poisoning (see exceptions). 
- the most common t agent 
- indicated for most toxins except: 
cyanide, ethanol, methanol, iron, sodium chloride 
alkalies in anic acids anic solvents 
Adverse Reactions: 
- black stools and constipation 
Contraindications and Precautions: 
Drug 
- ineffective in cases of poisoning by: cyanide, ethanol, methanol, 
iron, sodium chloride, alkalies, inorganic acids, organic solvents 
Interactions: 
- emetics (vomit inducers), are adsorbed by activated charcoal 
- use emetics before adsorbents and allow emesis (vomiting) to occur 
prior to administration of the adsorbents (enhances the effectiveness of 
the adsorbent by decreasing the amount of toxin in the Gl tract) 
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ANTIFLATULANTS 
Indications for Use: 
- used to treat conditions in which gas retention is a problem 
Mechanism of Action: 
- defoaming and water-repellent properties prevents and disperses gas 
pockets in the Gl tract 
simethicone 
Adverse Reactions: 
- expulsion of gas via belching or flatus (passing of gas from rectum) 
Contraindications and Precautions: 
- contraindicated in cases of pathological abdominal conditions 
Drug Interactions: 
- no significant drug interactions 
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DIGESTIVE AGENTS 
Indications for Use: 
- aid digestion in patients who lack one or more of the specific enzymes 
and substances that naturally digest food 
Mechanism of Action: 
replace the normal digestive substances 
-glutamic acids act by converting pepsinogen in the stomach to pepsin, 
the activated form of the enzyme 
- pancreatin and pancrelipase replace the normal pancreatic enzymes 
that aid in the digestion of protein, carbohydrates and fats 
glutamic acid 
hydrochloride and 
hydrochloric acid 
pancrel pase 
Adverse Reactions: 
m pore ne pancreas 
- longer lasting than pancreatin 
- indicated for pancreatic insufficiency associated 
with c fibrosis 
- pancreatic enzymes often cause nausea and diarrhea 
Contraindications and Precautions: 
- hydrochloric acid agrivates peptic ulcers 
- pancreatic enzymes derived from pigs or cattle are contraindicated in 
patients sensitive to porcine or bovine products 
Drug Interactions: 
- no significant drug interactions 
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ANTIDIARRHEAL AGENTS 
Indications for Use: 
for treatment of diarrhea 
Mechanism of Action: 
act systemically or locally to reduce the fluidity of the stool and the 
frequency of defecation 
- diphenoxin with atropine: 
diphenoxin has a local effect on the gastrointestinal wall to 
slow intestinal motility, while atropine decreases intestinal 
spasticity · 
- opium tincture and camphorated opium tincture: 
act on the brain to inhibit intestinal peristalsis and enhance 
anal sphincter tone; also decreases HCL secretion and 
stomach motility 
- loperamide and diphenoxylate: 
decrease peristalsis in the large and small intestines 
- kaolin and pectin: 
""' 
opium tincture & 
camphorated opium 
tincture 
Ioper am ide & 
diphenoxylate 
kaolin and pectin bind bacteria, toxins and other irritants on 
intestinal mucosa while pectin also reduces the pH in the 
intestine and soothes the irritated mucosa 
~ ·:.@iii. . . ..... : . ~ :; ><<.< 
- for acute nonspecific diarrhea 
- for acute nonspecific diarrhea and chronic 
diarrhea 
diphenoxin with atropine - a mod1fiction of phenoxylate 
- for acute nonspecific diarrhea and chronic 
diarrhea 
kaolin and pectin - for acute diarrhea from various causes 
mixtures 
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Adverse Reactions: 
-opium preparations: nausea, vomiting, dizziness 
- loperamide and diphenoxylate: nausea, vomiting, abdominal pain and 
distension, drowsiness, CNS depression, tachycardia 
- diphenoxin with atropine: anticholinergic effect of atropine occurs if 
recommended dose is exceeded (esp. in patients with Down's 
Syndrome) reulting in dryness of skin and mucous membranes, 
flush ing, hyperthermia, tachycardia, urinary retention 
- kaolin and pectin mixtures may cause constipation in elderly or 
debilitated patients 
Ocular Adverse Reactions: 
- atropine-containing agents such as diphenoxin rarely cause mydriasis, 
cycloplegia and decreased lacrimation 
Contraindlcations and Precautions: 
- diarrhea caused by an infection 
- use opium preparations cautiously in cases of decreased respiratory 
rate, asthma, narcotic dependence, liver dysfunction 
- hypersensitivity to any of the active ingredients 
- do not take kaolin and pectin concurrently with other medications as 
their binding effects may interfere with their absorption 
Drug Interactions: 
-opium preparations, loperamide and diphenoxylate interact with CNS 
depressants to increase the depressant effect 
- kaolin and pectin mixtures interfere with absorption of many drugs 
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LAXATIVE AGENTS 
Indications for Use: 
for relief of constipation 
Mechanism of Action: 
act by increasing water content of the feces and/or increasing peristalsis 
- hyperosmolar laxatives: 
lactulose 
produce an osmotic effect in the intestinal lumen that 
causes fluid accumulation by the feces 
- dietary fiber and related bulk forming laxatives: 
hydrophilic properties increase water content of the stool 
- emolient laxatives: 
detergent action allows water to penetrate fecal material 
and increase fluid accumulation 
-stimulant laxatives: 
simulate peristalsis and defecation by irritating the intestinal 
mucosa 
- lubricant laxatives: 
lubricates the feces and intestinal mucosa by preventing 
water reabsorbtion from the lumen of the bowel 
.·::·:=:· · 
h vperosmo ar axat1ves 
- for chronic constipation 
magnesium salts -to induce prompt and complete bowel evacuation 
glycerin 
d" t re ary fb I 
psyllium hydrophilic 
mucilloid 
methylcellulose 
docusate sodium 
- available as suppository or rectal liquid 
- to establish proper bowel patterns in laxative-
dependent adults 
er an d I t d b lk f rea e u - ormrng f axa 1ves 
- for prevention of constipation 
' 
- for prevention of constipation 
emolient laxatives 
- a stool softener for patients at risk for chronic 
constipation 
72 
Adverse Reactions: 
hyperosmolar laxatives: 
-abdominal distention, cramps, flatulance (gas), nausea, vomiting, 
diarrhea, fluid and electrolyte imbalances 
dietary fiber and related bulk-forming laxatives: 
- flatulance, intestinal obstruction, diarrhea 
stimulant laxatives: 
-weakness, nausea, abdominal cramps, reddish colored urine 
lubricant laxatives: 
-nausea, vomiting, diarrhea, abdominal cramping, fat soluble 
vitam ine deficiency 
Contraindications and Precautions: 
all laxatives contraindicated with intestinal obstruction, ulceration and 
symptoms of appendicitis 
hyperosmotic laxatives: 
- hyperosmolars, because they increase water retention, 
are contraindicated in cases of edema and congestive 
heart failure 
- use lactulose with caution in diabetics, pregnant or 
lactating women 
emoliant laxatives: 
- potassium salts contraindicated in renal dysfunction 
- use sodium salts with caution in cases of edema, 
congestive heart failure, or renal dysfunction 
stimulant laxatives: 
- castor oil contraindicated in pregnant or menstruating 
women 
- use with caution in cases of rectal bleeding 
lubricant laxatives: 
- contraindicated in children under 6 years of age, elderly 
patients, debilitated patients, pregnant patients 
Drug Interactions: 
- emolient laxatives increase intestinal mucosal damage with aspirin 
- emolient laxatives should not be used with oral mineral oil as they 
increase the systemic absorption of mineral oil 
- emolients enhance absorption of oral drugs 
- mineral oil impairs absorption of many oral medications and impairs 
antibacterial activity of sulfonamides 
- Lactulose contraindicated in patients taking oral anti-infectives 
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EMETIC AGENTS 
Indications for Use: 
- to induce vomiting after ingestion of toxic substances 
Mechanism of Action: 
-induces vomiting via a local affect on the gastric mucosa and a central 
effect on the chemoreceptor trigger zones (CTZ) located on the carotid 
body and aortic body in the carotid and aortic arteries 
Adverse Reactions: 
- ipecac syrup contains a cardiotoxin that may cause cardiac reactions 
such as arrhythmia, or fatal myocarditis (inflammation of the heart 
muscle) 
Contraindications and Precautions: 
- use with caution in pregnant or lactating women 
- emetics are contraindicated in poisoning by petroleum distilates or 
caustic substances because vomiting may cause the aspiration of toxic 
gases into the lungs resulting in aspiration pneumonitis 
Drug Interactions: 
- no significant interactions 
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ANTIEMETIC AGENTS 
Indications for Use: 
-to decrease nausea and hence, the urge to vomit 
- to prevent and treat motion sickness 
Mechanism of Action: 
- antihistamine antiemetics: 
block histamine (H1) receptors and decrease nausea, vomiting, 
and vertigo 
- phenothiazine antiemetics: 
block dopaminergic receptors in the chemoreceptor trigger 
zone (CTZ) located on the carotid body and aortic body in the 
carotid and aortic arteries 
antihistamine antiemetics 
dimenhydrinate - to prevent motion sickness 
hydroxyzine - taken with narcotic analgesics for its synergistic 
analgesic effect and because it decreases the 
nausea associated with narcotic administration 
meclizine - to prevent motion sickness 
trimethobenzam ide -to prevent and treat mild nausea and vomiting 
phenothiazine antiemetics 
prochlorperazine and -to prevent and treat severe nausea and vomiting 
promethazine • not effective for motion sickness 
• prochlorpaerazine indicated prior to administering 
oral hyperosmotics in patients with angle closure 
glaucoma experiencing nausea or vomiting 
Adverse Reactions: 
antihistamine antiemetics 
- drowsiness, mild nausea, anorexia, anticholinergic effects (dry 
mouth, dry throat, painful or difficult urination, urine retention and 
impotence), rarely hypersensitivity reactions 
phenothiazine antiemetics: 
- sedation, hypotension, anxiety, euphoria, depression, headache 
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Ocular Adverse Reactions: 
effects are rare, reversible and usually of little clinical significance 
- decreased vision, mydriasis, decreased contact lens tolerance, 
diplopia, hallucinations 
Contraindications and Precautions: 
antihistamine antiemetics: 
- use caution in narrow angle glaucoma, urine retention, asthma 
phenothiazine antiemetics: 
- contraindicated in coma, CNS depression, bone marrow 
depression, subcortical brain damage 
- use with caution in encephalitis, tetanus, hepatic disease, 
cardiovascular disease, respiratory disorders, convulsive 
disorders, patients undergoing electroshock therapy, brain tumor, 
glaucoma, elderly or debilitated patients, children with acute 
illnesses 
Drug Interactions: 
antihistamine antiemetics: 
- additive effects with other agents that have anticholinergic and 
sedative properties 
phenothiazine antiemetics: 
- CNS depressants: CNS depressant effects increased 
- anticholinergic agents: anticholinergic effects increased 
- antacids decrease phenothiazine absorption 
- barbiturates decrease phenothiazine's effect 
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PEPTIC ULCER AGENTS 
Indications for Use: 
antacids: 
over the counter drugs used alone or in conjunction with others for 
treatment of peptic ulcer disease 
h istam in e2- recepto ran ta gon ists: 
for duodenal and gastric ulcers 
sucralfate: 
for short term treatment of duodenal ulcers 
Mechanism of Action: 
antacids: 
increase the pH of the stomach, neutralizing gastric acid and 
decreasing pepsin's proteolytic activity 
histamine2-receptor antagonists: 
block histamine-receptor sites on the parietal cells of the stomach, 
inhibiting acid secretion 
sucralfate: 
by binding to the ulcer site, it protects the ulcer from acid & pepsin 
antacids 
magnesium hydroxide, - over the counter drugs 
aluminum hydroxide with - used alone or in conjuction with others for 
simethicone treatment of peptic ulcer disease 
magaldrate or aluminum 
magnesium complex 
histamine2-receptor antagonists 
cimetidine - for duodenal and gastric ulcers 
ranitidine 
famotidine 
nizatidine 
sucralfate 
I sucralfate I - for short term treatment of duodenal ulcers I 
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Adverse Reactions: 
antacids: 
diarrhea and constipation 
histamine2-receptor antagonists: 
headache, dizziness, malaise, nausea, diarrhea, constipation 
sucralfate: 
constipation, nausea, metalic taste 
Ocular Adverse Reactions: 
histamine H2 receptor antagonists: occular reactions uncommon unless 
taken in large doses 
- decreased vision secondary to cycloplegic effect 
- hallucinations 
- photophobia secondary to mydriasis 
- lid and conjunctiva irritation 
Contraindications and Precautions: 
antacids: 
- those containing magnesium are contraindicated in patients with 
severe renal disease due to risk of hypermagnesemia 
- calcium carbonate contraindicated for long term use: 
hypercalcemia can result 
- use with caution in patients with decreased bowel motility: 
constipation can result 
histamine2-receptor antagonists: 
- use with caution in cases of impaired renal or hepatic function 
because the drug's metabolism and elimination will be delayed 
Drug Interactions: 
- antacids: impairs absorption of many oral drugs 
- histamine2-receptor antagonists: inhibited by antacids 
- sucralfate: impairs absorption of many oral drugs and is inhibited by 
antacids 
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~ benzalkonium chloride (Zephiran) 
~boric acid 
~ chlorobutanol 
~ chlorhexidine (Hibiclens) 
~ EDTA 
~ ethyl alcohol 
~ hexachlorophen (pHisoHex) 
~ hydrogen peroxide 
~ iodine (Betadine) 
~ isopropyl alcohol 
~ potassium permanganate 
~ sorbic acid 
~ thimerosal (Thimerosal} 
"~ • indicates major agents ·- see tables 
Indications for Use: 
·antiseptics prevent and control infection by killing or inhibiting the growth 
of microorganisms on living tissue 
-disinfectants act by destroying microorganisms on instruments and in 
solutions 
• some disinfectants can be used as antiseptics in appropriate 
concentrations 
Mechanism of Action: 
- highly variable among agents 
r-¥J&ffitiifmtd~:agetnst;f@t:tftx0k!~~~iMDJM;t:::::::::::::=::::::::::::Jftin§s::ttJ/rem~rt~iW~~12 
benzalkonium chloride • active against bacteria and some viruses, fungi and 
protozoa 
• preoperative skin antiseptic and wound treatment 
·surgical equipment disinfectant 
• in RGP contact lens solutions 
boric acid • a preservative in eye washes 
chlorobutanol ·combined with EDTA in RGP contact lens solutions 
• seldom used 
chlorhexidine - affetive against gram + & • , including pseudomona~ 
• surgical scrub and pre-operative skin antiseptic 
• antibacterial wound cleanser 
• in soft contact lens solutions 
-causes buildup on lenses 
EDTA • a chelating agent, it binds divalent ions needed for 
bacterial growth 
• used in combination with other preservatives 
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table continued 
ethyl alcohol and - pre-injection skin antiseptic 
isopropyl alcohol 
hexachlorophene - a phenol antiseptic 
- bacteriostatic against gram + bacteria 
- used as a surgical scrub and to control outbreaks of 
gram + infections when other procedures are 
unsuccessful 
hydrogen peroxide - superficial wound cleanser 
iodine - superficial wound cleanser, pre-op antiseptic 
- affective against bacteria, fungi, viruses, protozoa 
-often combined with povidone to decrease irritation 
potassium permanganate - an oxidative antiseptic like hydrogen peroxide 
- may be used for athlete's foot and intertriginous 
candidiasis 
silver nitrate - drops given at birth to prevent gonorrheal 
ophthalmia neonatorium 
sorbic acid - in soft contact lens solutions 
thimerosal - contains mercury 
- 30% of people are allergic 
- bacteriostatic and fungistatic against common 
pathogens 
- used in combination with EDTA and chlorhexidine 
- found in soft and RGP contact lens disinfecting 
solutions 
Adverse Reactions: 
- most antiseptic agents are known to cause hypersensitivity reactions 
- hexachlorophene may cause brain lesions in newborns 
Contraindications and Precautions: 
- all agents are contraindicated in cases of hypersensitivity 
-thimerosal: hypersensitivity to the thio or mercuri radicals may cause 
erythematoous, papular and vesicular eruptions 
- hexachlorophene conraindicated for use on burned or denuded skin or 
any mucous membrane. contraindicated for infants 
Drug Interactions: 
-thimerosal is incompatible with strong acids, salts, heavy metal, potassum 
parmanganate, iodine, and aluminum 
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storage in solutions 
contain sorbic acid 
chlorhexidine and 
anionic dete ents 
thimerosal and 
benzalkonium chloride 
thimerosal and 
roxide 
ch ine and: 
bicarbonates, berates, 
tes sulfates 
quaternary ammonium 
compound and: 
isorbat chlorhexidine 
chemical disinfectants & 
oxidative disinfectants 
-causes brown lens discoloration 
- causes lens to become opaque 
rms a precipitate 
- thimerosal is degraded by hydrogen peroxide 
- form a precipitate 
-can cause red eye 
-form black, brown, yellow, pink or purple 
reci itates 
8 1 
aminoglycosides 
amikacin 
~ gentamicin 
kanamycin 
~neomycin 
netilmicin 
paromomycin 
~ streptomycin 
M tobramycin 
(Garamycin) 
(Mycifradin, Neobiotic, Neosporin) 
(Tobrex #173, Nebcin) 
bacitracin (Baciguent) 
used with polymixin 8 in Polysporin 
used with polymixin 8 and neomycin in Neosporin 
used with polymixin 8, neomycin, hydrocortisone in Cortisporin 
cephalosporins 
1ST GENERATION 
cephadine 
M cephadroxil 
M cephalexin 
~ cephalothin 
cephaprim 
~ cephazolin 
2ND GENERATION 
(Duricef, Ultracef #53) 
(Keflex #159) 
(Keflin) 
(Ancef, Kefzol) 
M cefaclor (Ceclor #7) 
~ cefamandole nafate (Mandole) 
cefonicid 
ceforanide 
~ cefoxitin 
M cefuroxime 
3RD GENERATION 
M cefixime 
cefotetan 
~ ceftizoxime 
~ ceftriaxone 
ceftazidime 
(Mefoxin) 
(Ceftin #63) 
(Suprax #118) 
(Cefizox) 
(Rocephin) 
~ cephoperazone (Cefobid) 
~ cephotaxime sodium(Ciaforan) 
moxalactam disodium 
chloramphenicol 
M clindamycin 
(Chloromycetin) 
(Cieocin T #142) 
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M erythromycin 
penicillins 
NATURAL PENICILLINS 
!!.. penicillin G 
M penicillin V 
(PCE #56, E-Mycin #64, E.E.S. #87, 
Eryc #1 04, Erythromycin Base #11 0, 
Ery-Tab #121, Erythrocin Stearate #141) 
(Wycillin, Pentids, Bicillin, Bicillin L-A) 
(generic Penicillin V # 72, Veetids #79, Pen-Vee 
K #85, Penicillin VK #174, Beepen VK #188, V-
Cillin K) 
PENICILLINASE-RESITANT PENICILLINS 
cloxacillin 
!!.. dicloxacillin 
methicillin 
nafcillin 
!!.. oxacillin 
AMINOPENICILLINS 
M amoxicillin 
!!.. ampicillin 
bacampicillin 
cyclacillin 
(Dynapen) 
(Prostaph lin) 
(Amoxil #1, Trim ox #27, generic Amoxicillin #30, 
Polymox #36, Wymox #136) 
(Omnipen) 
EXTENDED-SPECTRUM PENICILLINS 
M amoxicillin I clavalunate (Augmentin #20) 
azlocillin 
carbenicillin 
mezlocillin 
piperacillin 
!!.. ticarcillin 
guinolones 
cinoxacin 
M ciprofloxacin 
nalidixic acid 
M norfoxacin 
sulfonamides 
(Ticar) 
(Cipro #25) 
(Noroxacin #150) 
!!.. sulfacetamide and Prednisolone {Biephamide) 
sulfacytine 
sulfadiazine 
!!.. sulfamethoxizole (Gantanol) 
M sulfamethoxizole and Trimethoprim (SMZ-TMP #73) 
sulfapyridine 
sulfasalazine 
!!.. sulfisoxazole (Gantrisin) 
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tetracyclines 
~ chlortetracycline 
demeclocycline 
~ doxycycline 
methacycline 
M minocycline 
oxytetracycline 
M tetracycline 
vancomycin 
(Aureomycin) 
(Vibramycin) 
(Minocin #179) 
(Sumycin #156, Achromycin-V #181) 
(Vancocin) 
·~· indicates major drugs-- see table 
•M• indicates a Top 200 Drug in 1991 --note ranking after trade name 
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THE AMINOGL YCOSIDES 
A streptomycin 
A neomycin 
paromomycin 
kanamycin 
A gentamicin 
M tobramycin 
netilmicin 
amikacin 
(Mycifradin, Neobiotic, Neosporin) 
(Garamycin) 
(Tobrex #173, Nebcin) 
"A• indicates major drugs-- see table 
•M• indicates a Top 200 Drug in 1991 --note ranking after trade name 
Indications for Use: 
-aerobic gram negative bacilli 
-some aerobic gram +(many strains of staph), but resistance is common 
- mycobacteria 
-some protozoa 
Mechanism of Action: 
- inhibit protein synthesis in pathogens by binding to 30S subunit of 
ribosome 
gentamycin 
tobramyc ut more 
Adverse Reactions: 
- nausea, vom itting, diarrhea when used systemically 
-toxicity with systemic use: damages auditory (8th neNe), vestibular, 
renal and neuromuscular functions (especially neomycin) 
- allergic reactions 
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Ocular Adverse Reactions 
with sytemic administration: (reactions are rare) 
~ double vision and ptosis due to muscle paresis 
- decreased pupillary light reflex 
- gentamycin: papilledema secondary to pseudotumor cerebri 
with ocular administration: 
• neomycin: contact allergic reactions in lids and conjunctiva in 4% 
of patients 
- overgrowth of nonsusceptible organisms 
Contraindications and Precautions: 
-known allergies to aminoglycosides 
Drug Interactions: 
- extended spectrum penicillins can inactivate aminoglycosides when 
administered simultaneously 
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BACITRACIN 
bacitracin (Baciguent) 
used with polymixin B in Polysporin 
used with polymixin Band neomycin in Neosporin 
used with polymixin 8, neomycin, hydrocortisone in Cortisporin 
Indications for Use: 
- a topical ointment for gram +skin and ocular infections such as 
impetigo, staph. blepharitis and corneal ulcers caused by Neisseria 
gonorrhea 
- narrow spectrum includes gram positives and Neiseria gonorrhea 
Mechanism of Action: 
- inhibits cell wall synthesis 
Adverse Reactions: 
- contact dermatitis 
- delayed wound healing 
Ocular Adverse Reactions: 
with systemic application: (reactions are rare) 
-muscle paralysis leading to ptosis, blurred vision and diplopia 
with ocular application: (reactions are rare) 
- irritation upon application 
- allergic reactions of lids and conjunctiva 
-keratitis 
- overgrowth of nonsusceptible organisms 
Contraindications and Precautions: 
- known sensitivity to bacitracin 
Drug Interactions: 
- inactivated by silver nitrate 
87 
THE CEPHALOSPORINS 
1st generation 
il cephazolin 
il cephalothin 
cephaprim 
cephadine 
M cephalexin 
M cephadroxil 
2nd generation 
M cefaclor 
il cefoxitin 
il · cefamandole nafate 
M cefuroxime 
cefonicid 
ceforanide 
3rd generation 
M cefixime 
cefotetan 
.1. cephoperazone 
.1. cephotaxime sodium 
moxalactam disodium 
.1. ceftizoxime 
.1. ceftriaxone 
ceftazidime 
".1." indicates major drug -- see table 
(Ancef, Kefzol) 
(Keflin) 
(Keflex #159) 
(Duricef, Ultracef #53) 
(Ceclor #7) 
(Mefoxin) . 
(Mandole) 
(Ceftin #63) 
(Suprax #118) 
(Cefobid) 
(Ciaforan) 
(Cefizox) 
(Rocephin) 
"M" indicates a Top 200 Drug in 1991 --note ranking after trade name 
Indications for Use: 
1st generation 
-most gram+ (staph and strep) 
-some gram-, including E. Coli, Klebsiella, Proteus, H. influenza 
2nd generation 
same spectrum as 1st generation, plus: 
-gram negatives including N. gonorroheae 
-anaerobes 
3rd generation 
same spectrum as 1st and 2nd generations, plus: 
- most gram -, including Pseudomonas Auruginosa 
- less affective on gram + 
Mechanism of Action: 
-similar to penicillins, they block the terminal step in the synthesis of 
peptidoglycan, thus inhibiting cell wall synthesis. 
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1 st generation 
cephalothin (Keflin) - for severe Staph infections 
-administered l.V. or l.M. 
- the 1st cephalosporin developed 
cephazolin (Ancef, Kefzol 1 -similar to cephalothin, except better for E. Coli and 
Klebsiella 
cephalexin (Keflex) -administered orally 
- for urinary tract infections 
cephadroxil (Duricef) - only oral cephalosporin that can be taken with food 
2 d n generataon 
cefaclor (Ceclor) -administered orally 
-for respitratory infections, otitis media (ear 
infections) 
cefoxitin (Mefoxin) - administered I.V. 
- for diabetic foot ulcers, pelvic inflammatory disease, 
lung abscess, aspiration pneumonia 
-penicillinase producing N. Gonorrhorea, Proteus 
cefamandole nafate -administered I.V or I.M. 
(Mandel) - for H. Influenza, Enterobacter, Proteus 
3d r generation 
cefixime (Suprax) - only oral 3rd gen. cephalosporin, also in IV and IM 
- for urinary tract infections, ear infections due to H. 
influenza, pharyngitis and tonsillitis, bronchitis 
cephoperazone (Cefobid) -administered I.V. or I.M. 
- used topically for corneal ulcers 
- effective against Pseudomonas Auruginosa 
cephotaxime sodium - administerd I.V. or l.M. 
(Ciaforan) - for gram -, except P. Auruginosa 
- for gram +, except enterococci 
ceftriaxone (Rocephin) - for ophthalmic neonatorum due to N. gonorrhea 
Adverse Reactions: 
Cephalosporins are relatively safe but second generation drugs are more 
toxic than first, and third generation more toxic than second. 
- cross-sensitivity occurs with penicillins 
- pain at injection site 
- seizures in high doses of cefazolin 
-coagulation disorders in elderly and poorly nourished 
-nausea, vomiting and diarrhea upon oral administration 
- pseudomembranous colitis 
- nephrotoxicity in patients with renal dysfunction 
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Ocular Adverse Reactions: 
with systemic application: (reactions are rare) 
-nystagmus 
- allergic reactions in lids and conjunctiva 
with ocular application: (reactions are rare) 
- irritation upon application 
- allergic reaction to lids and conjunctiva 
Contraindications and Precautions: 
- cases of renal dysfunction 
- patients with a known allergy to penicillins or cephalosporins 
Drug Interactions: 
- alcohol intolerance 
- probenicid is used to increase and prolong cephalosporin concentrations 
-nephrotoxicity may occur when cephalothin is administerred with an 
am inog lycoside 
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CHLORAMPHENICOL 
ch loram ph en icol (Chloromycetin) 
Indications for Use: 
- most gram + and gram -
- reserved for severe infections due to risk of fatal aplastic anemia 
- drug of choice for ampicillin resistant typhoid fever and other 
Salmonella infections · 
- for H. influenza meningitis 
Mechanism of Action: 
- inhibits protein synthesis by binding to the 50S subunit 
(same as erythromycin and clindamycin) 
Adverse Reactions: 
- bone marrow suppression 
- Gl reactions: nausea, vomiting, glossitis, unpleasant taste, stomatitis, 
diarrhea, perineal irritation 
- gray syndrome in neonates causing fatalities in 40% of cases 
- hypersensitivity reactions: fever, rash, anaphlyaxis 
- fatal aplastic anemia 
Contraindications and Precautions: 
- hepatic or renal dysfunction 
- use caution in pregnant women and young children 
Drug Interactions: 
-inhibits metabolism of hypoglycemic agents, phenytoin, oral 
anticoagulants and cyclophosphamide 
- interferes with the action of penicillins 
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CLINDAMYCIN 
M clindamycin (Cieocin T #142) 
•M• indicates Top 200 Drug in 1991 --note ranking after trade name 
Indications for use: 
-effective against most gram+ and anaerobes, but used only when safer 
drugs are contraindicated or not available 
- used primarily to treat anaerobic intraabdominal or pleuropulmonary 
infections caused by B. tragi/is 
Mechanism of Action: 
- Inhibits protein synthesis by binding with the 50S subunit of ribosomes 
(same as erythromycin and chloramphenicol) 
Adverse Reactions: 
- Gl reaction with diarrhea in 80% of patients 
- pseudomembranous colitis caused by overgrowth of Clostridium dificil 
- hypersensitivity reactions 
Ocular Adverse Reactions: 
with systemic application: (reactions are rare) 
- allergic reactions of lids and conjunctiva 
-ptosis and diplopia due to muscle paresis 
with ocular application: (reactions are rare) 
- irritation upon installation 
- allergic reactions of lid and conjunctiva 
- overgrowth of nonsusceptible organisms 
Contraindications and Precautions: 
- intestinal disorders 
Drug Interactions: 
-erythromycin may block their site of action (the 50S subunit) 
-effects of muscle relaxants are enhanced by clindamycin 
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ERYTHROMYCIN 
M. erythromycin (PCE #56, E-Mycin #64, E.E.S. #87, Eryc #104, 
Erythromycin Base #11 0, Ery-Tab #121, Erythrocin Stearate 
#141) 
"M• indicates a Top 200 Drug in 1991 --note ranking after trade name 
Indications for Use: 
- gram + and some gram -
- drug of choice for Mycoplasma pneumonia and Legionella pneumonia 
- for syphillis and gonorrhea when penicilllin and tetracyclines are 
contraindicated 
-for minor staph infections Including blepharitis 
Mechanism of Action: 
-inhibits protein synthesis by binding to the 50S subunit of the ribosome 
(similar to chloramphenicol and clindamycin) 
Adverse Reactions: 
- one of the safest antibiotics 
- Gl reactions: stomatitis (inflammation of mucous membranes, heartburn, 
anorexia, melena black {tarry feces due to action of intestinal secretions 
on free blood}) 
- allergic reactions: rashes, fever, anaphylaxis 
- cholestatic hepatitis: nausea, vomiting, and abdominal pain followed by 
. jaundice, fever and abnormal tiver function 
Ocular Adverse Reactions: 
with sytemic administration: (reactions are rare) 
- blue yellow color defect 
- allergic reactions 
- photosensitivity 
- extraocular muscle paresis 
with ocular administration: (reactions are rare) 
-irritation: hyperema, pain, edema 
- allergic reactions 
- overgrowth of nonsusceptible organisms 
Contraindications and Precautions: 
- known allergy to erythromycin 
- hepatic dysfunction 
Drug Interactions: 
- spectrum of activity of chloramphenicol, clindomycin and lincomycin 
changes when used with erythromycin due to competition for common 
binding sites (the 50S subunit) 
- inhibits metabolism of theophyline and carbemazepine 
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THE PENICILLINS 
natural penicillins 
.1. penicillin G 
.M. penicillin V 
(Wycillin, Pentids, Bicillin, Bicillin L-A) 
.(generic Penicillin V # 72, Veetids #79) 
penicillinase-resitant penicillins 
cloxacillin 
.1. dicloxacillin (Dynapen) 
methicillin 
nafcillin 
.1. oxacillin (Prostaphlin) 
aminopenicillins 
.M. amoxicillin 
.1. ampicillin 
bacampicillin 
cyclacillin 
extended-spectrum penicillins 
azlocillin 
carbenicillin 
mezlocillin 
piperacillin 
.1. ticarcillin 
.M. amoxicillin I clavalunate 
• .1." indicates major drugs -- see table 
(Amoxil #1, Trim ox #27) 
(Omnipen) 
{Ticar) 
(Augmentin #20) 
"M" indicates a Top 200 Drug in 1991 -- note ranking after trade name 
Indications for Use: 
Used to treat a variety of bacterial infections, this class has the widest 
spectrum of antimicrobial activity. 
Mechanism of Action: 
inhibits cell wall synthesis by preventing synthesis of peptidoglycan 
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na ura pemca ms t • "II" 
penicillin G -available in oral, IV; and IM forms 
- ineffective against Staph. due to resistance 
- drug of choice for syphillis 
penicillin V - in oral form 
- for infections of throat, respiratory tract, soft tissues 
• "II" • "II" penaca anase-resastant pemca ans 
oxacillin - for Staph. aureus, Staph. epidermis and some 
streptococci infections 
dicloxacillin - oral drug of choice for Staph infections 
• "II" ammopemca ms 
ampicillin - spectrum same as amoxicillin but many ampicillin 
resistant strains have emerged 
amoxicillin -#1 prescribed drug of 1991 
-for Haemophilus influenza, urinary tract infections, 
gonorrhea 
t d d ex en e t • "II" spec rum penacr ms 
amoxicillin I clavulanate - clavulanate inhibits beta-lactamases that can 
inactivate amoxicillin, which extends it's spectrum to 
include Staph aureus and Klebsiella. 
-for skin infections, otitis media (ear infection) and 
urinary tract infections 
ticarcillin - spectrum similar to ampicillin but also effective with 
P. auruginosa, Proteus, Enteropacter 
Adverse Reactions: 
- few because the peptidoglycan in cell walls is unique to bacteria 
- allergic reactions may occur 
-neurotoxicity, nephrotoxicity 
-changes in normal Gl flora may occur causing nausea, vomiting, diarrhea 
- Pseudomembranous colitis due to overgrowth of Clostridium difficile 
- potasium imbalance (hyperkalamia or hypokalamia) with ticarcillin 
-hemolytic anemia 
- blood platelet dysfunction 
Ocular Adverse Reactions: 
with systemic administration: (reactions are rare) 
- allergic reaction of lids and conjunctiva (esp. with ampicillin) 
- ptosis and diplopia due to muscle paresis 
with ocular administration: (reactions are rare) 
- irritation upon application 
- allergic reactions of lids and conjunctiva 
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Contraindications and Precautions: 
- penicillin allergy 
- use with caution in cases of cardiac dysfunction, renal dysfunction, 
hepatic disease, uremia 
Drug Interactions: 
-efficacy is increased by concurrent administration of probenicid 
- high doses of penicillin G and extended spectrum penicillins inactivate the 
cephalosporins, aminoglycosides 
- tetracyclines and chloramphenicol inactivate penicillins 
-penicillins interfere with renal tubular secretion of methtrexate 
- sulfonamides inhibit Gl absorbtion of oxacillin 
Other Notes: 
- Many bacteria, especially Staph, produce penicillinase, which inactivates 
most penicillins. Only penicillinase resistant penicillins are effective in 
these cases. 
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THE SULFONAMIDES 
.1. sulfamethoxizole 
M sulfamethoxizole and Trimethoprim 
.1. sulfisoxazole 
.1. sulfacetamide and Prednisolone 
sulfadiazine 
sulfapyridine 
su lfacytine 
sulfasalazine 
".1." indicates major drugs-- see table 
(Gantanol) 
(SMZ-TMP #73) 
(Gantrisin) 
(Biepham ide) 
II M II indicates a Top 200 Drug in 1991 -- note ranking after trade name 
Indications for Use: 
-broad spectrum gram +and gram -, but widespread resistance limits use 
- primarily for·acute urinary tract infections caused by chlamydia, 
plasmodia, toxoplasma 
Mechanism of Action: 
- inhibits bacterial growth by preventing folic acid synthesis 
su amethoxizole 
-com 
cal treatment of 
Adverse Reactions: 
- Gl reactions: nausea, vomiting and diarrhea are common 
- crystalluria (sulfonamide crystals in the urine) and tubular deposits of 
sulfonamide crystals 
- hypersensitivity reactions such as Stevens-Johnson syndrome 
- increases UV sensitivity of skin and eyes 
- transient myopia 
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Ocular Adverse Reactions: 
with systemic administration: 
- transient myopia resulting from ciliary body edema is most 
common ocular reaction 
-paresis of extraocular muscles 
- ocular irritation, lacrimation and photophobia 
- color defects 
with ocular administration: 
- ocular irritation 
- allergic reactions to lid and conjunctiva such as anaphylaxis, 
and Stevens-Johnson syndrome 
-follicular conjunctivitis 
Contraindications and Precautions: 
-known sensitivity to sulfonamides 
- pregnancy or breast feeding 
-because presence of pus inhibits sulfonamides, they are contraindicated 
in purulent infections 
Drug Interactions: 
-local anesthetics and PABA (para-aminobenzoic acid) decreases the 
activity of sullfonamides 
- sulfamethoxazole decreases the hepatic metabolism of anticoagulants 
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THE QUINOLONES 
cinoxacin 
M ciprofloxacin 
nalidixic acid 
M norfoxacin 
(Cipro #25) 
(Noroxin #150) 
.. M" indicates a Top 200 Drug in 1991 --note ranking after trade name · 
Indications for Use: 
- these are new drugs with broad spectrum of gram + and gram -
- primary use is for treatment of urinary tract infections 
- ciprofloxacin: also used systemically for Gl infections and 
topically for corneal ulcers and conjunctivitis 
- norfloxacin: also used topically for conjunctivitis 
Mechanism of Action: 
- inhibit DNA gyrase activity, preventing the supercoiling unique to 
bacterial DNA 
Adverse Reactions: 
- usually well tolerated 
- Gl reactions: nausea, vomiting, diarrhea, abdominal pain 
- CNS reactions: headaches, drowsiness, seizures, depression, agitation 
- hypersensitivity reactions 
- photosensitivity 
Ocular Adverse Reactions: 
with systemic administration of nalidixic acid: 
- most common ocular reaction involves a color disturbance in 
which objects appear bright and with a tinge of green, yellow, blue 
or orange 
- photophobia 
-paresis of extraocular muscles causing diplopia 
- mydriasis and cyloplegia 
- papilledema secondary to increased intracranial pressure in 
adolescents 
with ocular administration: 
-discomfort, itching and foreign body sensation 
- may form white precipitate 
- causes bitter taste following installation 
Contraindications and Precautions: 
- known allergy to drug 
- convulsive disorders 
Drug Interactions: 
- few significant drug interactions occur 
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THE TETRACYCLINES 
.1. chlortetracycline 
demeclocycline 
.1. doxycycline 
methacycline 
M minocycline 
oxytetracycline 
M tetracycline 
(Aureomycin) 
(Vibramycin) 
(Minocin #179) 
(Sumycin #156, Achromycin-V #181) 
"S' indicates major drugs -- see table 
"M" indicates a Top 200 Drug in 1991 --note ranking after trade name 
Indications for Use: 
-widespread resistance (esp. by Staph and Strep) limits their use 
-broad spectrum: gram+, gram-, anaerobes and aerobes 
-spirochetes (syphilus) when patient is allergic to penicillin 
-mycoplasmas (drug of choice forM. pneumonia) 
- ricketsiae (Rocky Mountain Spotted Fever) 
- some protozoa (not Pseudomonas Auruginosa) 
- for sebaceous gland disorders such as acne and acne rosacea 
Mechanism of Action: 
- inhibits protein synthesis by binding to the 308 subunit of ribosome 
ortetracycline - in ointment form for topical use 
- for skin infections and bacterial co ctivitis 
tetracycline - in oral, I.V., and I.M. 
-for chronic bronchitis illis 
doxycycline - oral form may be taken on an empty somach 
- a prophylaxis for traveler's diarrhea 
-for chlam a 
minocycl ne - oral form may be taken on an empty stomach 
- for acne and acne rosacea 
Adverse Reactions: 
-hepatotoxicity, nephrotoxicity, CNS toxicity 
- Gl reactions: nausea, vomiting, diarhea and superinfections 
- bone growth depression and discoloration of developing teeth 
- increases UV sensitivity of skin and eyes 
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Ocular Adverse Reactions: 
with systemic application: (reactions are rare) 
-myopia 
- papilledema secondary to pseudotumor cerbri 
- photophobia 
-diplopia and ptosis due to muscle paresis 
- chlortetracycline: causes color defects possibly due to yellowing 
of cornea 
with ocular application: (reactions are rare) 
- irritation upon installation 
- allergic reactions of lids and conjunctiva 
-overgrowth of nonsusceptible organisms 
Contraindications and Precautions: 
- pregnant women, breast feeding mothers, and children under age 8 due 
to inhibition of bone growth and tooth discoloration 
- cases of renal dysfunction 
Drug Interactions: 
-doxycycline metabolism is enhanced by alcohol, barbiturates and 
carbamazepine 
-antacids and ferrous sulfate cause decreased abs_orption of tetracycline 
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VANCOMYCIN 
vancomycin (Vancocin) 
Indications for Use: 
- for pseudomembranous colitis caused by Clostridium dificil 
- for serious Staph or Strep infections with resistance to less toxic agents 
Mechanism of Action: 
-damages bacterial cell wall by inhibiting synthesis of peptidoglycan 
Adverse Reactions: 
-ototoxicity: tinnitis (ringing of the ears) followed by deafness due to 8th 
nerve damage if drug is continued 
-nephrotoxicity: toxic to kidneys 
-hypersensitivity may occur with rapid I.V. administration 
Ocular Adverse Reactions: 
with systemic administration: (reactions are rare) 
- Allergic reactions 
- photosensitivity 
Contraindications and Precautions: 
- use of other nephrotoxic drugs 
- cases of renal dysfunction 
Drug Interactions: 
-increased nephrotoxicity when used with aminoglycosides, amphotericin 
B, cisplatin 
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L1 amphotericin B (Fungizone) 
M clotrimazole (lotrimin # 193, Gyne-Lotrimin, Mycelex) 
M clotrimazole and betamethasone (lotrisone #74) 
L1 flucytosine (Ancobon) 
griseofulvin 
M ketoconazole 
miconazole 
L1 natamycin 
L1 nystatin 
M terconazole 
(Nizoral #198) 
(Natacyn) 
(Mycostatin, Nilstat) 
{Terazol #67) 
BAM indicates a major drug-- see table 
"M M indicates a Top 200 Drug in 1991-- note ranking after trade name 
Indications for Use: 
amphotericin B: 
drug of choice for serious yeast and filamentous fungal infections 
including histoplasmosis, blastomycosis, cryptococcosis and 
coccidioidmycosis 
clotrimazole: 
popular for topical treatment of superficial, oral (with an oral troche 
which dissolves in the mouth), and vaginal dermatophyte 
and Candida infections 
flucytosine: 
used in combination with amphotericin B to reduce the dose and 
toxicity of amphotericin B or by itself for treatment of urinary tract 
Candida infections 
ketoconazole: 
effective treatment for most topical and systemic fungal infections, it 
is also active against some gram+ bacteria 
natamycin: 
only topical ophthalmic drug approved for treatment of fungal 
keratitis, conjunctivits, blepharitis and corneal ulcers 
nystatin: 
used primarily to treat local yeast infections of the skin, vagina and 
oral cavity due to Candida species 
terconazole: 
a new suppository agent used to treat vaginal Candida infections 
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Mechanism of Action: 
amphotericin B, nystatin and natamycin: 
they bind to sterols in the fungal cell membrane, producing 
channels that increase membrane permeability resulting in leakage 
of intracellular components leading to inhibition of cell growth or cell 
death 
flu cytosine: 
penetrates fungal cell where it is conveted to the metabolite, 
fluorouracil, and is incorportated into the cells' RNA, altering protein 
synthesis and causing cell death 
ketoconazole, miconazole and clotrimazole: 
interact with sterol synthesis to damaging the cell membrane and 
increase its premeability- the result is the loss of essential 
intracellular elements and inhibition of cell growth or cell death 
terconazole: 
kills fungus by disrupting fungal cell membrane permeability 
am 
clotrimazole 
clotrimazole and 
be tam ethasone 
flucytosine 
ketoconazole 
natamycin 
nystatin 
- the most tox ant c in use 
- usually reserved for life-threatening infections 
- adminsterred IV intrathecal and to ical 
- a popular topical agent for superficial, oral and 
va inal de and candida infections 
- a popular new topical combination drug, adds anti-
inflamm effect to clortimazole 
- used in combination with amphotericin B 
- administered oral 
- oral and topical drug used for systemic and topical 
infections 
-only antifungal approved for ophthalmic use 
- for treatment off al corneal ulcers 
- administerred orally and topically 
- few adverse reactions 
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Adverse Reactions: 
amphotericin B: 
- the most toxic antibiotic in use today 
- IV administration almost always causes chills, fever, nausea, 
vomiting, anorexia, muscle and joint pain, headache, abdominal 
pain, weight loss, dyspepsia (severe indigestion) and often 
normocytic anemia (reduction in ABC count without changes in 
size or functioning of ABC's). 80% develop nephrotoxicity, 25% 
develop hypokalemia (low blood potasium levels). Other reactions 
to IV administration include phlebitis (inflammation of a vein), 
thrombophlebitis (inflammation of a vein in conjunction with a 
thrombus formation), hypotension, flushing, parasthesias and 
seizures. 
- intrathecal administration may cause headaches, leg and back 
pain, paresthesias, peripheral neuropathies, sensory loss, and 
urine retention 
- topical application may result in pruritis, skin dryness, thickening 
and discoloration, erythema, and contact dermatitis 
nystatin: 
- reactions are rare and mild 
-oral use may cause diarrhea, nausea, vomiting, abdominal pain 
and hypersensitivity reactions 
- topical use may cause skin irritation and hypersensitivity reactions 
natamycin: 
- hypersensitivity 
flu cytosine: 
- affects rapidly proliferating cells causing bone marrow depression 
leading to leukopenia, thrombocytopenia, anemia, pancytopenia, 
agranulocytosis 
- may also cause nausea, vomiting, abdominal distension, diarrhea 
and anorexia 
- increases photosensitivity 
ketoconazole: 
- Gl: nause and vomiting, diarrhea, flatulence (gas), abdominal pain 
- CNS: headache, insomnia, dizziness, vivid dreams, lethargy, 
paresthesias 
- dermatological: pruritis, rash 
-endocrine effects: gynecomastia (breast enlargement), breast pain 
clotrimazole: 
-various skin irritations may occur with topical treatment: blistering, 
stinging, pruritis, erythema, urticaria, peeling 
- treatment with oral troches may cause elevated liver function test 
results, nausea and vomiting 
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terconazole: 
-headaches and genital pain 
Ocular Adverse Reactions: 
amphotericin 8: 
with systemic administration: 
- decreased vision 
- extraocular muscle paresis resulting in diplopia 
- retinal exudates 
-subconjunctival or retinal hemorrhages due to anemia 
with topical ocular administration: 
- pain and burning 
- punctate keratits 
- allergic reactions 
with ocular subconjunctival injection: 
- nodules on conjunctiva 
- permanent yellowing of conjunctiva 
-uveitis 
Contraindications and Precautions: 
amphotericin 8: 
-contraindicated in cases of known hypersensitivity unless patient 
has a life-threatening condition that can only be treated with 
amphotericin 8 
nystatin: 
- contraindicated in cases of known hypersensitivity to nystatin 
- use caution with patient with allergy to penicillin because a cross-
sensitivity exists 
natamycin: 
- contraindicated in cases of known hypersensitivity 
flu cytosine: 
- contraindicated in cases of known hypersensitivity or bone marrow 
depression 
ketoconazole: 
- contraindicated in cases of known hypersensitivity 
clotrimazole: 
- contraindicated in cases of known hypersensitivity 
terconazole: 
- contraindicated in cases of known hypersensitivity 
106 
Drug Interactions: 
amphotericin B: 
-with aminoglycosides and cyclosporin- increased nephrotoxicity 
- with corticosteroids, digitalis glycosides and extended-spectrum 
penicillins - increased hypokalemia 
-with nondepolarizing skeletal muscle relaxants and flucytosine-
amphotericin B increases the effects of these agents 
-with miconazole- amphotericin B decreases its antimycotic affects 
- with electrolyte solutions - precipitate & inactivate amphotericin B 
nystatin: 
- no significant drug interactions are known 
natamycin: 
- no significant drug interactions are known 
flucytosine: 
- antacids delay flucytosine absorption 
- amphotericin B decreases renal excretion of flucytosine, 
increasing its antimycotic activity 
- bone marrow depressants such as antineoplastics enhance bone 
marrow toxicity 
ketoconazole: 
-drugs that decrease gastric activity such as cimetidene, ranitidine, 
famotidine, antacids, and anticholinergics may decrease the 
absorption of topical ketoconazole 
clotrimazole: 
- no sigificant drug interactions occur 
terconazole: 
Other Notes: 
- suppository may interact with rubber latex products such as 
contraceptive devices 
-when using two or more topical agents concurrently on an affected area, 
apply them 1/2 to i hour apart to avoid any interactions or inactivations of 
the agents. 
- fungi should be cultured on a Saborad plate to select proper drug 
therapy 
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antimalarials 
~ chloroquine 
~ primaquine 
~ pyrimethamine · 
~quinine 
other antiprotozoals 
~pentamidine 
~ metronidazole 
iodoquinol 
emetrine 
~ quinacrine 
furazolidone 
anthelmintic agents 
~ mebendazole 
~ piperazine 
~ pyrantel 
~ thiabendazole 
~ niclosamide 
paromomycin 
~ praziquantel 
~ oxamniquine 
(Aralan) 
(Daraprim) 
(Quinamm, Strema) 
(Pentam 300) 
(Fiagyl, Metryl, Satric) 
(Moebiquin) 
(Atabrine) 
(Furoxone) 
(Vermox) 
(Antepar) 
(Antiminth) 
(Mintezol) 
(Niclocide) 
(Biltricide) 
(Vansil) 
M!!.M indicates a major drug-- see table 
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ANTIMALARIALS 
Indications for Use: 
-prevention and treatment of infections caused by the protozoa, malaria 
chloroqwne 
primaquine 
pyrimethamine 
quinine 
Mechanism of Action: 
- chloroquine disrupts the parasite's mitochondria, affecting metabolism 
- primaquine acts on the parasite's mitochondria, affecting metabolism 
-pyrimethamine inhibits folic acid synthesis 
-quinine incorporates into parasite's DNA rendering it ineffective 
Adverse Reactions: 
In normal doses, few serious reactions occur 
- Gl: anorexia, nausea, vomiting, abdominal cramps, diarrhea 
- CNS reactions: hearing disturbances, excitement, delerium, confusion 
-anemia 
-pyrimethamine can cause folic acid dieficiency 
-with quinine a mild poisoning may occur called cinchonism, caused by 
the dried bark of the cinchona tree, the source of quinine. 
Adverse Ocular Reactions: 
-chloroquine: bull's eye maculopathy, corneal changes and blurred vision 
may occur 
- primaquine: difficulty in focusing may be experienced 
Contraindications and Precautions: 
- chloroquine: known allergy, retinal disorders, hepatic disorders, 
alcoholism, concurrent use of other hepatotoxic agents, children 
-primaquine: known allergy, arthritis, lupus 
-pyrimethamine: anemia, folic acid deficiency 
- quinine: known allergy, tinnitus, optic neuritis 
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Drug Interactions: 
- chloroquine: antacids with magnesium trisillicate decrease absorption 
- primaquine: quinacrine increases toxicity of primaquine 
-pyrimethamine: folic acid inhibits action 
-quinine: interactions occur with antacids with aluminum, neuromuscular 
blocking agents, anticoagulants, cardiac glycosides 
Other Notes: 
-The sulfonamides, sulfones and tetracyclines are often used in 
conjuction with these drugs to treat malaria 
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OTHER ANTIPROTOZOALS 
Indications for Use: 
- for cases of P. carinii pneumonia, amebiasis, giardiasis, 
trichomoniasis, toxoplasmosis, African trypanosomiasis and 
leishmaniasis 
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pentamidine -for P. carinii pneumonia, African trypanosomiasis 
and leishmaniasis 
metronidazole -drug of choice for amoebic hepatic abcess, 
intestinal amebiasis and vaginal trichomoniasis 
quinacrine - drug of choice for giardiasis 
Mechanism of Action: 
-pentamidine: interferes with the metabolic systems of protozoa 
- metronidazole: disrupts protozoal DNA 
- quinacrine: binds with DNA, preventing replication and protein synthesis 
Adverse Reactions: 
Several of these drugs can produce severe and life-threatening reactions 
- all commonly cause various Gl reations 
- pentamidine: nephrotoxicity, leukopenia, anorexia 
- metronidazole: headache, anorexia, dry mouth, metalic taste 
- quinacrine: headache, discolored urine, nervousness, aplastic anemia 
Ocular Adverse Reactions 
- quinacrine: corneal deposits 
Contraindications and Precautions: 
- pentamidine: caution in cases of hypotension, hypertension, 
hypoglycemia, hyperglycemia, leukopenia, anemia, hepatic or renal 
dysfunction 
- quinacrine: caution in cases of cardiac disease, renal disease, hepatic 
disease, alcoholism, psychosis, over age 60 
Drug Interactions: 
-metronidazole: interacts with anticoagulants and disulfiram 
- pentamidine: interacts with aminoglycosides, cisplatin, amphoteracin B 
-quinacrine: increases toxicity of primaquine 
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ANTHELMINTIC AGENTS 
antinemetode agents 
A mebendazole (Vermox) 
(Vermox) 
(Antiminth) 
(Mintezol) 
A piperazine citrate 
A pyrantel pamoate 
A thiabendazole 
antisectode agents 
A n iclosam ide 
paromomycin sulfate 
A praziquantel 
(Niclocide) 
(Biltricide) 
antitrematode agents 
A oxamniquine (Vansil) 
(Biltricide) A praziquantel 
"AM indicates a major drug-- see table 
Indications for Use: 
anthelmintic agents destroy helminths- parasitic worms that infect humans 
- antinematodes are for roundworm infections (in intestines) 
- antisectodes are for tapeworm infections (in intestines) 
- antitrematodes are for fluke infections (in blood, lungs or liver) 
anti nematodes 
mebendazole -drug of choice for whipworm, pinworm, hookworm, 
and giant intestinal roundworm 
- low toxicity 
piperazine citrate - alternative to mebendazole for severe infections 
- greater toxicity than mebendazole 
pyrantel pamoate - alternative to mebendazole 
thiabendazole - drug of choice for threadworm infections 
-acts as an anti-inflammato_ry in trichinosis 
r t d an 1sec o t e agen s 
niclosamide - for all tapeworm species 
praziquantel - drug of choice for tapeworm infections 
ft t d t an 1rema o e agen s 
oxamniquine -for the blood flukeS. mansoni 
praziquantel - drug of choice for all fluke infections 
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ANTINEMATODES 
Mechanism of Action: 
- mebendazole interferes with the roundworm's microtubule system, 
blocking glucose uptake 
- piperazine paralyzes worm by blocking acetylcholine 
- pyrantel pamoate interferes with neuromuscular transmission causing 
spastic paralysis 
- thiabendazole acts on microtubules, inhibitting fumerate reductase critical 
to anaerobic metabolism 
Adverse Reactions: 
- ·GI reactions: abdominal pain, nausea, vomiting, diarrhea 
- other side effects occur, but are rare 
Contraindications and Precautions: 
- known hypersensitivity 
- piperazine is contraindicated in cases of epilepsy 
Drug Interactions: 
-none 
ANTISECTODE AGENTS 
Mechanism of Action: 
- niclosamide: inhibits tapeworm's metabolism 
- paramomycin: inhibits protein synthesis 
Adverse Reactions: 
- side effects are uncommon 
- Gl reactions: nausea, abdominal pain, cramps, vomiting, diarrhea 
Contraindications and Precautions: 
- hypersensitivity 
- paromycin contraindicated in cases of renal dysfunction because 
accumulation of drug in blood may cause ototoxicity and nephrotoxicity 
Drug Interactions: 
- no significant drug interactions exist 
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ANTITREMATODE AGENTS 
Mechanism of Action: 
- oxamniquine: induces migration of adult flukes to the liver, where they die 
- praziquantel: causes spastic paralysis and eventual disintigration of flukes 
Adverse Reactions: 
- 1/3 of patients experience drowsiness, dizziness, headache, nausea, 
diarrhea 
- oxamniquine causes orange-red discoloration of urine 
Contraindications and Precautions: 
-pregnant women (embryocidal) 
- oxamniquine may cause seizure in epileptic patients 
Drug Interactions: 
-studies suggest that concommittant administration of these two drugs 
enhances their effectiveness against S. mansoni 
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M acyclovir 
.1. vidarabine 
.1. amantadine 
.1. zidovudine (AZT) 
.1. ganciclovir 
(Zovirax #68) 
(Vira-A) 
(Symmetrel) 
(Retrovir) 
(Cytovene) 
(Viroptic) 
(Stoxil, Herplex) 
.1. trifluridine 
.1. idoxuridine (IOU) 
".1. • indicates a major drug -- see table 
"M• indicates a Top 200 Drug in 1991-- note ranking after trade name 
Indications for Use: 
- used in the treatment and prevention of viral infections 
Mechanism of Action: 
- acyclovir, vidarabine and zidovudine: inhibits virus specific DNA 
polymerase, disrupting viral replication 
- amantadine: works by inhibiting the uncoating of the virus - an early 
stage of viral replication 
- ganciclovir: (1) competitive inhibition of viral DNA polymerase and (2), 
direct incorporation into viral DNA, terminating viral DNA elongation 
- trifluridine: interferes with viral DNA synthesis in a way not yet known 
- idoxuridine: prevents incorporation of thymidine into viral DNA, 
preventing viral replication 
vidarabine 
amantadine 
zidovudine 
ganciclovir 
trifluridine 
aga st erpes stm vtrus types 
and the varicella-zoster virus 
- available in ora tal and ointment forms 
- IV orm used for erpes simplex virus 
encephalitis and varicella-zoster infections in 
immunocompromised patients 
- ophthalmic ointment for corneal involvement of 
HSV I and II 
- treatment and prevention of influenza A infections 
- also used to treat Parkinson's disease 
- available in oral form 
- used to reduce the incidence and severity 
opportunistics infections in patients with AIDS and 
AIDS-related com ex 
- used to treat cytomegalovirus MV) retinitis in 
immunocom remised atients 
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Possible Adverse Reactions: 
- minimal toxicity to host cells due to specificity for virus 
- acyclovir: renal impairment, headaches, nausea, vomiting, diarrhea, 
vertigo, hematuria (blood in the urine) and rarely; diaphoresis (profuse 
sweating), fatigue, insomnia, irritability, depression, hypotension, muscle 
cramps and leg pain 
- vidarabine: nausea, vomiting, diarrhea, anorexia, weakness, tremors 
hallucinations, malaise, confusion, and hypersensitivity reactions. 
-amantadine: (usually well tolerarated) nausea, anorexia, nervousness, 
fatigue, depression, irritability, insomnia, psychosis, anxiety, confusion, 
hallucinations, headache, dizziness, light headedness, seizures in 
patients already prone to seizures 
- zydovudine: anemia, granulocytopenia (low neutrophil count), 
headache, nausea, insomnia, myalgia (muscle pain) are the most 
common reactions 
- ganciclovir: granulocytopenia, thrombocytopenia (low platelet count), 
anemia, fever, rash and liver dysfunction are the most common reactions 
Ocular Adverse Reactions: 
-acyclovir: 
-systemic administration reactions include decreased vision, 
hallucinations, subconjunctival or retinal hemorrhages, eyelid 
erythema and urticaria 
- ocular aplication may cause irritation, SPK, allergic reactions, 
blepharitis, follicular conjunctivitis, narrowing of puncta 
- idoxuridine, trifluridine, vidarabine: 
-systemic administration reactions include visual hallucinations 
blepharospasm and subconjuctival and retinal hemmorhages due 
to drug induced anemia 
-ocular application may cause irritation, corneal reactions (SPK, 
edema, erosions, opacities, delayed wound healing), lid reactions 
(allergy, hyperemia, blepharitis, follicular conjunctivitis, edema), 
ptosis, and narrowing of the puncta 
- amantadine: transient decrease of vision, hallucinations 
Contraindications and Precautions: 
- known hypersensitivity 
- use caution in renally impaired, pregnant or lactating patients 
- amantadine: use caution in cases of advanced age,epilepsy, hepatic 
disease, renal impairment, cardiovascular disease 
- idoxuridine: use caution in pregnant or breast feeding women 
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Drug Interactions: 
- acyclovir: probenicid increases plasma concentration of acyclovir, 
nephrotoxic agents increase the chance of renal dysfunction, and 
interferon and intrathecal methotrexate increase the chance of 
neurotoxicity 
- amantadine: enhances the effects of anticholinergic agents and CNS 
stimulants. Triamterene and thiazide diuretics increase CNS toxicity of 
amantadine by slowing its renal elimination. 
- zidovudine and ganciclovir: These agents increase their nephrotoxic 
and cytotoxic effects: dapsone, pentamidine, flucytosine, vincristine, 
vinblastine, doxorubicin, interferon and amphoteracin B. The following 
agents inhibit their metabolism and increase their toxicity: probenicid, 
aspirin, acetaminophen and indomethacin. (concurrent use of gancyclovir 
and zidovudine is not well tolerated) 
- idoxuridine causes discomfort in presence of boric acid-containing 
solutions 
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alkylating agents 
~ mechlorethamine 
~ cyclosphamide 
melphalan 
~ chlorambucil 
thiotepa 
estramustine 
uracil mustard 
~ busulfan 
~ carmustine 
lomustine 
streptozocin 
~ dacarbazine 
~ cisplatine 
antimetabolite agents 
~ methotrexate 
~ fluorouracil 
fluroxidine 
~ cytarabine 
5-azacytidine 
~ mercaptopurine 
~ thioguanine 
(Mustargen) 
(Cytoxan) 
(Leukeran) 
(Myleran) 
(BiCNU) 
(OTIC-Dome) 
(Piatinol) 
(Folex, Mexate) 
(Adurucil, Efudex) 
(Cytosar-U) 
(Purinethol) 
(Tabloid) 
antineoplastic antibiotic agents 
~ bleomycin (Bienoxane) 
dactinomycin 
~ daunorubicin 
~ doxorubicin 
mitomycin 
mitoxantrone 
~ plicamycin 
(Cerubidine) 
(Adriamycin) 
(Mithracin) 
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hormonal antineoplastic agents 
estrogens 
~ diethylstilbestrol 
antiestrogen 
M tamoxifen 
androgens 
~ fluoxymesterone 
adrenocortical suppressants 
~ aminoglutethimide 
progestins 
M medroxyprogesterone acetate 
corticosteroids 
~ hydrocortisone 
M prednisone 
~ prednisolone 
M methylprednisolone 
~ dexamethasone 
other antineoplastic agents 
~ vinblastine sulfate 
~ vincristine sulfate 
~etoposide 
~ asparaginase 
~ procarbazine 
• t:..• indicates major drugs -- see table 
(Stilphostrol) 
(Nolvadex #131) 
(Halotestin) 
(Cytadren) 
(Depo-Provera #26) 
(Cortef) 
(Deltasone #138) 
(Delta-Cortef) 
(Medrol #192) 
(Decadron) 
(Velban) 
(Oncovin) 
(VePesid) 
(Eispar) 
(Matulane) 
•M• indicates a Top 200 Drug in 1991 --note ranking after trade name 
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ALKYLATING AGENTS 
Indications for Use: 
Effective against a variety of malignant neoplasms including leukemias, 
non-Hodgkin's lymphomas, multiple myeloma, melanoma, sarcoma, 
and cancers of the breast, ovaries, uterus, lung, brain, testes, bladder, 
prostate, and stomach. 
Mechanism of Action: 
It is believed that the alkylating agents enter cells and cause covalent 
bonding to occur (alkylation). Alkylation of the DNA inhibits its function 
and slows cell division. Effect is greatest in rapidly replicating cells 
including cancer cells, as well as hair follicles, bone marrow cells and 
cells lining the gastric mucosa. 
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mechlorethamine - tor Hodgkin's and non-Hodgkin's lym_Q_homas 
cyclosphamide - for Hodgkin's and non-Hodgkin's lymphomas, 
breast cancer, lung cancer, leukemia 
busulfan - primarily affects granulocytes 
-drug of choice for · chronic myelocytic leukemia 
carmustine - for primary and metastatic CNS tumors, myeloma, 
melanoma, lymphomas 
dacarbazine - for malignant melanomas, Hodgkin's disease, 
soft-tissue sarcomas 
cisplatine - an •alkylating-like• agent containing platinum 
-for cancer of testicles, lungs, ovaries, bladder, 
colon, head, neck 
- for melanomas and intraarterial sarcomas 
chlorambucil -for chronic lymphocytic leukemia, Hodgkins 
disease, and non-Hodgkins lymphomas 
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Adverse Reactions: 
nitrogen mustards (mechlorethamine and cyclosphamide): 
- bone marrow suppression leading to anemia and leukopenia 
and fatigue 
-nausea and vomiting due to CNS irritation 
- damage to rapidly proliferating cells produces stomatitis 
(inflammation of mucous membranes) and alopecia (hair loss) 
- less commonly: hemorrhagic cystitis, alterations in fertility, 
hepatotoxicity and anaphylaxis 
busulfan: 
- decrease in WBC count 
-nausea, vomiting and diarrhea 
- hyperuricemia (elevated uric acid levels in blood) 
- with long term therapy: hyperpigmentation, weight loss, 
interstitial pulmonary fibrosis 
carmustine: 
- bone marrow depression 
-severe nausea and vomiting 
- pain at infusion site 
- renal dysfunction 
-less commonly: nephrotoxicity, hepatotoxicity, blood 
toxicity, glucose intolerance 
dacarbazine: 
- leukopenia and thrombocytopenia 
- nausea and vomiting 
- pain at site of infusion 
- phototoxicity, flu-like syndrome, alopecia 
cisplatin: 
- nephrotoxicity 
- tinnitus and hearing loss 
- rarely: neurotoxicity 
Contraindications and Precautions: 
- use cisplatin with caution in cases of renal impairment, 
myelosuppression, hearing impairment 
Drug Interactions: 
cyclophosphamide: 
- allopurinol prolongs cyclophosphamide's half life causing 
greater bone marrow suppression 
-corticosteroids inhibit metabolism of cyclophosphamide. 
- phenobarbital induces enzymes of the hepatic oxidase system 
cisplatin: 
-. aminoglycosides administered concurrently can lead to 
nephrotoxicity and ototoxicity 
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ANTIMETABOLITE AGENTS 
Indications for Use: 
used in the treatment of a wide variety of neoplams 
Mechanism of Action: 
- These agents closely resemble the natural metabolites sufficiently 
enough to become involved in the processes of protein synthesis, but 
differ sufficiently to interfere with this synthesis in both normal as well as 
cancer cells. However, their effect is greatest on rapidly proliferating 
cells. The antimetabolites are classified by the metabolite they 
resemble. 
methotrexate 
fluorouracil 
cytarabine 
mercaptopurine 
thioguanine 
Adverse Reactions: 
follic acid analogues 
-for leukemia, choriocarcinoma, meningeal 
leukemia, lymphoma, sarcoma 
pynm1 1ne ana ogues "d" I 
- for solid tumors of the Gl tract and breast 
- for cancers of the colon, rectum and lungs 
- for inducing remission of leukemia 
punne ana ogues 
- for acute lymphoblastic leukemia and chronic 
granulocytic leukemia 
-for acute leukemia, acute granulocytic leukemia 
- bone marrow suppression 
-stomatitis (inflammation of mucous membranes) 
-fatigue 
- nausea and vomiting caused by some antimetabolite agents 
- mercaptopurine often causes cholestatic jaundice 
- less commonly: hepatotoxicity, nephrotoxicity, photosensitivity 
Contraindications and Precautions: 
- Flourouracil should be used with caution in cases of post surgery, poor 
nutritional state, serious infection, bone marrow depression, pelvic 
irradiation, hepatic dysfunction or renal dysfunction. 
Drug Interactions: 
methotrexate 
- oral anticoagulants are enhanced 
- phenytoin, digoxin, salicylates, and sulfonamides may increase 
the toxicity of methotrexate 
mercaptopurine 
- allopurinol may increase bone marrow suppression 
• warfarin's anticoagulant effect decreases with mercaptopurine 
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ANTINEOPLASTIC ANTIBIOTIC AGENTS 
Indications for Use: 
Act against many tumors including: Hodgkin's disease; non-Hodgkin's 
lymphomas; testicular carcinoma; squamous cell carcinoma of the head, 
neck and cervix; carcinomas of the breast, ovaries and bladder. 
Mechanism of Action: 
These agents insert themselves into the DNA chain resulting in mutant 
DNA after replication. The overall effect is cell death. They are most 
effective on rapidily proliferating cells. 
Possible Side Effects: 
- With the exception of bleomycin, they cause bone marrow suppression 
resulting in pancytopenia (a reduction of all blood cells) and leukopenia 
(decrease in WBC). 
- nausea and vomiting 
- alopecia (hair loss) 
-stomatitis (inflammation of mucous membranes) 
Contraindications and Precautions: 
- use caution in cases of hypersensitivity 
- doxorubicin: 
caution in cases of pre-existing myelosuppression or heart disease 
- plicamycin: 
caution in cases of thrombocytopenia, blood coagulation disorders, 
bone marrow suppression 
Drug Interactions: 
-concurrent administration of bleomycin and cisplatin can decrease 
creatine clearance 
-barbiturates and heparin diminish the effects of doxorubicin 
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HORMONAL ANTINEOPLASTIC AGENTS 
Indications for Use: 
used to treat hormone dependent tumors such as those of the prostate, 
breast and endometrium of the uterus 
Mechanism of Action: 
these agents exhibit a cytostatic action stopping growth of hormone 
dependent tumors through a process not entirely understood 
tamoxifen 
fluoxymesterone 
aminoglutethimide 
medroxy progesterone 
the corticosteroids --
hydrocortisone 
prednisone 
prednisolone 
methylprednisolone 
dexamethasone 
- an estrogen 
- for breast cancer in women at least 5 years 
usa I 
- an antiestrogen 
- drug of choice for advanced breast cancer 
involv est rece itive tumors 
- an androgen, a synthetic derivative of testosterone 
-for metastatic breast cancer and restate cancer 
- an adrenocortical suppressant 
- for breast and prostate cancer 
- also for Cushin s disease 
- a progestin 
- for endometrial breast and renal cancer 
- lymphocytic activity is us I in treating lymphatic 
leukemias, myeloma, and malignant lymphomas 
-used to reduce edema in metastatic cancer 
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Adverse Reactions: 
estrogens 
- nausea, abdominal cramps 
- increased urination 
-temporary feminization in males; decreased libido and breast 
tenderness in females 
antiestrogens 
- nausea, vomiting, hot flashes 
- rare ocular lesions, retinopathy, corneal opacities 
androgens 
-nausea and vomiting 
- fluid retention 
- masculinization of females (reversible if discontinued promptly) 
-jaundice 
adrenocortical suppressants 
-rash 
-fatigue, hypotension, drowsiness, dizziness 
progestins 
- one of the best tolerated antineoplastic agents 
- mild fluid retention 
- local allergic reaction to the oil carrier used for injection 
- thromboemboli can develop 
corticosteroids 
-fluid and sodium retention 
- hyperglycemia (high blood sugar) 
- epigastric distress due to increased HCI secretion and 
decreased gastric mucous secretion 
- mood swings, insomnia, nervousness 
Contraindications and Precautions: 
- all contraindicated in cases of hypersensitivity 
-estrogens 
- use with caution in cases of thromboembolic disorders 
- progestins 
- use with caution in cases of pregnancy, thromboembolic 
disorders, history of stroke, breast cancer 
Drug Interactions: 
corticosteroid action enhanced or prolonged by: 
- erythromycin, troleandomycin, estrogen 
corticosteroid action decreased by: 
- barbiturates, phenytoin, rifampin 
corticosteroids produce complications with : 
-furosemide: increased incidence of hypokalemia 
- salicylates: decreased salicylate activity, increased risk of ulcer 
- NSAIAs: increased risk of peptic ulcer 
- vaccines & toxoids: decreases patient's response to vaccines 
and toxoids; may increase replication of attenuated viruses 
-warfarin: anticoagulant effect decreased by corticosteroids 
125 
OTHER ANTINEOPLASTIC AGENTS 
Indications for Use: 
used to treat a variety of neoplasms 
Mechanism of Action: 
vin 
- vinca alkaloids: 
bind to the microtubule protein tubulin, disrupting miosis in all 
cells, but particularly detrimental to rapidly replicating cells 
including cancer cells as well as hair follicles, bone marrow, 
gastric mucosa 
- podophilotoxins: 
by mechanisms not understood, podophyllotoxins block 
replication of cells at the late S or G2 phase; etoposide and 
teniposide may cause breaks in the DNA strand and inhibit 
nucleoside transport and incorporation into nucleic acids; affect 
all cells, but particularly the most rapidly replicating cells 
- asparaginase: 
breaks down exogenous asparagine, needed by leukemia cells 
for survival; non-leukemic cells are less affected 
- procarbazines: 
produces various cell changes resulting in damaged DNA which 
disrupts miosis and protein synthesis; has greatest effect on 
rapidly proliferating cells 
-a ncaa 
- for breast carcinoma, neuroblastoma, metastatic 
testicular cancer, lymphomas, Kaposi's sarcoma, 
choriocarcinoma 
vtncristine su ate 
etoposide 
asparag nase 
procarbazine 
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Adverse Reactions: 
- vinca alkaloids: 
- bone marrow suppression leading to leukopenia 
-alopecia 
- neuromuscular abnormalities 
- stomatitis 
- podophyllotoxins: 
- bone marrow suppression leading to leukopenia 
-alopecia 
-nausea, vomiting, anorexia 
- stomatitis 
- asparaginase: 
- anaphylaxis 
- nausea and vomiting 
- fever, headache, abdominal pain 
- hepatotoxicity manifested by elevated liver enzyme levels 
- personality changes, seizures, abnormal electroencephalogram 
results (EEG's) 
- procarbazine: 
- bone marrow suppression 
- nausea and vomiting 
- flu-like syndrome (fever, chills, sweating) 
Contraindications and Precautions: 
- due to the serious nature of neoplastic disease, few circumstances 
warrant the contraindication of these drugs 
Drug Interactions: 
- procarbazine: 
- alcohol causes a •disulfiram-like., reaction: nausea, vomiting, 
headache, visual disturbances 
- CNS depressants: enhancement of CNS depressant action 
- sympathomimetics and antidepressants cause hypertension, 
tremors, excitation, tachycardia, angina 
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ANTINEOPLASTIC AGENTS: GLOSSARY 
alopecia: hair loss 
anaphylaxis: an allergic hypersensitivity reaction to a foreign protein or drug; reactions include: 
irritability, labored breathing, cyanosis (blue discoloration of skin), convulsions, unconsiousness 
and death 
aplastic anemia: anemia caused by deficient red cell production due to disorders of bone 
marrow. 50% of cases are idiopathic. Many cases are caused by exposure to chemical and 
antineoplastic agents and ionizing radiation 
cholastic jaundice: characterized by yellow bile deposits in skin, membranes and sclera due 
to excess bilirubin in the blood as a result of failure of bile to reach the duodenum 
choriocarcinoma: a rare malignant neoplasm of the uterus 
Cushing's disease: protein loss, abnormal adipose deposits, fatigue osteoporosis, etc. due 
to hypersecretion of glucocorticoids from the adrenal cortex or prolonged administration of large 
doses of adrenocortical hormones 
cystitis: inflammation of the bladder 
gray syndrome: occurs in neonates as a result of decreased ability to conjugate 
cloramphenicol and to excrete the active form in the urine. May also occur in adults receiving high 
doses of chloramphenicol ' 
Hodgkin's disease: of unknown etiolgy, it produces enlargement of lymphoid tissue, spleen, 
and liver with invasion of other tissues 
Kaposi's sarcoma: multiple neoplasias of the skin which spread to other body sites; 
associated with AIDS 
leukemia: of unknown etiology, it produces unrestrained growth of leukocytes and their 
precursors in the tissues 
leukopenia: decrease in white blood cell count below 5000 per cubic mm 
lymphoma: a general term for growth of new tissue in the lymphatic system 
metastasis: movement of a body of cells (especially cancer cells) from one part of the body to 
another 
myelocytic leukemia: overgrowth of granulocytes in the bone marrow most often caused by a 
chromosome abnormality 
myelocythemia: an excess number of myelocytes in the blood 
myeloma: a tumor originating in the bone marrow 
myelosuppression: inhibition of bone marrow function 
neuroblastoma: a malignant hemmorhagic tumor affecting neuroblastic cells that give rise to 
the sympathetic nervous system; occurs primarily in infants and children 
ototoxic: detrimental to the 8th nerve or the organs of hearing 
pseudotumor cerebri: benign intracranial hypertension 
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stomatitis: inflammation of the mucus membranes 
thrombocytopenia: a decrease in the number of blood platelets 
tinnitus: a subjective ringing sound in the ear 
tumor: a spontaneous new growth of tissue fanning an abnormal mass 
carcinoma: malignant tumor of epithelial tissues which tend to metastasize (spread 
through out the body) 
melanoma: a pigmented mole or tumor that may or may not be malignant 
sarcoma: cancer of connective tissues such as muscle, bone, bladder, kidneys, liver, 
lungs parotids, spleen 
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CORTICOSTEROIDS AS IMMUNOSUPPRESSANTS 
systemic glucocorticoids 
M beclomethasone 
betamethasone 
~ cortisone 
~ dexamethasone 
.6 dexamethasone acetate 
M hydrocortisone acetate 
M methylprednisone 
~ prednisolone 
M prednisone 
M triamcinolone 
topical glucocorticoids 
.6 fluocinolone 
.6 flurandrenolide 
.6 triamcinolone 
mi nera locorti coi ds 
.6 desoxycorticosterone 
~ fludrocortisone 
"~~~ indicates major drugs -- see table 
(Beconase AQ #95) 
(Celestone) 
(Cortone) 
(Decadron) 
(Decadron-LA) 
(Anusoi-HC #195) 
(Medrol #192) 
(Cortalone) 
(Deltasone #138) 
(Azmacort # 151) 
(Fiuonid) 
(Cordran) 
(Aristocort) 
(Doca Acetate) 
(Fiurinef) 
•M• indicates a Top 200 Drug in 1991 -- note ranking after trade name 
Background Information: 
Natural corticosteroids are are hormones produced in the adrenal cortex 
and are classified by their biological activities: 
- glucorticoids affect carbohydrate and protein synthesis 
- mineralocorticoids regulate electrolyte and water balance 
Production of the natural corticosteroids is stimulated by trauma, 
infection, heat, cold, and mental stress. Corticotropic releasing hormone 
(CRH) is released from the hypothalamus which stimulates the secretion 
of adrenocorticotropic hormone (ACTH) from the anterior pituitary gland 
which in turn triggers the release of the corticosteroids from the adrenal 
cortex. 
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Indications for Use: 
GLUCOCORTICOI OS: 
- primarily used for inflammation, immunosuppression, replacement 
therapy in patients with adrenocortical insufficiency and 
suppression of adrenocortical hyperfunction in patients with 
adrenogenital syndrome 
-their primary immunosuppressant application is treatment of 
hypersensitivity reactions by reducing inflammation. Specific 
indications are: rheumatoid arthritis, osteoarthritis, rheumatic fever, 
nephrotic syndrome, collagen diseases, asthma, chronic obstructive 
pulmonary disease, hay fever, bee stings, systemic and topical 
hypersensitivity reactions, prevention and treatment of transplant 
rejection, leukemias, lymphomas and myelomas 
Ml NERALOCORTICOIDS: 
- used in replacement therapy for patients with adrenocortical 
insufficiency and in the treatment of salt-losing congenital adrenogenital 
syndrome after the patient's electrolyte balance has been restored 
Mechanism of Action: 
GLUCOCORTICOIDS: 
- controling inflammation primarily by inhibiting the release of the 
arachadonic acid metabolites (the prostoglands and platelet activating 
factor); thereby decreasing platelet agregation, chemotaxis, 
macrophage accumulation and histamine activity. 
MINERALOCORTICOIDS: 
- act on the distal renal tubule to enhance the reabsorption of sodium and 
secretion of potassium and hydrogen -- resulting in sodium retention 
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SYSTEMIC GLUCOCORTICOIDS 
beclomethasone - used in inhalants for asthma sufferers 
- low dosage decreases risk of side effects 
cortisone - drug of choice for replacement therapy in 
adrenocortal insufficiency 
dexamethasone -for self-limiting allergic disorders and 
exacerbation of chronic allergies 
dexamethasone acetate - for chronic inflammations and cancer 
hydrocortisone - the prototype systemic glucocorticoid 
- for adrenocortal insufficinency and severe 
inflammation 
methylprednisolone - used for anti-inflammatory and 
immunosuppressive effects 
prednisolone - used for anti-inflammatory and 
immunosuppressive effects 
prednisone - oral glucocorticoid of choice for anti-inflammatory 
and immunosuppressive effects 
triamcinolone - used for anti-inflammatory and 
immunosuppressive effects 
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TOPICAL GLUCOCORTICOIDS 
fluocinolone 
flurandrenolide 
triamcinolone 
desoxycorticosterone 
fludrocortisone 
- for acute and chronic inflammatory dermatoses, 
psoriasis, atopic ezema, pruritis ani, 
neurodermatitis, exfoliative dermatitis, seborrheic 
dermatitis, contact dermatitis 
MINERALOCORTICOIDS 
- the most potent mineralocorticoid 
- to treat salt-losing adrenogenital syndrome 
- given with cortisone to treat salt losing 
adrenogenital syndrome 
Relative Potencies of Glucocorticoids: 
The table below groups the glucocorticoids by their length of action and 
compares their anti-inflammatory potencies relative to hydrocortisone. 
Adverse Reactions: 
SYSTEMIC GLUCOCORTICOIDS: 
4 
4 
5 
5 
5-30 
25 
- adrenocortical insufficency (decreased production of corticosteroids in 
the adrenal cortex, temporary or permanent) may occur in response to 
the introduction of exogenous steroids-- this affect is minimized by 
tapering dosages when ending therapy 
- severe muscle weakness 
- immunosuppression predisposes patients to infection 
- Cushing's syndrome (abnormal fat distibution -- depleting fat from 
extremities and depositing it in face, abdomen and between shoulder 
blades) 
- Gl reactions: abdominal distension, pancreatitis, ulcerative esophagitis 
gastric irritation, increased appetite, peptic ulcers 
- skin atrophy and thinning, acne, excessive diaphoresis, facial eythema, 
etechiae, ecchymosis (easy bruising). 
- CNS reactions: insomnia, headache, restlessness, seizures, severe 
mood swings 
- may slow the growth of young children by interfering with DNA 
synthesis and cell division 
- others: electrolyte imbalances, increased red blood cell and 
hemoglobin levels, increased risk of emboli formation 
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TOPICAL GLUCOCORTICOIDS: 
- local effects include: skin atrophy, muscle and fat wasting, rosacea 
eruptions 
- absorbtion of topical glucocorticoids through the skin can cause the 
same adverse reactions as systemic glucocorticoids 
MINERALOCORTICOIDS: 
- fluid and electrolyte imbalances and these associated symptoms: 
edema, hypertension, congestive heart failure (CHF), hypernatremia, 
hypokalemia, hypocalcemia. 
Ocular Adverse Reactions: 
SYSTEMIC AND TOPICAL GLUCOCORTICOIDS: 
- posterior subcapsular cataracts 
- increased intraocular pressure 
- exophthalmos 
- secondary ocular infections due to immunosuppression 
Contraindications and Precautions: 
SYSTEMIC GLUCOCORTICOIDS: 
- contraindicated in pregnant or breast feeding women 
- cases of Cushing's syndrome, tuberculosis, severe infections, 
psychosis 
- use caution in patients with diabetes melitus, hypothyroidism, 
congestive heart failure, cardiac disease, hypertension, hepatic 
dysfunction, renal dysfunction, glaucoma, thromboembolic disorders, 
seizures 
TOPICAL GLUCOCORTICOIDS: 
- contraindicated in cases of skin infections 
- use cautiously in ophthalmic applications in cases of glaucoma 
MINERALOCORTICOIDS: 
- contraindicated in cases of hypertension, congestive heart failure 
(CHF), or cardiac disease. 
- use cautiously in pregnant women, diabetics, and cases of Addison's 
disease 
- use fludrocortisone cautiously in patients with Gl ulceration, renal 
disease, hypertension, osteoporosis, varicella, vaccinia, exanthema, 
cushingoid symptoms, thromboembolic disorders 
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Drug Interactions: 
SYSTEMIC GLUCOCORTICOIDS AND MINERALOCORTICOIDS: 
- steroid action increased by: erythromycin, troleandomycin, estrogen 
- steroid action decreased by: barbiturates, phenytoin, rifampin 
- complications with: furosemide (hypokalemia), salicylates & 
NSAIAs(peptic ulcers), vaccines (decrease immune response), warfarin 
(steroids decrease its anticoagulant effect) 
TOPICAL GLUCOCORTICOIDS: 
- ethylenediamine, a stabilizing agent in some topical glucocorticoid 
agents interacts with systemic aminophylline, antazoline, antazoline 
hyrochloride ophthalmic solution, and edatate disodium, a preservative 
common in ophthalmic solutions -- these interactions can cause allergic 
contact dermatitis, urticaria, and systemic eczematous contact-type 
dermatitis 
- parabens, another additive in glucocorticoid preparations can interact 
with other paraben-containing formulations such as toothpaste, 
cosmetics, and soaps, resulting in allergic contact dermatitis and 
urticaria 
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OTHER IMMUNOSUPPRESSANTS 
A ATG (antithymocyte globulin) 
A azothiprine 
A cyclosporine 
lymphocyte immune globulin 
A muromonab-CD3 
"A" indicates major drugs -- see table 
Indications for Use: 
(Atgam) 
(lmuran) 
(Sandimmune) 
(Orthoclone OKT3) 
used with corticosteroids for patients undergoing allograft transplantation 
(such as kidney, bone marrow, heart, or skin allografts) to prevent or treat 
tissue rejection 
Mechanism of Action: 
- ATG: believed to eliminate T-cells in peripheral blood or alter T-cell 
function. 
- azathioprine: suppresses cell-mediated hypersensitivities, alters 
antibody production 
- muromonab-CD3: inhibits T-cell function 
- cyclosporine: inhibits helper T cells and suppressor T cells 
-prevent or 
allograft rejections 
-also for treatment of a lastic anemia 
azathioprine - for prevention of kidney transplant rejection 
- for severe rheumatoid arthritis unresponsive to 
less toxic thera 
cyclosporin 
Adverse Reactions: 
secondary infections are a common side effect of these drugs, as well as: 
ATG: 
- fever, chills 
- leukopenia, thrombocytopenia 
- nausea, vomiting, diarrhea 
- rash, urticaria, erythema 
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azathioprine: 
severe bone marrow depression leading to leukopenia, 
thrombo-cytopenia, hemorrhaging, anemia, nausea, vomiting, 
anorexia, diarrhea 
cyclosporin: 
-nephrotoxicity, hyperkalemia, hyperuricemia, 
- hypertension, tremors, 
- diarrhea, nausea, vomiting, 
- muromonab-CD3: 
-fever, chills, dyspnea, chest pain 
-vomiting, nausea 
Ocular Adverse Reactions: 
- azathioprine: retinopathy 
- cyclosporin: rarely conjuctivitis 
Contraindicatlons and Precautions: 
- hypersensitivity to the drug 
- contraindicated in pregnant patients 
- rheumatoid arthritis patients who have previously been treated with 
alkylating agents have a prohibitive risk of neoplasia if treated with 
azathioprine 
Drug Interactions: 
- ATG, cyclosporin and muromonab-CD3 
-other immunosuppressives increase risk of infection, lymphoma 
- azothioprime 
- allopurinol decreases the hepatic metabolism of azathioprine 
- depolarizing muscle relaxants are inhibited by azathioprine 
- cyclosporin 
-acyclovir, aminoglycosides, amphotericin 8 increase the 
potential for nephrotoxicity 
- ketoconazole and cimetidine increases blood cyclosporin levels 
- rifampin, phenytoin, sulfamethazine, trimethoprim decrease 
plasma cyclosporin levels 
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ACTIVE IMMUNITY AGENTS 
.1 diptheria and tetanus toxoids and pertussis vaccine [DTP] (Tri-lmmunol) 
tetanus and diptheria, adsorbed [Td] 
tetanus toxoid 
L1 measles, mumps, and rubella virus vaccine live [MMR] (M-M-R II) 
L1 poliovirus vaccine, live, oral, trivalent [OPV] (Orimune) 
rabies vaccine, human diploid cell [HDCV] (lmovax) 
L1 influenza virus vaccine, trivalent types A and 8, split virus (Fiuogen) 
L1 influenza virus vaccine, trivalent types A and 8, whole virus (Fiuzone) 
L1 hepatitis B vaccine (Heptavax-B) 
Haemophilus influenza b polysaccharide vacine [HIB] (Hiblmmune) 
L1 pneumococcal vaccine, polyvalent (Pneumovax-23) 
• ,:1• indicates major drugs -- see table 
Indications for Use: 
to prevent or eradicate commonly occurring communicable diseases. 
Mechanism of Action: 
Vaccines and toxoids initiate the formation of specific antibodies by 
stimulating the body's antigen-antibody mechanism. This action 
provides active, aquired immunity for the individual. Bacterial vaccines 
are prepared from whole bacteria or from purified capsular polysac-
charides. Viral vaccines are prepared from nonliving or living viruses. 
a an tetanus 
toxoids and pertussis 
vaccine 
tetanus diphtheria 
adsorbed [Td] 
pneumococcal vaccine, 
polyvalent 
to a, tetanus 
aged 2 months to 7 
- to provide immunity in high risk groups 
veterinarian and also used to treat afte 
- prevents uenza infection 
- the split virus form causes fewer adverse reactions 
than the whole virus 
- a polysaccharide vaccine used to prevent 
pneumococcal diseases. 
- especially useful for the elderly and those with 
cardiac, ulmona , he tic and renal disease 
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Adverse Reactions: 
all immunizations can cause mild symptoms of the disease they prevent 
- DTP: fever in 50% of children within 48 hours. Local reactions include 
erythema, induration, tenderness. Also, mild anorexia, fretfullness and 
drowsiness may occur. 
- MMR: rash, lymphadenopathy, fever within 6-11 days. arthralgia, 
arthritis and painful! parasthesias may occur 2-8 wks after shot. 
- OPV produces no predicatable reactions 
- HDCV: pain, swelling, erythema, itching at injection site. Also 
headaches, nausea, dizziness, muscle aches and abdominal pain. 
- influenza virus vaccines: fever, malaise, malgia 
- hepatitis 8 vaccine: discomfort at injection site, local inflammation, fever 
transient malaise, headache, dizziness, nausea, vomiting 
- Hib: ·erythema, swelling tenderness at injection site, and fever irritability 
and anorexia may occur 
- pneumococcal vaccine: soreness at injection site, fever, mild myalgia 
Ocular Adverse Reactions: 
- MMR: subacute sclerosing panencephalitis and blindness associated 
with optic neuritis 
Contraindications and Precautions: 
- children with neurologic disorders (except hydrocephalus or cerebral 
palsy) should not be immunized as it may aggravate the disorder 
- avoid live-virus vaccines in immunosuppressed patients 
Drug Interactions: 
- DTP: antimetabolites, alkylating agents, cytotoxic drugs and 
corticosteroids decrease the immune response. 
- MMR: other live-virus vaccines may impair its immune response 
- OPV: plasma, whole blood, immune serum globulin and other live-virus 
vaccines may impair the immune response 
- HDCV: steroids may activate the injected rabies virus 
- Hib: chemotherapeutic agents may impair the antibody response 
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PASSIVE IMMUNITY AGENTS 
~ immune globulin [IG] (Gamastam) 
~ hepatitis B immune globulin [HBIG] (H-BIG) 
~ rabies immune globulin [RIG] (Hyperab) 
~ Rho(D) immune globulin, human (Gamulin Rh) 
~ tetanus immune globulin [TJG] (Hyper-Tet) 
~ varicella-zoster immune globulin [VZIG] 
• ~ • indicates major drugs -- see table 
passive immunity agents contain preformed antibodies obtained from humans 
or animals that have had a disease or were injected with live organisms or their 
toxins 
Indications for Use: 
-temporary protection from a disease for nonimmunized individuals 
when time does not allow for the production of immunity by the active 
processes 
- when a disease is present to either alleviate the disease or prevent it 
from becoming worse 
- to prevent the formation of active antibodies, as in Rh 0-negative mothers 
who deliver Rh 0-positive infants 
Mechanism of Action: 
- provides passive immunity by increasing the antibody concentration 
hepatitis B immune 
globulin [HBIG] 
rabies immune globulin 
Rho(D) immune globulin, 
human 
tetanus immune globulin 
[TIG] 
mmune 
r pa ents with immunodefic 
immunoglobin deficiency 
- also for ients with titis A 
-for post exposure prophylaxis against hepatitis B 
- for adults and newborns whose mothers are 
titis B surface an en itive 
- for patients exposed to rabies 
- a iven with the rabies vaccine 
- to suppress the active antibody response and 
formation of ant- Rh 0(D) in Rh0(0)-negative 
individuals to itive blood 
-for nonimmunized patients with susceptible 
wounds 
-for post tetanus exposure prophylaxus and to treat 
tetanus 
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Adverse Reactions: 
IG: pain at injection site, malaise, fever, chills, headache, nausea, 
vomiting, chest tightness, faintness, dyspnea, chest or back pain 
HBIG: tenderness at injection site, urticaria, angioedema 
Rho(D) immune globulin, RIG and TIG: pain at injection site, mild fever 
TIG: IV administration may cause rapid fall in blood pressure and 
anaphylaxis 
VZIG: mild rash and mild fever 
Ocular Adverse Reactions: 
- ocular reaction are rare 
Contraindications and Precautions: 
- use IG cautiously in pregnant women 
- use these agents cautiously in patients with known hypersensitivity to 
imm unoglobins 
- use RIG and TIG cautiously in patients with sensitivity to thimerosal 
- Rho(D) contraindicated in Rh 0-positive patients and those previously 
immunized against Rh 0 (0) blood factor 
Drug Interactions: 
no known drug interactions 
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